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About this document 
This document was prepared on behalf of the Secretariat to the Health Evidence Expert 
Group by the Centre for Public Health, Liverpool John Moore University. The Health 
Evidence Expert Group was established by the UK Chief Medical Officers to review the 
evidence on the health impacts from alcohol.  
The purpose of this document is to provide a map of the systematic review level evidence 
and to describe the type and quantity of published material on the health impacts from 
alcohol. 
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1 Methods 
1.1 Search strategy 
A database of systematic reviews and meta-analyses was compiled from systematic 
searches of electronic sources (Medline, EMBASE and PsycINFO; see Appendix 1 for a 
sample search strategy), and selected, published reviews (Rehm et al., 2010) and recent 
reports on the development of alcohol guidelines in Canada (Butt et al., 2010) and Australia 
(National Health and Medical Research Council, 2009).  
1.2 Inclusion and exclusion criteria 
Systematic reviews and meta-analyses published since 1995 that synthesized data from 
studies on health and social impacts of alcohol exposure (any measure) were eligible for 
inclusion. One reviewer independently screened all titles and abstracts to identify any 
potentially relevant articles. Full titles of any titles/abstracts that were considered relevant 
were obtained for further screening and the relevance of each article reassessed against 
criteria to determine if the review was relevant to the research questions. These criteria were 
adapted from Methods for the development of NICE public health guidance [third edition] 
and were as follows: 
1. Does the review address an appropriate and clearly-focused question that is 
relevant to one or more of the key review questions? 
Reviews that provided a clear description of the population(s) considered, comparators, 
and how the outcomes evaluated were selected for inclusion. Outcomes considered 
needed to be clearly described within the methodology, include a precise definition and 
how validated. 
2. Does the review include the types of studies relevant to the key review questions? 
Only reviews that reported the types of studies sought (including any inclusion/exclusion 
criteria) were included. The inclusion of cohort and/or case-control studies was 
considered as the minimum design requirement for inclusion. 
3. Is the literature search sufficiently rigorous to identify all the relevant studies? 
To be eligible, the methods used to locate studies needed to be clearly reported. As a 
minimum, reviews were required to have conducted searches of at least two databases 
and searched the reference lists of retrieved studies for further references. 
4. Is the study quality of included studies appropriately assessed and reported? 
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Review needed to have used appropriate and clear criteria to assess the quality of the 
individual studies before deciding whether to include or exclude them. Reviews that did 
not include such an assessment were excluded. 
 
5. Is an adequate description of the analytical methodology used included, and are the 
methods used appropriate to the question? 
The approach and meta-analytic techniques used to analyse the data needed to be 
clearly described and justified where appropriate. Approaches to dealing with 
heterogeneity including the specification of any subgroup analyses and sensitivity 
analyses needed to be reported for studies described as meta-analyses. 
The criteria were used to identify systematic reviews and meta-analyses incorporating 
systematic methods of study retrieval and inclusion. 
1.3 Data extraction 
Data relating to the individual studies was extracted by one reviewer into a pre-designed 
form and then tabulated. Data extraction and tabulation included the following information 
(where available): author(s), year, aims; review search parameters; inclusion and exclusion 
criteria (including study design, date range and country); type of alcohol exposure (including 
whether specific beverage types were considered; dose and patterns of alcohol 
consumption); outcomes and methods of analysis (mortality and/or morbidity; threshold 
effects; sick quitter effect considered where appropriate); results (whether quantitative effect 
sizes calculated and confidence intervals). 
1.4 Quality assessment 
Quality assessment was undertaken using the AMSTAR measurement tool (see Appendix 2 
for AMSTAR criteria). The tool consists of 11 items and has good face and content validity 
for measuring the methodological quality of systematic reviews. To derive a summary quality 
score for each study based on the AMSTAR tool, a score of 1 was awarded for each of the 
criteria marked with a ‘yes’ on the tool (or 0.5 for partially meeting the criteria). These scores 
were summed across the criteria to provide a score for each study out of a maximum 
possible score of 11. 
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2 Results of the mapping  
2.1 Summary of study identification 
A total of 2,068 references were identified through searches, of which 147 were identified as 
potentially relevant. Fifteen additional references were identified through reference screening.  
Forty three references were excluded prior to full screening as they were not systematic 
reviews or meta-analyses (n=24); the population focus was not applicable to the UK (n=15); 
the topic was not applicable (n=4); they were foreign language articles (n=3) or a full text 
copy was not available (n=1). A further 16 articles were not screened against the full criteria 
as they were meta-analyses based on pooled analysis of data (n=10) or used a Mendelian 
randomisation approach (n=3). 
A total of 103 articles were screened against the full criteria. The identified systematic 
reviews and meta-analyses examined the relationship between alcohol consumption and risk 
across the following diseases and health problems: 
 Infectious and parasitic diseases (n=5) 
 Neoplasms (n=37) 
 Endocrine, nutritional and metabolic diseases (n=4) 
 Mental and behavioural disorders (n=4) 
 Diseases of the nervous system (n=1) 
 Diseases of the eye (n=1) 
 Diseases of the circulatory system (n=21) 
 Diseases of the respiratory system (n=1) 
 Diseases of the digestive system (n=3) 
 Diseases of the skin and subcutaneous tissue (n=1) 
 Diseases of the musculoskeletal system (n=2) 
 Diseases of the genitourinary system (n=1) 
 Pregnancy and conditions originating in the perinatal period (n=9) 
 External causes of morbidity and mortality (n=6) 
A further seven articles examined: all-cause mortality (n=2); multiple conditions (n=2); the 
adult consequences of alcohol consumption in adolescence (n=1); effects of alcohol use in 
older people (n=1); and the derivation of tolerable upper alcohol intake levels (n=1). 
2.2 Outcomes of inclusion criteria screening 
The outcomes of the inclusion criteria screening are presented in full in Table 11 in Appendix 
4. Nineteen studies met all five criteria and a further 35 studies met four of the five criteria. 
Of the studies meeting four criteria: (i) 27 did not formally assess the quality of the included 
studies; (ii) four had not conducted a sufficiently rigorous literature search; (iii) three did not 
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provide an adequate description of the analytical methods used; and (iv) one included types 
of study designs not relevant to the review question (i.e. cross-sectional studies). Thirty eight 
studies met three criteria, with the majority of these studies (n=31) lacking a sufficiently 
rigorous search and formal quality assessment of the included studies. Due to the relatively 
low number of articles meeting all five inclusion criteria, the 92 articles which met three or 
more of the criteria were therefore considered for inclusion. The remaining 11 articles, which 
met two or fewer of the criteria, were poor quality or had not used relevant methodology (i.e. 
one article was a review of reviews) and were excluded from the review.  
The 92 articles were organised according the broad disease/health problem area examined 
and then by the specific condition examined. For specific conditions where only one 
systematic review or meta-analysis was identified, the article was included. Where more 
than one systematic or meta-analyses examined a specific condition, the article meeting the 
highest number of criteria was included, or where it was not possible to select on the number 
of criteria, the most recently published article was selected. For a few conditions, it was not 
possible to select on the number of criteria or year (i.e. bladder cancer, renal cell cancer and 
atrial fibrillation) and two articles were included per condition in these cases. In total, 51 
articles were selected for data extraction and quality assessment. 
2.3 Outcomes of data extraction 
A summary of the methods of the included systematic reviews and meta-analyses are 
presented in Table 12 in Appendix 5. 
2.4 Outcomes of quality assessment 
Scores on the AMSTAR tool ranged from 2 to 7.5; however the majority of reviews received 
a score of 5 or less (n=38; Figure 1). A summary of the AMSTAR tool measurement results 
for each study is presented in Table 15 in Appendix 5.  
 
Figure 1. Summary of scores on the AMSTAR tool 
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None of the included systematic reviews and meta-analyses reported that an ‘a priori’ design 
had been used in the conduct of the review or meta-analysis. For 25 studies it was not 
possible to tell from the publication whether duplicate study selection and/or data extraction 
had been undertaken; for 5 studies it was clear that it had not been undertaken. In 11 
reviews it was reported that duplicate study selection and data extraction had been 
undertaken. In a further 10 reviews either duplicate study selection or data extraction was 
reported to have been undertaken. The majority of reviews were based on a comprehensive 
literature search; 18 reviews were based on inadequate searches and two reviews were 
based on searches of at least two electronic sources but were not supplemented by other 
strategies. Authors of only a very small number of reviews reported that they searched for 
reports regardless of their publication type; the vast majority of reviews were limited to 
inclusion of English language and/or peer-reviewed publications. A list of studies included 
and excluded from the review were not commonly included in the publications. Whilst the 
majority of articles provided a flowchart for the inclusion and exclusion process, full 
reference details were generally not provided in the articles or in supplementary material. 
The characteristics of the included studies were provided in an aggregated form in most of 
the reviews; however a summary of data from the original studies was missing in seven 
reviews. The scientific quality of the included studies was assessed in 14 reviews and of 
these, only nine were judged to have used the scientific quality of the included studies 
appropriately in formulating conclusions. The methods used to combine the findings of 
studies were judged to be appropriate in all of the included studies. Four reviews did not 
undertake a meta-analysis and were based on a narrative synthesis. For the 47 systematic 
reviews that included a meta-analysis, all reported that heterogeneity tests were used to 
assess whether studies were combinable and the likelihood of publication bias was 
assessed in the majority of reviews. 
Table 1. Summary of outcomes on the AMSTAR tool criteria 
 Criteria met? 
AMSTAR measurement tool criteria 
1 2 3 4 5 6 7 8 9 10 11 
Yes 0 11 31 3 4 44 13 9 50 25 34 
Partially 0 10 2 0 6 0 1 0 0 13 0 
No 0 5 18 33 40 7 37 4 0 9 17 
Can't answer 51 25 0 15 1 0 0 1 1 0 0 
Not applicable 0 0 0 0 0 0 0 37 0 4 0 
2.5 Assessment of publication bias 
Thirty-eight reviews reported assessment of publication bias across 13 major disease areas. 
The vast majority reported that there was no evidence of publication bias either on visual 
inspection of funnel plots and/or based on the Begg-Mazumdar and Egger tests. Eight 
reviews reported some evidence of publication bias; three (Costanzo et al., 2011; Kodama et 
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al., 2011; Roerecke & Rehm, 2012) related to diseases of the circulatory system, two (Taylor 
& Rehm, 2012; Zeisser et al., 2013) to external causes of morbidity and mortality, and one 
each to disease of the eye (Chong et al., 2008), infectious and parasitic diseases (Lönnroth 
et al., 2008) and neoplasms (Islami et al., 2011). For two reviews of diseases of the 
circulatory system (Costanzo et al., 2011; Roerecke & Rehm, 2012), omitting studies from 
the analyses did not have a substantial influence on pooled effect estimates, and in the third 
review (Kodama et al., 2011) while use of the “trim and fill” procedure attenuated the pooled 
estimate for heavy alcohol consumption and atrial fibrillation it remained statistically 
significant. Two reviews, one of fatal motor vehicle injury (Taylor & Rehm, 2012) and one of 
age-related macular degeneration (Chong et al., 2008) attributed the presence of publication 
bias to a scarcity of studies reporting small or null effects. Both studies included a low 
number of studies and use of the tests proposed by Egger and by Begg and Mazumdar are 
not recommended with fewer than 10 studies (Higgins & Green, 2011). In their review of 
injury, Zeisser et al. (2013) attributed the presence of publication bias to one study with a 
large effect size and large standard error; following exclusion of this study the funnel plot no 
longer showed asymmetry. Two further reviews (Lönnroth et al., 2008; Islami et al., 2011) 
found evidence of publication bias for studies of heavy alcohol consumption. Both reviews 
eliminated the studies contributing to publication bias, finding that the subsequent analyses 
remained quantitatively similar to the main analyses conducted. In their review of 
oesophageal squamous cell carcinoma, Islami et al. (2011) noted that their findings indicated 
that ‘small study effects’ mainly originated from case-control rather than prospective studies.  
2.6 Summary of risk estimates information 
Tables summarising risk estimates of the relationship between alcohol consumption and the 
various diseases and health problems examined are presented in Section 3. 
 Mapping systematic review level evidence           10 
 
3 Summary of risk estimates 
3.1 Summary of data from systematic reviews and meta-analyses 
 
Table 2. Summary of risk estimates: All-cause mortality 
Study details 
N
 
s
t
u
d
i
e
s
 Study 
design 
Years Countriesa N cases 
Reference 
category 
Pooled risk estimates 
Co Ca Group N Maximum 
protection, % (99% 
CI) 
Heterogeneity Dose-response 
analysis 
Subgroup analyses 
Di 
Castelnuovo 
et al., 2006 
34 - - NR Jpn, UK, Dnk, 
Pol, Ger, Rus, 
USA, Swe, 
Scotland, Fra, 
Chn, Aus, Ita 
94,533 Non-
drinkers 
(excluding 
former 
drinkers in 
30 curves) 
All studies  19% (17%–20%)   Protection was 
significantly lower in 
studies that used the 
category of no 
alcohol intake and 
excluded light and/or 
former drinkers from 
the reference group. 
With light and/or 
former drinkers: 23% 
(20%–26%) 
Without light and/or 
former drinkers: 16% 
(14%–18%) 
Adjusted (age)  17% (15%–18%)  
Adjusted (age, SES)  18% (15%–21%)  
Adjusted (age, SES, 
dietary factors) 
 18% (12%–24%)  
Males  17% (15%–19%)  
Females  18% (13%–22%)  
Key 
Co = cohort studies; Ca = case-control studies; sig = significantly; g/d = grams per day; NA = not applicable; NR = not reported 
aArg = Argentina; Aus = Australia; Bel = Belgium; Bgr = Bulgaria; Bls = Belarus; Bra = Brazil; Can = Canada; Chl = Chile; Chn = China; Cri = Costa Rice; Cub = Cuba; Cze = Czech Republic; Dnk = Denmark; Egy = 
Egypt; Est = Estonia; Eur = Europe (individual countries not specified); Fin = Finland; Fra = France; Ger = Germany; Gmb = Gambia; Gnb = Guinea Bissau; Grc = Greece; Hkg =Hong Kong; Ice = Iceland; Ind = India; 
Int = International (individual countries not specified); Irn = Iran; Ire = Ireland; Isr = Israel; Ita = Italy; Jam = Jamaica; Jpn = Japan; Kor = Korea; Lva = Latvia; Mex = Mexico; Moz = Mozambique; Mwi = Malawi; Mys = 
Malaysia; Nzl = New Zealand; Nga = Nigeria; Nor = Norway; Pol = Poland; Pri = Puerto Rico; Rou = Romania; Rus = Russia; SAm = South America (individual countries not specified); Srb/Mne = Serbia and 
Montenegro; Sgp = Singapore; Spa = Spain; Sud = Sudan; Svn = Slovenia; Swe = Sweden; Swi = Switzerland; Tai = Taiwan; Tha = Thailand; Nld = The Netherlands; Tur = Turkey; Tza = Tanzania; Uga = Uganda; UK 
= United Kingdom; Uru = Uruguay; USA = United States of America; Vie = Vietnam; Yug = Yugoslavia; Zaf = South Africa.  
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Table 3. Summary of risk estimates: Overview of conditions 
Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa 
Reference 
category 
N cases 
Pooled risk estimates 
Co Ca Group N Effect estimate (95% CI) 
25 g/d 50 g/d 100 g/d 
Bagnardi et 
al., 2001 
 
Cancers 
229 46 183 NR NR Non-
drinkers 
7,954 Oral cavity 26 1.73 (1.67–1.78) 2.77 (2.67–2.95) 5.75 (5.22–6.34) 
7,239 Oesophagus  28 1.51 (1.48–1.55) 2.21 (2.11–2.31) 4.23 (3.91–4.59) 
4,518 Stomach 16 1.07 (1.04–1.10) 1.15 (1.09–1.22) 1.32 (1.18–1.49) 
415 Small intestine 2 - - - 
5,948 Colon 17 1.14 (1.07–1.21) 1.21 (1.11–1.32) 1.32 (1.16–1.49) 
3,872 Rectum 16 1.11 (1.03–1.20) 1.17 (1.06–1.30) 1.32 (1.16–1.51) 
1,961 Liver 19 1.20 (1.13–1.27) 1.41 (1.26–1.56) 1.83 (1.53–2.19) 
81 Gallbladder 2 - - - 
2,524 Pancreas 17 0.98 (0.90–1.05) 1.05 (0.93–1.18) 1.18 (0.94–1.49) 
3,759 Larynx 20 1.35 (1.31–1.40) 1.83 (1.72–1.95) 3.24 (2.89–3.65) 
2,314 Lung 6 1.02 (1.00–1.04) 1.04 (1.00–1.08) 1.08 (1.00–1.18) 
708 Melanoma 2 - - - 
44,033 Breast female 49 1.31 (1.27–1.36) 1.67 (1.56–1.78) 2.71 (2.33–3.08) 
242 Cervix 1 - - - 
2,473 Endometrium 6 1.05 (0.88–1.24) 1.09 (0.78–1.54) 1.20 (0.60–2.37) 
1,651 Ovary 5 1.11 (1.00–1.24) 1.23 (1.01–1.54) 1.53 (1.03–2.32) 
4,094 Prostate 11 1.05 (1.00–1.08) 1.09 (1.02–1.17) 1.19 (1.03–1.37) 
5,997 Bladder 11 1.04 (0.99–1.09) 1.08 (0.98–1.89) 1.17 (0.97–1.41) 
921 Kidney 2 - - - 
14,495 All sites combined 8 1.01 (0.90–1.05) 1.22 (1.11–1.27) 1.91 (1.77–2.06) 
Corrao et al., 
2004 
 
15 conditions 
156 57 99 NR NR Non-
drinkers 
4,507 Oral cavity and pharynx neoplasms 15 1.86 (1.76 –1.96)  3.11 (2.85– 3.39)  6.45 (5.76 –7.24)  
3,233 Oesophagus neoplasms 14 1.39 (1.36 –1.42)  1.93 (1.85– 2.00)  3.59 (3.34 –3.87)  
3,789 Larynx neoplasms 20 1.39 (1.36 –1.42)  1.93 (1.85– 2.00)  3.59 (3.34 –3.87) 
5,360 Colon neoplasms 16 1.05 (1.01 –1.09)  1.10 (1.03– 1.18)  1.21 (1.05 –1.39) 
1,420 Rectum neoplasms 6 1.09 (1.08 –1.12)  1.19 (1.14– 1.24)  1.42 (1.30 –1.55) 
1,321 Liver neoplasms 10 1.19 (1.12 –1.27)  1.40 (1.25– 1.56)  1.81 (1.50 –2.19) 
32,175 Breast neoplasms 29 1.25 (1.20 –1.29)  1.55 (1.44– 1.67)  2.41 (2.07 –2.80) 
5,801 Essential hypertension 2 1.43 (1.33 –1.53)  2.04 (1.77– 2.35)  4.15 (3.13 –5.52) 
49,640 Coronary heart disease 28 0.81 (0.79 –0.83)  0.87 (0.84– 0.90)  1.13 (1.06 –1.21) 
893 Ischaemic stroke 6 0.90 (0.75 –1.07)  1.17 (0.97– 1.44)  4.37 (2.28 –8.37) 
1,192 Haemorrhagic stroke 9 1.19 (0.97 –1.49)  1.82 (1.46– 2.28)  4.70 (3.35 –6.59) 
425 Gastroduodenal ulcer 2 0.98 (0.77 –1.25)  0.97 (0.59– 1.57)  0.93 (0.35 –2.45) 
2,202 Liver cirrhosis  9 2.90 (2.71 –3.09)  7.13 (6.35– 8.00)  26.52 (22.26– 31.59) 
247 Chronic pancreatitis 2 1.34 (1.16 –1.54)  1.78 (1.34– 2.36)  3.19 (1.82 –5.59) 
4,501 Injuries and violence 12 1.12 (1.06 –1.18)  1.26 (1.13– 1.40)  1.58 (1.27 –1.95) 
Key 
Co = cohort studies; Ca = case-control studies; sig = significantly; g/d = grams per day; NA = not applicable; NR = not reported 
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Table 4. Summary of risk estimates: Individual diseases/health problems  
NB: The following table is presented in order of ICD 10 code 
Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases Reference category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Lönnroth et al., 
2008 
 
Tuberculosis 
21 3 18 1961-
2007 
Fin, Can, Ind, 
Aus, UK, USA, 
Chn, Est, Mwi, 
Gnb, Gmb, Lva, 
Rus. 
4,762 No 
exposure 
to alcohol 
<40 g/day 4 1.08 (0.82–1.40) 0.82% (<0.01)  NA No sig. differences 
across strata explored. >40 g/day 11 3.50 (2.01–5.93)  
>40 g/day (adjustedb) 6 2.76 (2.09–3.64)  
Balinuas et al., 
2010a 
 
HIV 
10 8 2 1996-
2007 
USA, Aus, Uga, 
Tza, Tha, Jam, 
Nld 
Not 
clear 
Non-
drinkers - 
lifetime 
abstainers 
Overall 10 1.98 (1.59–2.47)   No sig. differences 
across strata explored. Consumption 4 1.77 (1.43–2.19)  
Binge consumption 5 2.20 (1.29–3.74)  
Prior to sex 4 1.87 (1.39–2.50)  
Mao et al., 
2010 
 
Bladder cancer 
19 6 13 1983-
2009 
USA, Can, Dnk, 
Ita, Ger, Nld, 
Fra, Jpn, Chn 
9,284 Not 
defined 
Overall 18 1.00 (0.89–1.10) 64.9% NA Estimates did not vary 
from overall findings. Males 10 0.96 (0.83–1.08) 72.4% 
Females 8 0.90 (0.60–1.21) 59.1% 
Beer 10 0.86 (0.76–0.96) 57.0% 
Wine 10 0.85 (0.71–1.00) 78.5% 
Spirits 9 1.01 (0.87–1.15) 69.5% 
Pelucchi et al., 
2012 
 
Bladder cancer 
19 16 3 1983-
2009 
USA, Spa, Ita, 
Ger, Fra, Nld, 
Jpn, UK. 
11,935 Non-
drinkers 
<37.5 g/d overall 24 1.00 (0.92–1.09) 42.3% NA No study had a notable 
influence on the overall 
estimate. 
<37.5 g/d males 11 1.09 (0.98–1.22) 25.1% 
<37.5 g/d females 7 0.91 (0.76–1.09) 41.4% 
≥37.5 g/d overall 10 1.02 (0.72–1.33) 67.7% 
≥37.5 g/d males 5 1.52 (0.99–2.33) 65.0% 
Key et al., 
2006 
 
Breast cancer 
98 21 77 1982-
2003 
Aus, Bra, Can, 
Chl, Dnk, Fin, 
Fra, Ger, Grc, 
Nld, Ita, Jpn, 
Kor, Nzl, Nga, 
Pol, Rus, Spa, 
Swe, Nor, UK, 
USA, Isr, Uru 
136,381 Non-
drinkers 
Overall 89 1.11 (1.06–1.17)  % excess risk per 10 
g/day: 12% (9%–15%) 
Retrospective studies 
with hospital controls 
associated with sig. 
higher risk estimates 
than community controls 
Sensitivity Ic 19 1.22 (1.09–1.37)  
Beer 30 1.16 (1.04–1.29)  
Wine 32 1.14 (1.05–1.24)  
Spirits 31 1.14 (1.06–1.23)  
Fedirko et al., 
2011 
 
Colorectal 
cancer 
61 27 34 1986–
2010 
Jpn, Kor, Chn, 
Hkg, Sgp, Aus, 
USA, Can, Fra, 
Ita, Swe, Nld, 
Dnk, UK, Fin, 
Eur 
42,644 Non-
drinkers or 
occasional 
alcohol 
drinkers 
Overall 57 1.12 (1.06–1.19)  10 g/d = 1.07 (1.04–
1.10); 25 g/d =1.18 
(1.12–1.25); 50 g/d 
=1.38 (1.28–1.50); 100 
g/d =1.82 (1.41–2.35) 
Factors explored in 
analyses were not 
sources of heterogeneity. 
Colon 42 1.05 (0.99–1.12)  
Rectum 38 1.19 (1.09–1.31)  
Male 33 1.25 (1.13–1.39)  
Female 26 1.00 (0.94–1.07)  
≤12.5 g/d 43 1.00 (0.95–1.05)  
≤12.5 g/d male 27 1.02 (0.92–1.14)  
≤12.5 g/d female 25 0.95 (0.89–1.01)  
>12.5 to <50 g/d 53 1.21 (1.13–1.28)  
>12.5 to <50 g/d male 32 1.24 (1.13–1.37)  
>12.5 to <50 g/d female 21 1.08 (1.03–1.13)  
≥50 g/d 19 1.52 (1.27–1.81)  
≥50 g/d male 15 1.62 (1.31–2.01)  
≥50 g/d female 2 1.54 (1.04–2.29)  
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Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases Reference category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Sun et al., 
2011 
 
Endometrial 
cancer 
20 6 14 1986-
2009 
USA, Swe, Can, 
Nld, Ita, Chn, 
Grc, Jpn 
7,638 Non-
drinkers 
Cohort 6 1.04 (0.91–1.18) (NS)  Majority heterogeneity 
accounted for in 4 case-
control studies. 
Sensitivity analyses did 
not show any sig. 
differences in summary 
estimates. 
Case-control 14 0.89 (0.76–1.05) (p<0.001) 
Case-control 10 0.90 (0.80–1.00 (NS) 
Beer 7 0.91 (0.75–1.11)  
Wine 7 1.07 (0.92–1.25)  
Liquor 7 1.22 (1.03–1.45)  
Kan et al., 
2011 
 
Extrahepatic 
bile system 
cancer 
 
10 1 9 1987–
2009 
USA, Can, Jpn, 
Nld, Aus, Pol, 
Fra, Ger, Ita, 
Swe, Irn 
113,767
d 
Non-
drinkers 
and low 
drinkers 
Overall 10 0.82 (0.72–0.94) 27.2%   
Case-control 9 0.80 (0.68–0.93) 29.6%   
>80 g/d 3 1.58 (0.97–2.57) (0.06)   
Tramacere et 
al., 2012a 
 
Gastric cancer 
59 15 44 1963-
2010 
Jpn, USA, Ice, 
Svn, Fra, Chn, 
Ita, Uru, Tur, 
Tai, Spa, Ind, 
Pol, Swe, Rus, 
Bra, UK, Tha, 
Vie, Dnk, Nor, 
Kor, Nld 
34,557 Non-
drinkers 
and 
occasional 
drinkers 
Overall 59 1.07 (1.01–1.13) 52.0% (0.00) 10 g/d =0.95 (0.91–
0.99); 25 g/d =1.01 
(0.96–1.06); 50 g/d = 
1.14 (1.08–1.21); 75 
g/d = 1.30 (1.19–1.40); 
100 g/d =1.45 (1.31–
1.62); 125 g/d =1.62 
(1.42–1.85) 
No sig. differences 
across strata of sex, 
geographic area or 
studies with and without 
adjustment for smoking 
and fruit and vegetable 
consumption. 
 
Case–control 44 1.08 (1.00–1.18) 56.6% (0.00) 
Cohort 15 1.04 (0.97–1.11) 31.2% (0.11) 
Gastric cardia 12 0.94 (0.78–1.13) 29.7% (0.16) 
Gastric noncardia 14 1.07 (0.91–1.26) 65.9% (0.00) 
>50 g/d 13 1.20 (1.01–1.44) 58.9% (0.00) 
Tramacere et 
al., 2012b 
 
Hodgkin 
lymphoma 
10 2 8 2006-
2009 
Ita, Cze, Fra, Ire, 
Spa, Ger, UK, 
Can, Jpn, USA 
1,488 Non-
drinkers 
Overall 10 0.70 (0.60–0.81) 0.0% (0.48) Inverse, but not 
significant; 10 g/d = 
0.95 (0.89–1.02); 20 
g/d = 0.87 (0.72–1.05); 
30 g/d = 0.82 (0.64–
1.04) 
Plot suggested absence 
of publication bias, no 
asymmetry. 
≤12.5 g/d 7 0.71 (0.57–0.89) 11.7% (0.34) 
>12.5 g/d 8 0.73 (0.60–0.87) 0.0% (0.85) 
Islami et al., 
2010 
 
Laryngeal 
cancer 
40 2 38 1956-
2009 
USA, UK, Can, 
Dnk, Uru, Fra, 
Ita, Spa, Swi, 
Kor, Chn, Tur, 
Ger, Tai, Bel, 
Eur 
9,351 Non-
drinkers 
and 
occasional 
drinkers 
Overall 40 1.90 (1.59–2.28) 85.8% (<0.001) 12.5 g/d = 1.20 (1.15–
1.25); 25 g/d = 1.45 
(1.33–1.57); 37.5 g/d = 
1.72 (1.52–1.90); 50 
g/d = 2.04 (1.76–2.36); 
100 g/d = 3.77 (2.93–
4.86) 
Results did not differ 
from overall analyses. 
Estimates based on non-
drinkers only as the ref. 
group did not differ from 
the overall results 
Adjusted 20 1.84 (1.50–2.26) 81.5% (<0.001) 
≤12.5 g/d 12 0.88 (0.71–1.08) 24.8% (0.19) 
Adjusted 6 0.88 (0.70–1.12) 22.6% (0.26) 
>12.5 to <50 g/d 35 1.47 (1.25–1.72) 66.7% (0.001) 
Adjusted 20 1.50 (1.23–1.83) 64.2% (0.001) 
≥50 g/day 33 2.62 (2.13–3.23) 81.4% (0.001) 
Adjusted 17 2.46 (1.88–3.22) 79.7% (0.001) 
Bagnardi et al., 
2011 
 
Lung cancer 
10 4 6 1988-
2010 
USA, Ita, Can, 
Jpn, Nld, Pol, 
Chn, Eur 
 
1,913 Non-
drinkers 
Overall  10 1.21 (0.95–1.55) 77% Increase in 10 g/d = 
1.01 (0.92–1.10) 
No sig. differences 
across strata explored. Male 4 1.22 (0.83–1.80) 51% 
Female  6 1.26 (0.81–1.95) 86% 
Case–control  6 1.25 (0.68–2.31) 86% 
Cohort 4 1.02 (0.92–1.28) 31% 
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Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases 
Reference 
category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Tramacere et 
al., 2011 
 
Oesophageal 
and gastric 
cardia AC 
24 4 20 1989-
2010 
Jpn, USA, Chn, 
Grc, Uru, Swe, 
Rus, Rou, Cze, 
Pol, Ire, Aus, UK, 
Nld 
5,500 Non-
drinkers or 
occasional 
drinkers 
Any intake 24 0.96 (0.85–1.09) 49.2% (0.003) No sig. increased risk 
at any level; nadir = 25 
g/day; RR<1 up to 70 
g/day. Risk estimates 
for higher doses not 
sig. 
No sig. differences 
across strata explored. ≤12.5 g/d  15 0.86 (0.75–0.99)  
>12.5 to <50 g/d  16 0.90 (0.73–1.10)  
≥50 g/d 13 1.16 (0.92–1.46)  
Case-control  20 0.99 (0.83–1.17) 55.7% (0.001) 
Cohort  4 0.96 (0.85–1.09) 0.0% (0.60) 
Oesophageal AC 13 0.87 (0.74–1.01) 35.7% (0.10) 
Gastric cardia 15 0.89 (0.76–1.03) 24.9% (0.18) 
Tramacere et 
al., 2010 
 
Oral and 
pharyngeal 
cancer 
45 2 43 1957-
2008 
USA, Pri, Can, 
Fra, Ita, Chn, Kor, 
Uru, Dnk, Ger, 
Jpn, Spa, Cub, 
Grc, Ind, Pol, Swi, 
Tai, Swe, 
Srb/Mne, Eur 
17,085 Non-
drinkers or 
occasional 
drinkers 
≤12.5 g/d  20 1.21 (1.10–1.33) (0.71) 10 g/d = 1.29 (1.25–
1.32); 25 g/d = 1.85 
(1.74–1.96); 50 g/d = 
3.24 (2.89–3.64); 75 
g/d = 5.42 (4.58–6.40); 
100 g/d = 8.61 (6.91–
10.73); 125 g/d = 
13.02 (9.87–17.18) 
No sig. differences 
across strata explored. ≥50 g/d 31 5.24 (4.36–6.30) (<0.01) 
Rota et al., 
2012 
 
Epithelial 
ovarian cancer 
27 4 23 1983-
2012 
USA, Grc, Jpn, Ita, 
Ind, Can, Swe, 
Tai, Aus, Kor, UK, 
UK, Int 
16,554 Non-
drinkers or 
occasional 
drinkers 
Overall 27 1.00 (0.95–1.05) 8.8% (0.33) Meta-regression 
models indicated a 
lack of a dose–risk 
relationship. 
No sig. differences 
across strata explored. ≤12.5 g/d 20 0.97 (0.92–1.02) 14.6% (0.27) 
>12.5 to <37.5g/d  16 1.03 (0.96–1.11) 22.4% (0.20) 
≥37.5 g/d 4 1.09 (0.80–1.50) 46.7% (0.13) 
Tramacere et 
al., 2010 
 
Pancreatic 
cancer 
32 11 21 1983-
2009 
USA, Jpn, Swe, 
Fra, UK, Swi. Aus, 
Grc, Chn, Ita, Can, 
Fin, Nld, Int 
13,728 Non-
drinkers 
and 
occasional 
drinkers 
Overall 32 0.92 (0.86–0.97) (0.06) NA Sig. association in: 
cohort studies (cohort 
1.29 [1.15–1.45] vs. 
case-control 1.10 [0.97–
1.25]); studies reporting 
estimates adjusted for 
tobacco smoking 
(adjusted 1.23 [1.12–
1.35] vs. non-adjusted 
1.09 [0.90–1.32]). 
Estimates based on non-
drinkers only as the 
reference group did not 
differ from the overall 
results 
Females 12 0.89 (0.85–0.93)  
Males 16 0.95 (0.86–1.11)  
>37.5 g/day  13 1.22 (1.12–1.34)  
Females 6 1.16 (0.94–1.44)  
Males 11 1.19 (1.05–1.33)  
Rota et al., 
2011 
 
Prostate 
cancer 
72 22 50 1971-
2010 
USA, Jpn, Zaf, 
Chn, Nld, Uru, 
Swe, UK, Ind, 
Can, Grc, Tai, Ita, 
Aus, Chl, Nzl, Ger, 
Nor, Dnk, Fin, Eur 
52,899 Non-
drinkers 
and 
occasional 
drinkers 
Overall 72 1.06 (1.01–1.10) 39.0% (0.001) 10 g/day = 1.02 (1.00–
1.04); 25 g/ day = 1.05 
(1.01–1.09); 50 g/day 
= 1.09 (1.02–1.16); 
100 g/day = 1.12 
(0.97–1.30) 
Results consistent with 
the overall findings. Adjusted 17 1.11 (1.04–1.18) 36.7% (0.07) 
≤12.5 g/d  36 1.05 (1.02–1.08) 0.0% (0.70) 
Light adjusted 12 1.06 (1.02–1.10) 0.0% (0.67) 
>12.5 to <50 g/d  40 1.06 (1.01–1.11) 29.9% (0.04) 
Adjusted 11 1.10 (1.03–1.18) 33.3% (0.13) 
≥50 g/d  17 1.08 (0.97–1.20) 40.6% (0.04) 
Adjusted 4 1.19 (1.13–1.26) 0.0% (0.51) 
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Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases 
Reference 
category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Bellocco et al., 
2012 
 
Renal cell 
carcinoma 
 
20 5 15 1986-
2011 
USA, Can, Fra, 
Dnk, Swe, Ita, Jpn, 
UK, Kor, Eur, Int 
12,481 Non-
drinkers 
Overall 20 0.85 (0.80–0.92) 45.4% (0.005) 12 g/day = 0.84 (0.79–
0.90); 32 g/day = 0.68 
(0.59–0.78); 50 g/day 
= 0.60 (0.50–0.73); 
100 g/day = 0.61 
(0.39–0.95) 
Did not differ from the 
overall findings. Men 14 0.88 (0.78–0.98)  
Women 12 0.79 (0.72–0.86)  
<12.5 g/d 14 0.90 (0.84–0.97) 32.1% (0.08) 
≥12.5 to <50 g/d 13 0.79 (0.71–0.88) 43.1% (0.03) 
≥50 g/d  5 0.89 (0.58–1.39) 63.7% (0.02) 
Song et al., 
2012 
 
Renal cell 
cancer 
24 4 20 1974-
2011 
USA, Fra, Can, 
Aus, Dnk, Swe, 
Ger, Ita, Rus, Rou, 
Pol, Cze, Fin, Nld, 
UK 
13,819 
renal 
cell  
1,537 
kidney 
Non-
drinkers or 
occasional 
drinkers 
Overall 22 0.73 (0.67–0.79) 7.9% (0.34) Significant non-
linearity for the overall 
association; risk 
attenuated > ~15 g/d. 
Stronger inverse 
association in cohort 
studies (vs. case–control 
p=0.02) and more recent 
studies (data NR). 
Case-control  18 0.76 (0.68–0.85) 14.7% (0.25) 
Cohort 4 0.73 (0.67–0.79) 0.0% (0.60) 
Beer 12 0.81 (0.70–0.91) (0.26) 
Wine 12 0.75 (0.59–0.91) (<0.001) 
Liquor 12 0.76 (0.66–0.87) (0.12) 
Chen et al., 
2008 
 
Nasopharyn-
geal 
carcinoma 
14 0 14 1976-
2001 
USA, Sgp, Hkg, 
Mys, Tai, Tha 
3,486 Non-
drinker or 
light intake 
Overall 11 1.33 (1.09–1.62) 17.1% (0.28) Inverse association up 
to ~29 g/day with risk 
increasing with higher 
intake. 
Studies controlling for 
smoking and studies 
conducted in China had a 
weaker association. 
Adjusted (smoking) 6 1.26 (0.99–1.62)  
Islami et al., 
2011 
 
Oesophageal 
squamous cell 
carcinoma 
53 13 40 1961-
2010 
USA, Pri, Fra, Uru, 
Dnk, Kor, Hkg, 
Jpn, Chn, Grc, 
SAm Ita, Swe, UK, 
Ger, Tha, Ind, Tai, 
Eur, Spa, Aus, 
Can 
9,826 Non-
drinkers or 
occasional 
drinkers 
<12.5 g/d 26 1.31 (1.10–1.57) 56.2% (0.001) NA Similar to overall 
analysis, except for 
geographic region 
(stronger association for 
light intake in Asian 
countries). 
Adjusted  19 1.38 (1.14–1.67) 51.5% (0.002) 
≥12.5 to <50 g/d 47 2.27 (1.89–2.72) 85.3% (0.001) 
Adjusted 28 2.62 (2.07–3.31) 82.8% (0.001) 
≥50 g/d 39 4.89 (3.84–6.23) 87.1% (0.001) 
Adjusted  21 5.54 (3.92–7.82) 89.9% (0.001) 
Baliunas et al., 
2010b 
 
Type II 
diabetes 
20   1988-
2007 
USA, Nld, Fin, 
Aus, Kor, Ger, 
Jpn, UK 
12,556 Lifetime 
and 
current 
abstainers 
    Males: nadir 22 g/day: 
RR 0.87 (0.76–1.00); 
deleterious >60 g/day: 
RR 1.01 (0.71–1.44) 
Females: nadir 24 
g/day: RR 0.60 (0.52–
0.69); deleterious >50 
g/day: RR 1.02 (0.83–
1.26) 
 
Anstey et al., 
2009 
 
Dementia 
15 15 0  Not clear Not 
clear 
Non-
drinkers 
Any intake    NA NA; some discussion of 
former drinkers vs. 
lifetime abstainers but 
not explored in meta-
analysis 
Alzheimer disease 2 0.66 (0.47–0.94) (NS) 
Any dementia 4 0.66 (0.53–0.82) (NS) 
Cognitive decline 2 0.28 (0.03–2.83) (0.00) 
Light to moderate intake    
Alzheimer disease 6 0.70 (0.39–1.26) (0.04) 
Vascular dementia 4 0.75 (0.57–0.98) (NS) 
Any dementia 7 0.74 (0.61–0.91) (NS) 
Heavy intake    
Alzheimer disease 4 0.92 (0.59–1.45) (NS) 
Vascular dementia 3 1.36 (0.68–2.71) (NS) 
Any dementia 4 1.04 (0.69–1.56) (NS) 
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Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases 
Reference 
category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Samokhvalov 
et al., 2010 
 
Epilepsy 
6 0 6 1987-
2003 
Chn, Ita, Nga, 
USA 
934 Non-
drinkers 
Overall 6 2.19 (1.83–2.63) 9.0% (0.36) 12 g/d = 1.17 (1.13–
1.21); 48 g/d = 1.81 
(1.59–2.07) ; 72 g/d = 
2.44 (2.00–2.97); 96 
g/d = 3.27 (2.52–4.26) 
NA 
<50 g/d 4 1.29 (1.03–1.61) 0.0% (0.84) 
Chong et al., 
2008 
Age-related 
macular 
degeneration 
5 5 0 1999-
2007 
USA, Dnk, Ice 1,923 Not cleare Early AMD 5 1.47 (1.10–1.95) 30.9% (0.01) NA NA 
Late AMD 4 Not pooled   
Kodama et al., 
2011 
Atrial 
fibrillation 
14 9 5 1985-
2008 
USA, Can, Swe, 
Dnk, Spa, Swi 
7,558 Not cleare Overall 14 1.51 (1.31–1.74) 45.8% (0.02) Increase in risk per 10 
g/d: 1.08 (1.05–1.10) 
Results consistent with 
the overall findings vs. non-drinkers 8 1.36 (1.18–1.57) 44.6% (0.08) 
Samokhvalov 
et al., 2010 
 
Atrial 
fibrillation 
6 5 1 1987-
2008 
UK, USA, Fin, Dnk 4,767 Non-
drinkers 
>0 to 24 g/d - 1.00 (0.92–1.09) - Females: 24 g/d = 
1.07 g/d (1.04– 1.10), 
60 g/d 1.42 (1.23–
1.64); 120 g/d 2.02 
(1.60–2.97)  
Males: 24 g/d = 1.08 
(1.04–1.11); 60 = 1.44 
(1.23–1.69); 120 g/d = 
2.09 (1.52–2.86) 
NA 
>24 to 36 g/d  - 1.11 (0.98–1.25) - 
>36 to 48 g/d - 1.22 (1.02–1.46) - 
>48 g/d - 1.50 (1.22–1.85) - 
>0 to 24 g/d female - 0.99 (0.91–1.07) - 
>24 to 36 g/d female - 1.17 (1.01–1.36) - 
>36 to 48 g/d female - 1.17 (0.84–1.65) - 
>48 g/d female - 2.18 (1.38–3.43) - 
>0 to 24 g/d male - 1.02 (0.90–1.16) - 
>24 to 36 g/d male - 1.09 (0.94–1.26) - 
>36 to 48 g/d male - 1.25 (1.01–1.55) - 
>48 g/d male - 1.53 (1.23–1.91) - 
Roerecke & 
Rehm, 2011 
 
Ischaemic 
heart disease 
44 32 12 1980-
2010 
USA, Nzl, Jpn, 
UK, Aus, Swe, 
Dnk, Bgr, Ita, Fra, 
Fin, Cri, Chn, Spa 
38,627 Lifetime 
abstainer 
Mortality    Stratified only (24 
studies) 
 
Mortality 
Males: nadir 32 g/d; 
reversion point 63 g/d. 
Females: nadir 11 g/d; 
reversion point 31 g/d 
Morbidity 
Males: nadir 69 g/d; no 
reversion point. 
Females: nadir 14 g/d; 
reversion point 57 g/d.  
 
NB: Heterogeneity 
was highly statistically 
significant in most 
models. 
Omitting studies 
individually did not reveal 
any substantial influence 
of any particular study on 
the pooled effect 
estimates.  
 
None of the interaction 
terms examined 
explained the 
heterogeneity in the 
models, except age at 
time of IHD event (<65 
years vs. >65 years) in 
women 
<2.5 g/day male 5 0.94 (0.74–1.21) 37% (0.18) 
2.5 to <12 g/d male 17 0.89 (0.79–1.00) 65% (<0.001) 
12 to <24 g/d male 12 0.86 (0.73–1.02) 72% (<0.001) 
24 to <36 g/d male 11 0.78 (0.63–0.97) 76% (<0.001) 
<2.5 g/day female 3 0.98 (0.74–1.30) 58% (0.10) 
2.5 to <12 g/d female 8 0.84 (0.74–0.96) 23% (0.24) 
12 to <24 g/d female 7 1.03 (0.84–1.27) 3% (0.40) 
24 to <36 g/d female 5 0.89 (0.57–1.40) 48% (0.10) 
Morbidity    
<2.5 g/day male 3 0.82 (0.65–1.02) 15% (0.31) 
2.5 to <12 g/d male 9 0.77 (0.65–0.92) 68% (0.001) 
12 to <24 g/d male 8 0.75 (0.64–0.88) 42% (0.08) 
24 to <36 g/d male 3 0.74 (0.53–1.02) 65% (0.06) 
<2.5 g/day female 2 0.91 (0.78–1.07) 0% (0.49) 
2.5 to <12 g/d female 5 0.54 (0.45–0.65) 0% (0.95) 
12 to <24 g/d female 5 0.61 (0.38–0.99) 70% (0.009) 
24 to <36 g/d female 3 0.40 (0.14–1.13) 84% (0.002) 
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Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases Reference category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Roerecke & 
Rehm, 2010 
 
Ischaemic 
heart disease 
(heavy 
drinking 
occasions) 
14 10 4 1982-
2007 
Dnk, Fin, USA, 
Can, Rus, UK, 
Yug, Cri, Aus, 
Swe 
3,808 Regular 
moderate 
drinking 
Overall 14 1.45 (1.24–1.70) 53.9% (0.008) NA Factors examined in 
meta-regression model 
did not result in statistical 
significance. Omitting 
each study  separately 
resulted in random 
variation around the 
overall estimate 
Taylor et al., 
2009 
 
Hypertension 
12 12 0 1989-
2006 
USA, Kor, Jpn NR Lifetime 
abstainer 
Risk increase per 10 g/d    Males: linear 
relationship 
Females: ‘J-shaped’ 
nadir 4 g/d, reversion 
point 15 g/d  
Suggested that Asian 
populations may have an 
increased risk of 
hypertension compared 
to the non-Asian 
populations. 
Males 9 1.09 (1.07–1.12) 0.0% (0.509) 
Females 9 1.10 (1.06–1.14) 75.0% (0.000) 
Patra et al.,  
2010 
 
Ischaemic 
stroke (IS); 
Haemorrhagic 
stroke (HS) 
26 17 9 1986-
2009 
USA, Jpn, Fin, 
Kor, Chn, UK, 
Spa, Aus 
14,418 Lifetime 
abstainers 
Haemorrhagic stroke      
Mortality males 12 1.11 (1.06–1.15) 40% (0.006) Mortality 
Males: linear 
relationship. 
Females: ‘J-shaped’. 
Inverse association 
≤12 g/d.  
 
Morbidity 
Males: linear 
relationship. 
Females: ‘J-shaped’. 
nadir 12 g/d (0.69; 
0.54–0.89); reversion 
point 36 g/d;  
 
Morbidity males 11 1.12 (1.06–1.19) 56% (0.000) 
Mortality females 6 1.21 (1.07–1.38) 24% (0.179) 
Morbidity females 5 1.14 (1.03–1.27) 53% (0.005) 
Ischaemic stroke     
Mortality males 11 1.04 (1.01–1.07) 10% (0.297) Mortality  
Males: ‘J-shaped’. 
nadir 12 g/d; reversion 
point 35 g/d 
Females: ‘J-shaped’. 
nadir 12 g/d; reversion 
point 44 g/d. 
 
Morbidity 
Males: ‘J-shaped’. 
reversion point 37 g/d 
Females: ‘J-shaped’. 
reversion point 46 g/d 
Morbidity males 16 1.04 (1.02–1.07) 35% (0.007) 
Mortality females 5 1.04 (1.01–1.08) 10% (0.344) 
Morbidity females 9 1.05 (1.01–1.08) 43% (0.010) 
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Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases Reference category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Samokhvalov 
et al., 2010 
 
Pneumonia 
 
5 2 3 1994-
2008 
Fin, Spa, USA 2,371 Non-
drinkers 
    24 g/d = 1.12 (1.02–
1.23), 60 g/d = 1.33 
(1.06–1.67); 120 g/d = 
1.76 (1.13–2.77) 
NA 
Rehm et al., 
2010 
 
Liver cirrhosis 
17 14 3 1980-
2003 
USA, Jpn, Ita, 
Dnk, Chn,  
3,384 Lifetime 
abstainers 
Mortality    Continuous dose–
response relationship 
between alcohol 
consumption and risk 
of liver cirrhosis in 
both mortality and 
morbidity studies. 
 
Mortality 
Females: 24 g/d = 4.9 
(4.0–6.2); 60 g/d = 
(8.8–17.7) 
Morbidity 
Females: 24 g/d = 3.2 
(2.6–3.9); 60 g/d = 6.2 
(4.4–8.7). 
 
Similar pattern for 
males (data NR). 
 
>0 to 12 g/d females - 1.9 (1.1–3.1)  
>12 to 24 g/d females - 5.6 (4.5–6.9)  
>24 to 36 g/d females - 7.7 (6.3–9.5)  
>36 to 48 g/d females - 10.1 (7.5–13.5)  
>48 to 60 g/d females - 14.7 (11.0–19.6)  
>60 g/d females - 22.7 (17.2–30.1)  
>0 to 12 g/d males - 1.0 (0.6–1.6)  
>12 to 24 g/d males - 1.6 (1.4–2.0)  
>24 to 36 g/d males - 2.8 (2.3–3.4)  
>36 to 48 g/d males - 5.6 (4.5–7.0)  
>48 to 60 g/d males - 7.0 (5.8–8.5)  
>60 g/d males - 14.0 (11.7–16.7)  
Morbidity    
>0 to 12 g/d females - 0.4 (0.1–1.2)  
>12 to 24 g/d females - 1.0 (0.5–1.9)  
>24 to 36 g/d females - 2.4 (1.8–3.2)  
>36 to 48 g/d females - 1.9 (1.8–3.2)  
>48 to 60 g/d females - 5.9 (3.7–9.3)  
>60 g/d females - 6.1 (3.9–6.4)  
>0 to 12 g/d males - 0.3 (0.1–0.9)  
>12 to 24 g/d males - 0.3 (0.2–0.4)  
>24 to 36 g/d males - 0.7 (0.5–1.0)  
>36 to 48 g/d males - 2.0 (1.5–2.7)  
>48 to 60 g/d males - 2.3 (1.7–3.2)  
>60 g/d males - 5.0 (3.9–6.4)  
Irving et al., 
2012 
 
Pancreatitis 
6 2 4 1999-
2008 
Ita, Jpn, Swe, 
USA, Dnk 
1,671 Non-
drinkers 
>0 to 24 g/d - 1.0 (0.8–1.2)  36 g/d = 1.2 (1.2–1.3); 
96 g/d = 4.2 (3.1–5.7) 
 
>24 to 48 g/d - 1.2 (1.0–1.5)  
>48 g/d - 2.5 (2.0–3.1)  
Zhu et al., 
2012 
 
Psoriasis 
15 0 15 2002-
2011 
USA, Sgp, Fra, 
Swe, Chn, Mne, 
Nld, Swi, Ita, 
Spa, Ger, Tur 
7,681 Non-
drinkers 
Overall 15 1.53 (1.16–2.01) 92.2% (0.000) NA Limited discussion of 
heterogeneity. Omitting 
studies from the analysis 
did not materially alter 
the results. 
1–20 drinks ⁄ monthf 3 1.50 (0.72–3.09) (0.000) 
≥20 drinks ⁄ monthf 3 1.94 (0.97–3.86) (0.000) 
Berg et al., 
2008 
 
Hip fracture 
13 8 5 1988-
2007 
NR 4,293 Non-
drinkers 
>0 to 7 g/d 5 0.84 (0.70-1.01)   Heterogeneity not 
reported or discussed. 
Reference category 
discussed but not 
explored in analyses. 
 
>7 to 14 g/d 10 0.80 (0.71-0.91)  
>14 to 28 g/d 9 0.91 (0.76–1.09)  
>28 g/d 5 1.39 (1.08–1.79)  
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Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases Reference category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Parsons & Im, 
2009 
 
Benign 
prostatic 
hyperplasia 
19 - - 1985-
2008 
NR NR Not clearg >0 to 5 g/d 5 0.90 (0.80–1.01) (0.23)  No sig. differences 
across strata explored. 
No discussion of impact 
of reference category. 
>5 to 12 g/d 8 0.86 (0.79–0.94) (0.02) 
>12 to 15 g/d 5 0.66 (0.54–0.81) (0.008) 
>15 to 24 g/d 3 0.82 (0.69–0.97) (0.02) 
>24 to 36 g/d 7 0.78 (0.69–0.88) (<0.001) 
>36 g/d 6 0.65 (0.58–0.74) (<0.001) 
Key 
AC = adenocarcinoma; Co = cohort studies; Ca = case-control studies; sig = significantly; g/d = grams per day; NA = not applicable; NR = not reported 
aArg = Argentina; Aus = Australia; Bel = Belgium; Bgr = Bulgaria; Bls = Belarus; Bra = Brazil; Can = Canada; Chl = Chile; Chn = China; Cri = Costa Rice; Cub = Cuba; Cze = Czech Republic; Dnk = Denmark; Egy = Egypt; 
Est = Estonia; Eur = Europe (individual countries not specified); Fin = Finland; Fra = France; Ger = Germany; Gmb = Gambia; Gnb = Guinea Bissau; Grc = Greece; Hkg =Hong Kong; Ice = Iceland; Ind = India; Int = 
International (individual countries not specified); Irn = Iran; Ire = Ireland; Isr = Israel; Ita = Italy; Jam = Jamaica; Jpn = Japan; Kor = Korea; Lva = Latvia; Mex = Mexico; Moz = Mozambique; Mwi = Malawi; Mys = Malaysia; 
Nzl = New Zealand; Nga = Nigeria; Nor = Norway; Pol = Poland; Pri = Puerto Rico; Rou = Romania; Rus = Russia; SAm = South America (individual countries not specified); Srb/Mne = Serbia and Montenegro; Sgp = 
Singapore; Spa = Spain; Sud = Sudan; Svn = Slovenia; Swe = Sweden; Swi = Switzerland; Tai = Taiwan; Tha = Thailand; Nld = The Netherlands; Tur = Turkey; Tza = Tanzania; Uga = Uganda; UK = United Kingdom; Uru 
= Uruguay; USA = United States of America; Vie = Vietnam; Yug = Yugoslavia; Zaf = South Africa.  
bExclusion of studies with highest SE and two studies with the highest and lowest effect sizes 
cMultivariate adjusted odds ratio and quality score of 3. 
dUnclear whether number of cases or overall sample size. 
eHighest alcohol consumption categories compared with the lowest. 
fNot defined in grams per day. 
gAssumed non-drinkers and occasional drinkers. 
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Table 5. Summary of risk estimates: Injury 
Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases Reference category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Taylor et al., 
2010 
 
Injury 
28 0 21
b 
1983-
2008 
Aus, Fin, Mex, 
USA, Can, USA, 
Nzl, Ger, Pol, 
Arg, Bls, Bra, 
Chn, Cze, Ind, 
Mex, Moz, Zaf, 
Swe, Swi 
28,825 NA 10 g/d increase    Non-linear relationship 
= intentional injury, 
motor vehicle 
accidents, other 
unintentional injuries 
Linear relationship = 
falls 
Case–control studies 
presented lower overall 
risks than case–
crossover studies (p = 
0.02). 
All injury 20 1.30 (1.27–1.34) 51% (<0.0001) 
Intentional injury 5 1.38 (1.22–1.55)  
Falls 5 1.25 (1.14–1.36)  
Motor vehicle accidents 8 1.24 (1.18–1.31)  
Other unintentional 13 1.32 (1.27–1.36)  
Taylor et al., 
2012 
 
Fatal motor 
vehicle 
accidents 
5 0 5 1993-
2004 
USA, Aus, Nzl 6,038 NA 0.02% increase in BAC 5 1.74 (1.43–2.14) 99.4% (<0.0001) At 0.02% BAC (~12 g): 
OR = 3.64 (3.37–3.94) 
At 0.08% BAC (i.e. 
legal limit): OR = 13.0 
(11.1–15.2) 
Results of analyses were 
not statistically sig. 
different from the main 
meta-analysis. 
Zeisser et al., 
2013 
14   1988-
2009 
Aus, USA, Mex, 
Swi, Pol, Can, 
Ita, Arg, Bls, 
Bra, Cze, Nzl, 
Swe, Indc 
22,182d No alcohol 
intake 
Injury arising within 6 h     Significant differences in 
OR magnitude when 
comparing studies by 
design and by recall 
period. Studies that 
provided gender-specific 
estimates found a large 
and significant overall 
effect for females, but a 
small and non-significant 
effect for males. 
Overall 14 2.80 (2.21–3.54)  
Females 5 2.29 (1.36–3.84)  
Males 6 1.07 (0.72–1.61)  
Case-crossover 5 3.82 (2.65–5.50)  
ED case-control 5 1.98 (1.39–2.82)  
Population case-control 4 3.15 (1.58–6.25)  
Key 
BAC = blood alcohol concentration; Co = cohort studies; Ca = case-control studies; ED = emergency department; sig = significantly; g/d = grams per day; NA = not applicable; NR = not reported 
aArg = Argentina; Aus = Australia; Bel = Belgium; Bgr = Bulgaria; Bls = Belarus; Bra = Brazil; Can = Canada; Chl = Chile; Chn = China; Cri = Costa Rice; Cub = Cuba; Cze = Czech Republic; Dnk = Denmark; Egy = Egypt; 
Est = Estonia; Eur = Europe (individual countries not specified); Fin = Finland; Fra = France; Ger = Germany; Gmb = Gambia; Gnb = Guinea Bissau; Grc = Greece; Hkg =Hong Kong; Ice = Iceland; Ind = India; Int = 
International (individual countries not specified); Irn = Iran; Ire = Ireland; Isr = Israel; Ita = Italy; Jam = Jamaica; Jpn = Japan; Kor = Korea; Lva = Latvia; Mex = Mexico; Moz = Mozambique; Mwi = Malawi; Mys = Malaysia; 
Nzl = New Zealand; Nga = Nigeria; Nor = Norway; Pol = Poland; Pri = Puerto Rico; Rou = Romania; Rus = Russia; SAm = South America (individual countries not specified); Srb/Mne = Serbia and Montenegro; Sgp = 
Singapore; Spa = Spain; Sud = Sudan; Svn = Slovenia; Swe = Sweden; Swi = Switzerland; Tai = Taiwan; Tha = Thailand; Nld = The Netherlands; Tur = Turkey; Tza = Tanzania; Uga = Uganda; UK = United Kingdom; Uru 
= Uruguay; USA = United States of America; Vie = Vietnam; Yug = Yugoslavia; Zaf = South Africa.  
bSeven studies used a case-crossover design. 
cResults for India were later excluded given strong evidence of publication bias. 
dIncludes 556 cases from India later excluded. 
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Table 6. Summary of risk estimates: Pregnancy 
Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases Reference category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Latino-Martel 
et al., 2010 
 
Acute 
lymphoblastic 
leukaemia 
(ALL); Acute 
myeloid 
leukaemia 
(AML) 
21 0 21 1985-
2009 
Nld, USA, Can, 
Aus, Grc, Ger, 
Ita, Egy, Bra, 
Chl, Chn, Hkg, 
Jpn, Mex, Fra, 
Cri, Tai 
8,128 No alcohol 
intake in 
pregnancy 
ALL    Risk increase per 
drinkb:  
GL (4 studies) = 1.02 
(0.95-1.09) 
ALL (5 studies) = 1.04 
(0.97–1.12) 
AML (3 studies) = 1.24 
(0.94–1.64) 
Factors examined in 
subgroup analyses did 
not substantially change 
the risk estimates. 
Overall 11 1.10 (0.93–1.29) (0.001) 
Beer 5 1.04 (0.77-1.40) (0.09) 
Wine 5 1.02 (0.79-1.32) (0.04) 
Spirits 6 1.29 (1.05-1.59) (0.31) 
AML    
Overall 9 1.56 (1.13–2.15) (0.03) 
Beer 4 1.18 (0.79-1.75) (0.63) 
Wine 4 1.67 (1.21-2.32) (0.87) 
Spirits 4 1.62 (0.68-3.81) (0.03) 
Patra et al., 
2011 
 
Low birth 
weight, 
preterm birth 
and small for 
gestational 
age (SGA) 
36 - - NR NR 20,582 
low 
birth-
weight; 
12,888 
preterm 
births; 
8,679 
SGA 
Non-
drinkers 
Low birth weight 28 1.12 (1.04–1.20) 80% (<0.001) Low birth weight: Risk 
not apparent until >10 
g/d; linearly associated 
up to 120 g/d. 
Preterm birth: No risk 
associated with <19 
g/d; increased risk at 
an average of 36 g/d. 
SGA: No risk 
associated with <10 
g/d; increased risk at 
an average of 36 
g/day. 
Study type affected the 
risk estimate for preterm 
birth. 
Adjusted 16 1.06 (0.99–1.13) 62% (<0.001) 
Preterm birth 21 1.03 (0.91–1.16) 89% (<0.001) 
Adjusted 10 0.93 (0.86–1.01) 64% (<0.001) 
SGA 11 1.11 (0.95–1.30) 92% (<0.001) 
Adjusted 8 0.99 (0.89–1.10) 82% (<0.001) 
    
Key 
ALL = acute lymphoblastic leukaemia; AML = acute myeloid leukaemia; Co = cohort studies; Ca = case-control studies; sig = significantly; g/d = grams per day; NA = not applicable; NR = not reported; SGA = small for 
gestational age 
aArg = Argentina; Aus = Australia; Bel = Belgium; Bgr = Bulgaria; Bls = Belarus; Bra = Brazil; Can = Canada; Chl = Chile; Chn = China; Cri = Costa Rice; Cub = Cuba; Cze = Czech Republic; Dnk = Denmark; Egy = Egypt; 
Est = Estonia; Eur = Europe (individual countries not specified); Fin = Finland; Fra = France; Ger = Germany; Gmb = Gambia; Gnb = Guinea Bissau; Grc = Greece; Hkg =Hong Kong; Ice = Iceland; Ind = India; Int = 
International (individual countries not specified); Irn = Iran; Ire = Ireland; Isr = Israel; Ita = Italy; Jam = Jamaica; Jpn = Japan; Kor = Korea; Lva = Latvia; Mex = Mexico; Moz = Mozambique; Mwi = Malawi; Mys = Malaysia; 
Nzl = New Zealand; Nga = Nigeria; Nor = Norway; Pol = Poland; Pri = Puerto Rico; Rou = Romania; Rus = Russia; SAm = South America (individual countries not specified); Srb/Mne = Serbia and Montenegro; Sgp = 
Singapore; Spa = Spain; Sud = Sudan; Svn = Slovenia; Swe = Sweden; Swi = Switzerland; Tai = Taiwan; Tha = Thailand; Nld = The Netherlands; Tur = Turkey; Tza = Tanzania; Uga = Uganda; UK = United Kingdom; Uru 
= Uruguay; USA = United States of America; Vie = Vietnam; Yug = Yugoslavia; Zaf = South Africa. 
bNot defined in grams per day. 
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Table 7. Summary of risk estimates: Narrative systematic reviews 
Study details N studies Years Countries
a Narrative synthesis findings 
Main findings Subgroup findings/ Notes 
Bay & Kesmodel, 
2011 
39 1980-
2008 
NR Findings generally suggested a negative effect when maternal alcohol consumption exceeded 
4 drinks/day (equivalent to 48 g/day). Studies of the effect of alcohol consumption between 10 
to 30 drinks/week (equivalent to 120-360 g/week) showed inconsistent results. Lack of 
evidence on the effects of binge drinking on motor development. 
NA 
Henderson et al., 
2007a 
46 NR NR  Outcomes N Results Authors note that many of the reported studies had 
methodological weaknesses. Miscarriage 8 5 studies found significant increase; RRs = 2.0–3.79, OR = 
1.1 
Stillbirth 5 1 study found significant increase at 25–60 g/week, OR 7.6 
Impaired growth 7 1 study found significant increase 
Birthweight 19 1 study found a significant increase 
Preterm birth 16 1 study found a significant increase 
Malformations 6 1 study found a significant increase 
Henderson et al., 
2007b 
14 NR USA, UK, Aus, Dnk, 
Can 
Outcomes N Results Authors note that many of the reported studies had 
methodological weaknesses despite being 
assessed as having reasonable quality. Difficult to 
separate out the effect of binge-drinking from 
heavy drinking. 
Birthweight, gestational 
age & growth 
7 3 studies found an association 
Birth defects 3 Inconsistent evidence 
Neurodevelopment 4 Effects generally quite small but reported across all studies. 
McCambridge et 
al., 2011 
54 1983-
2008 
USA, Swe, UK, Nzl, 
Aus, Fin, Nld 
Consistent evidence that higher alcohol consumption in late adolescence continues into 
adulthood and is also associated with alcohol problems including dependence. Evidence from 
a single population-based cohort that late adolescent drinking can cause early death among 
men, principally through car crashes and suicides. Apparent effects of late adolescent drinking 
may persist beyond the age of 30. 
Authors note that uncontrolled confounding means 
there is uncertainty about long term effects and 
that the existing evidence is generally of 
insufficient quality to warrant causal inferences. 
Kool et al., 2009 8 1983-
2005 
USA, Fin, Swe, Can Two of four studies found an association between acute use of alcohol and fall risk. Modest 
evidence of a dose–response relationship with acute alcohol use was observed. Three of six 
studies found an association between usual alcohol use and increased fall risk, but the 
remaining studies did not. 
Authors note that confounding was not adequately 
considered in a number of studies. 
Key 
aArg = Argentina; Aus = Australia; Bel = Belgium; Bgr = Bulgaria; Bls = Belarus; Bra = Brazil; Can = Canada; Chl = Chile; Chn = China; Cri = Costa Rice; Cub = Cuba; Cze = Czech Republic; Dnk = Denmark; Egy = 
Egypt; Est = Estonia; Eur = Europe (individual countries not specified); Fin = Finland; Fra = France; Ger = Germany; Gmb = Gambia; Gnb = Guinea Bissau; Grc = Greece; Hkg =Hong Kong; Ice = Iceland; Ind = India; 
Int = International (individual countries not specified); Irn = Iran; Ire = Ireland; Isr = Israel; Ita = Italy; Jam = Jamaica; Jpn = Japan; Kor = Korea; Lva = Latvia; Mex = Mexico; Moz = Mozambique; Mwi = Malawi; Mys = 
Malaysia; Nzl = New Zealand; Nga = Nigeria; Nor = Norway; Pol = Poland; Pri = Puerto Rico; Rou = Romania; Rus = Russia; SAm = South America (individual countries not specified); Srb/Mne = Serbia and 
Montenegro; Sgp = Singapore; Spa = Spain; Sud = Sudan; Svn = Slovenia; Swe = Sweden; Swi = Switzerland; Tai = Taiwan; Tha = Thailand; Nld = The Netherlands; Tur = Turkey; Tza = Tanzania; Uga = Uganda; UK 
= United Kingdom; Uru = Uruguay; USA = United States of America; Vie = Vietnam; Yug = Yugoslavia; Zaf = South Africa. 
b Studies noted by authors to have a stronger capacity for causal inference. 
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3.2 Summary of data from Mendelian meta-analyses and pooled data analyses 
Table 8. Summary of risk estimates: Mendelian randomisation approach 
Study details 
N
 
s
t
u
d
i
e
s
 Study 
design Years Countriesa N cases Reference category 
Pooled risk estimates (categorical analysis) 
Co Ca Group N Effect estimate 
(95% CI) 
Heterogeneity  
I2 (p value) 
Dose-response 
analysis 
Subgroup analyses 
Lewis & Davey 
Smith, 2005 
 
Oesophageal 
cancer 
7 - 7 1997-
2002 
Jpn, Tai, Tha 905 NA   Odds ratio  NA No evidence that effect 
estimates were related to 
study size. 
ALDH2*2*2 vs. *1*1 5 0.36 (0.16–0.80) 0.0% (0.71) 
ALDH2*1*2  vs. *1*1  Odds ratio  
  Overall 4 3.19 (1.86–5.47) 81.3% (<0.001) 
  Non-drinkers 3 1.31 (0.70–2.47) 0.0% (0.84) 
  Heavy drinkers 4 7.07 (3.67–13.6) 66.7% (0.03) 
Chen et al., 
2008b 
 
Blood pressure 
10 - - 1994-
2005 
Jpn, UK NR NA Hypertension  Odds ratio  NA Some evidence that 
effect sizes were greater 
in smaller studies in 
meta-analysis of 
hypertension and in the 
analysis of male diastolic 
BP differences between 
ALDH2 genotypes. 
  ALDH2*1*1 vs. *2*2 3 2.42 (1.66–3.55) 0.0% (0.48) 
  ALDH2*1*2  vs. *2*2 3 1.72 (1.17–2.52) 0.0% (0.70) 
Diastolic BP  Mean diff mmHg  
  ALDH2 *1*1 vs. *2*2 5 3.95 (2.66–5.24) 0.0% (0.49) 
  ALDH2*1*2  vs. *2*2 5 1.58 (0.29–2.87) 0.0% (0.72) 
  Alcohol intake (per g/d) 3 0.16 (0.11–0.21) 0.0% (0.97) 
Systolic BP  Mean diff mmHg  
  ALDH2*1*1 vs. *2*2 5 7.44 (5.39–9.46) 18.0% (0.30) 
  ALDH2*1*2 vs. *2*2 5 4.24 (2.18–6.31) 12.1% (0.34) 
  Alcohol intake (per g/d) 3 0.24 (0.16–0.32) 0.0% (0.44) 
Wang et al., 
2011 
 
Colorectal 
neoplasia 
7 - 7 1999-
2009 
Jpn, Chn 2,392 NA   Odds ratio   Sensitivity analysis 
showed similar results to 
overall analysis: *1*1 vs. 
*2*2 = 1.46 (1.09–1.97); 
*1*2 vs. *2*2 = 1.25 
(0.92–1.69). 
ALDH2*1*1 vs. *2*2 6 1.31 (1.01–1.70) 42.7% (0.12) 
ALDH2*1*2 vs. *2*2 6 1.13 (0.86–1.48) 0.0% (0.46) 
Key 
aArg = Argentina; Aus = Australia; Bel = Belgium; Bgr = Bulgaria; Bls = Belarus; Bra = Brazil; Can = Canada; Chl = Chile; Chn = China; Cri = Costa Rice; Cub = Cuba; Cze = Czech Republic; Dnk = Denmark; Egy = Egypt; 
Est = Estonia; Eur = Europe (individual countries not specified); Fin = Finland; Fra = France; Ger = Germany; Gmb = Gambia; Gnb = Guinea Bissau; Grc = Greece; Hkg =Hong Kong; Ice = Iceland; Ind = India; Int = 
International (individual countries not specified); Irn = Iran; Ire = Ireland; Isr = Israel; Ita = Italy; Jam = Jamaica; Jpn = Japan; Kor = Korea; Lva = Latvia; Mex = Mexico; Moz = Mozambique; Mwi = Malawi; Mys = Malaysia; 
Nzl = New Zealand; Nga = Nigeria; Nor = Norway; Pol = Poland; Pri = Puerto Rico; Rou = Romania; Rus = Russia; SAm = South America (individual countries not specified); Srb/Mne = Serbia and Montenegro; Sgp = 
Singapore; Spa = Spain; Sud = Sudan; Svn = Slovenia; Swe = Sweden; Swi = Switzerland; Tai = Taiwan; Tha = Thailand; Nld = The Netherlands; Tur = Turkey; Tza = Tanzania; Uga = Uganda; UK = United Kingdom; Uru 
= Uruguay; USA = United States of America; Vie = Vietnam; Yug = Yugoslavia; Zaf = South Africa. 
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Table 9. Summary of pooled risk estimates: Injury 
Study details N sites Years Countriesa N cases Reference category 
Pooled risk estimates (categorical analysis) 
Group N Effect estimate 
(95% CI) 
Heterogeneity 
I2 (p value) 
Sensitivity analyses 
Cherpitel et al., 
2003a 
 
ERCAAP 
 
31 (15 
studies) 
1984-
2001 
USA, Mex, Can, 
Aus, Spa, Ita, Arg 
NR - 5+ monthly drinking    Among non-heavy drinkers, frequent drinkers 
were more likely to have an alcohol-related injury 
than infrequent drinkers (OR 5.93; 3.70–9.50). 
Frequent heavy drinkers (vs. frequent light but 
infrequent heavy) were significantly more likely to 
have an alcohol related injury (OR 2.24; 1.69–
2.99). 
Positive BAC 13 4.27 (3.52–5.17) (0.004) 
Self-report 14 3.89 (3.45–4.39) (0.000) 
Cherpitel et al., 
2003b 
 
ERCAAP 
 
24 1984-
2002 
USA, Mex, Can, 
Aus, Spa, Ita, Arg, 
Pol 
NR Negative 
BAC 
Positive BAC    Pooled OR was smaller for those who reported 
drinking less frequently than weekly compared 
with those who reported drinking at least weekly 
or more often. Pooled ORs for those never 
consuming 5+ drinks on at least one occasion in 
the last year was not significant, but it was 
significant for those reporting 5+ yearly drinking. 
  Fixed effect 12 1.13 (0.80–1.59) (0.02) 
  Random effect 12 1.00 (0.50–1.99) - 
No drinking Self-reported volume    
  Fixed effect 13 1.58 (1.40–1.78) (0.00) 
  Random effect 13 1.80 (1.37–2.37) - 
Cherpitel et al., 
2003c 
 
ERCAAP 
 
30 1984-
1997 
USA, Mex, Can, 
Aus, Spa, Ita 
NR Negative 
BAC 
Positive BAC    Level I trauma centre status was predictive of 
larger values of self-report effect size on 
admission to the ER with an injury. In multivariate 
analyses, both trauma centre and legal 
intoxication level were significant predictors. 
  Fixed effect 29 1.65 (1.31–2.06) (0.125) 
  Random effect 29 1.67 (1.26–2.22) - 
No drinking Self-reported drinking    
  Fixed effect 29 1.65 (1.48–1.84) (p<0.001) 
  Random effect 29 1.55 (1.24–1.93) - 
Borges et al., 
2006  
 
ERCAAP, WHO–
ER 
28 1984-
2002 
Arg, Aus, Bls, Bra, 
Can, Chn, Cze, Ind, 
Mex, Moz, Nzl, Pol, 
Spa, Swe, USA, Zaf 
11,536 No drinking   Fixed effect 28 5.47 (5.18–5.78) (<0.001) Higher levels of detrimental consumption 
patterns were associated with an increased effect 
size; higher per capita consumption was 
associated with a lower effect size. Only 
detrimental drinking pattern remained statistically 
significant in a multivariate model. 
  Random effect 28 5.69 (4.04–8.00)  
    
Key 
aArg = Argentina; Aus = Australia; Bel = Belgium; Bgr = Bulgaria; Bls = Belarus; Bra = Brazil; Can = Canada; Chl = Chile; Chn = China; Cri = Costa Rice; Cub = Cuba; Cze = Czech Republic; Dnk = Denmark; Egy = 
Egypt; Est = Estonia; Eur = Europe (individual countries not specified); Fin = Finland; Fra = France; Ger = Germany; Gmb = Gambia; Gnb = Guinea Bissau; Grc = Greece; Hkg =Hong Kong; Ice = Iceland; Ind = India; 
Int = International (individual countries not specified); Irn = Iran; Ire = Ireland; Isr = Israel; Ita = Italy; Jam = Jamaica; Jpn = Japan; Kor = Korea; Lva = Latvia; Mex = Mexico; Moz = Mozambique; Mwi = Malawi; Mys = 
Malaysia; Nzl = New Zealand; Nga = Nigeria; Nor = Norway; Pol = Poland; Pri = Puerto Rico; Rou = Romania; Rus = Russia; SAm = South America (individual countries not specified); Srb/Mne = Serbia and 
Montenegro; Sgp = Singapore; Spa = Spain; Sud = Sudan; Svn = Slovenia; Swe = Sweden; Swi = Switzerland; Tai = Taiwan; Tha = Thailand; Nld = The Netherlands; Tur = Turkey; Tza = Tanzania; Uga = Uganda; UK 
= United Kingdom; Uru = Uruguay; USA = United States of America; Vie = Vietnam; Yug = Yugoslavia; Zaf = South Africa. 
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Table 10. Summary of pooled risk estimates: Cancer sites 
Study details N studies Years Countries
a N cases 
Reference 
category 
Pooled risk estimates (categorical analysis) 
Group N Effect estimate 
(95% CI) 
Heterogeneity 
I2 (p value) 
Subgroup analyses 
Cho et al., 2004 
 
Pooling Project of 
Prospective 
Studies of Diet 
and Cancer 
 
Colorectal cancer 
8 1980-
1998 
NR 4,687 Non-drinkers 30 to <45 g/d    In analyses by type of beverage, drinking beer or 
wine was significantly associated with elevated 
risk and drinking spirits had a non-significant 
positive association. The difference among the 3 
types of beverage was not statistically significant. 
Overall - 1.16 (0.99–1.36)  
Men - 1.11 (0.86–1.45)  
Women - 1.19 (0.94–1.50)  
≥45 g/d    
Overall - 1.41 (1.16–1.72)  
Men - 1.41 (1.11–1.79)  
Women - 1.41 (0.98–2.02)  
Collaborative 
Group on 
Hormonal Factors 
in Breast Cancer, 
2002 
 
Breast cancer 
65 1984-
2001 
USA, Can, Nld, UK, 
Aus, Dnk, Nzl, Svn, 
Ger, Ita, Fra, Grc, Int 
58,515 Non-drinkers   Increase in RR / 10g  Compared to women who drank no alcohol, 
women drinking 35-44 g/d, RR = 1.32 (SE 0.059, 
P<0.00001) and drinking ≥45 g/d, RR = 1.46 (SE 
0.060, P<0.00001). 
 
All studies 65 7.1 (SE 0.8)  
Cohort - 5.0 (SE 1.7)  
Case-control / pop - 7.4 (1.1)  
Case-control / hosp - 7.3 (1.7)  
Freudenheim et 
al., 2005 
 
Pooling Project of 
Prospective 
Studies of Diet 
and Cancer 
 
Lung cancer 
5 1980-
1996 
NR 3,137 Non-drinkers ≥30 g/d    RRs recalculated after reassigning all never 
smokers as former smokers were similar to the 
original calculations. 
Men 4 1.21 (0.91–1.61) (0.09) 
Women 5 1.16 (0.94–1.43) (0.35) 
Genkinger et al., 
2006 
 
Pooling Project of 
Prospective 
Studies of Diet 
and Cancer 
 
Ovarian cancer 
10 1980-
2004 
NR 2,001 Non-drinkers ≥30 g/d - 1.12 (0.86–1.44) (0.50) No association was observed for alcohol from 
different types of beverages and ovarian cancer 
risk. 
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Study details N studies Years Countries
a N cases 
Reference 
category 
Pooled risk estimates (categorical analysis) 
Group N Effect estimate 
(95% CI) 
Heterogeneity 
I2 (p value) 
Subgroup analyses 
Morton et al., 
2005 
 
InterLymph 
 
Non-Hodgkin 
lymphoma 
 
 
 
 
 
 
9 1990-
2004 
USA, Swe, UK, Ita 6,492 Non-drinkers All studies 9 0.83 (0.76–0.89) (0.244) Data from 4 studies showed that compared with 
non-drinkers, risk for current drinkers was lower 
than that for former drinkers. The association 
between alcohol consumption and risk did not 
vary by beverage type, or by the combination of 
beverages consumed. 
Purdue et al., 
2009 
 
INHANCE 
 
Head and neck 
cancer 
15 1984-
2006 
Ita, Fra, Swi, Eur, 
USA, Pri, Sam, Spa, 
Ire, Pol, Can, Aus, 
Cub, Ind, Sud 
9,107 Never drinkers Beer 15 2.1 (1.6–2.7) (0.13) Observed similar associations among beer-only 
and spirits-only drinkers as main analyses. 
Among wine-only drinkers, increases in risk were 
observed only for higher consumption levels (>30 
drinks/week). Differences in the magnitude of risk 
at the highest consumption level were observed 
between geographic regions. 
Spirits 15 2.2 (1.4–3.4) (<0.01) 
Wine 15 1.6 (1.0–2.6) (<0.01) 
    
Key 
aArg = Argentina; Aus = Australia; Bel = Belgium; Bgr = Bulgaria; Bls = Belarus; Bra = Brazil; Can = Canada; Chl = Chile; Chn = China; Cri = Costa Rice; Cub = Cuba; Cze = Czech Republic; Dnk = Denmark; Egy = 
Egypt; Est = Estonia; Eur = Europe (individual countries not specified); Fin = Finland; Fra = France; Ger = Germany; Gmb = Gambia; Gnb = Guinea Bissau; Grc = Greece; Hkg =Hong Kong; Ice = Iceland; Ind = India; 
Int = International (individual countries not specified); Irn = Iran; Ire = Ireland; Isr = Israel; Ita = Italy; Jam = Jamaica; Jpn = Japan; Kor = Korea; Lva = Latvia; Mex = Mexico; Moz = Mozambique; Mwi = Malawi; Mys = 
Malaysia; Nzl = New Zealand; Nga = Nigeria; Nor = Norway; Pol = Poland; Pri = Puerto Rico; Rou = Romania; Rus = Russia; SAm = South America (individual countries not specified); Srb/Mne = Serbia and 
Montenegro; Sgp = Singapore; Spa = Spain; Sud = Sudan; Svn = Slovenia; Swe = Sweden; Swi = Switzerland; Tai = Taiwan; Tha = Thailand; Nld = The Netherlands; Tur = Turkey; Tza = Tanzania; Uga = Uganda; UK 
= United Kingdom; Uru = Uruguay; USA = United States of America; Vie = Vietnam; Yug = Yugoslavia; Zaf = South Africa. 
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Appendix 1: Example search strategy 
 
Medline via Ovid 
1.  Meta-Analysis As Topic/ 
2.  (meta analy*).ti,ab 
3.  metaanaly*.ti,ab 
4.  Meta-Analysis/ 
5.  (systematic adj1 (review* or overview*)).ti,ab 
6.  exp Review Literature As Topic/ 
7.  or/1-6 
8.  cochrane.ti,ab 
9.  embase.ti,ab 
10.  (psychlit OR psyclit).ti,ab 
11.  (psychinfo OR psycinfo).ti,ab 
12.  (cinahl OR cinhal).ti,ab 
13.  (science citation index).ti,ab 
14.  bids.ti,ab 
15.  cancerlit.ti,ab 
16.  or/8-15 
17.  (reference list*).ti,ab 
18.  bibliograph*.ti,ab 
19.  hand-search*.ti,ab 
20.  (relevant journals).ti,ab 
21.  (manual search*).ti,ab 
22.  or/17-21 
23.  (selection criteria).ti,ab 
24.  (data extraction).ti,ab 
25.  23 or 24 
26.  Review/ 
27.  25 and 26 
28.  7 or 16 or 22 or 27 
29.  exp Alcohol Drinking/ 
30.  exp Alcoholic Beverages/ 
31.  Alcohol-Related Disorders/ 
32.  Alcoholism/ 
33.  Alcoholic Intoxication/ 
34.  (alcohol* adj2 (drink or drinks or beverage*)).ti,ab 
35.  ((alcohol or ethanol) adj1 (consumption or drinking or intake or abuse or 
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misuse)).ti,ab 
36.  ((harmful or hazardous or problem or risky or heavy or excessive or binge or light or 
moderate) adj1 drinking).ti,ab 
37.  (drinking behavio?r or beer or wine or spirits or absinthe or liquor*).ti,ab 
38.  or/29-37 
39.  28 AND 38 
40.  39 [Limit to: Humans and Publication Year 1995-Current] 
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Appendix 2. AMSTAR tool criteria 
Reproduced from: Shea et al. (2007). Development of AMSTAR: a measurement tool to 
assess the methodological quality of systematic reviews. BMC Medical Research 
Methodology, 7, 10. 
1. Was an ‘a priori’ design provided? 
The research question and inclusion criteria should be established before the 
conduct of the review.    
 Yes 
 No 
 Can’t answer 
 Not applicable 
 
2. Was there duplicate study selection and data extraction? 
There should be at least two independent data extractors and a consensus 
procedure for disagreements should be in place. 
 
 Yes 
 No 
 Can’t answer 
 Not applicable 
 
3. Was a comprehensive literature search performed? 
At least two electronic sources should be searched. The report must include 
years and databases used (e.g. Central, EMBASE, and MEDLINE). Key words 
and/or MESH terms must be stated and where feasible the search strategy 
should be provided. All searches should be supplemented by consulting 
current contents, reviews, textbooks, specialized registers, or experts in the 
particular field of study, and by reviewing the references in the studies found. 
 
 Yes 
 No 
 Can’t answer 
 Not applicable 
4. Was the status of publication (i.e. grey literature) used as an inclusion 
criterion? 
The authors should state that they searched for reports regardless of their 
publication type. The authors should state whether or not they excluded any 
reports (from the systematic review), based on their publication status, 
language etc. 
 
 Yes 
 No 
 Can’t answer 
 Not applicable 
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5. Was a list of studies (included and excluded) provided? 
A list of included and excluded studies should be provided. 
 
 Yes 
 No 
 Can’t answer 
 Not applicable 
 
 6. Were the characteristics of the included studies provided? 
In an aggregated form such as a table, data from the original studies should be 
provided on the participants, interventions and outcomes. The ranges of 
characteristics in all the studies analyzed e.g. age, race, sex, relevant 
socioeconomic data, disease status, duration, severity, or other diseases 
should be reported.  
 
 Yes 
 No 
 Can’t answer 
 Not applicable 
 
7. Was the scientific quality of the included studies assessed and 
documented? 
‘A priori’ methods of assessment should be provided (e.g., for effectiveness 
studies if the author(s) chose to include only randomized, double-blind, 
placebo controlled studies, or allocation concealment as inclusion criteria); for 
other types of studies alternative items will be relevant. 
 
 
 Yes 
 No 
 Can’t answer 
 Not applicable 
 
8. Was the scientific quality of the included studies used appropriately in 
formulating conclusions? 
 The results of the methodological rigor and scientific quality should be 
considered in the analysis and the conclusions of the review, and explicitly 
stated in formulating recommendations. 
 
 
 Yes 
 No 
 Can’t answer 
 Not applicable 
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9. Were the methods used to combine the findings of studies 
appropriate? 
For the pooled results, a test should be done to ensure the studies were 
combinable, to assess their homogeneity (i.e. Chi-squared test for 
homogeneity, I²). If heterogeneity exists a random effects model should be 
used and/or the clinical appropriateness of combining should be taken into 
consideration (i.e. is it sensible to combine?). 
 
 Yes 
 No 
 Can’t answer 
 Not applicable 
10. Was the likelihood of publication bias assessed? 
An assessment of publication bias should include a combination of graphical 
aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger 
regression test).   
 Yes 
 No 
 Can’t answer 
 Not applicable 
 
11. Was the conflict of interest stated? 
Potential sources of support should be clearly acknowledged in both the 
systematic review and the included studies. 
 
 Yes 
 No 
 Can’t answer 
 Not applicable 
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Appendix 4: Results of inclusion criteria screening 
Table 11. Summary of inclusion criteria screening 
Key to table 
Q1: Does the review address an appropriate and clearly-focused question that is relevant to one or more of the key review questions? 
Q2: Does the review include the types of studies relevant to the key review questions? 
Q3: Is the literature search sufficiently rigorous to identify all the relevant studies? 
Q4: Is the study quality of included studies appropriately assessed and reported? 
Q5: Is an adequate description of the analytical methodology used included, and are the methods used appropriate to the question? 
 
# Reference details Disease/health problem area Q1 Q2 Q3 Q4 Q5 
1.  Anstey, K. J., Mack, H. A. & Cherbuin, N. (2009) Mental and behavioural disorders Yes Yes Yes No Yes 
2.  Bagnardi, V., Blangiardo, M., La Vecchia, C. & Corrao, G. (2001) Neoplasms  No Yes Yes No Yes 
3.  Bagnardi, V., Rota, M., Botteri, E., Scotti, L., et al. (2011) Neoplasms Yes Yes No No Yes 
4.  Bagnardi, V., Zatonski, W., Scotti, L., La, C., et al. (2008) Diseases of the circulatory system Yes Yes No No Yes 
5.  Baliunas, D. O., Taylor, B. J., Irving, H., Roerecke, M., et al. (2009) Endocrine, nutritional and metabolic diseases  Yes Yes Yes No Yes 
6.  Baliunas, D., Rehm, J., Irving, H. & Shuper, P. (2010) Infectious and parasitic diseases Yes Yes Yes No Yes 
7.  Bandera, E., Freudenheim, J. & Vena, J. (2001) Neoplasms Yes Yes Yes No No 
8.  Bay, B. & Kesmodel, U. S. (2011) Pregnancy and conditions originating in the perinatal period  Yes Yes Yes Yes Yes 
9.  Bellocco, R., Pasquali, E., Rota, M., Bagnardi, V., et al. (2012) Neoplasms Yes Yes Yes Yes Yes 
10.  Berg, K. M., Kunins, H. V., Jackson, J. L., Nahvi, S., et al. (2008) Diseases of the musculoskeletal system Yes Yes Yes Yes Yes 
11.  Burger, M., Bronstrup, A. & Pietrzik, K. (2004) Other No No No Yes No 
12.  Carlsson, S., Hammar, N. & Grill, V. (2005) Endocrine, nutritional and metabolic diseases  Yes Yes No No No 
13.  Chao, C. (2007) Neoplasms Yes Yes No No Yes 
14.  Chen, L., Gallicchio, L., Boyd-Lindsley, K., Tao, X., et al. (2008a) Neoplasms Yes Yes Yes Yes Yes 
15.  Cheng, G. & Xie, L. (2011) Neoplasms Yes Yes No No Yes 
16.  Cheng, J. Y. W., Ng, E. M. L., Chen, R. Y. L. & Ko, J. S. N. (2007) Mental and behavioural disorders Yes No Yes Yes Yes 
17.  Chong, E. W.-T., Kreis, A. J., Wong, T. Y., Simpson, J. A., et al. (2008) Diseases of the eye Yes Yes Yes Yes Yes 
18.  Cleophas, T. J. (1999) Diseases of the circulatory system Yes Yes No No Yes 
19.  Cook, R. L. & Clark, D. B. (2005) Infectious and parasitic diseases Yes No No No No 
20.  Corrao, G., Bagnardi, V., Zambon, A. & Arico, S. (1999) Other Yes Yes Yes Yes Yes 
21.  Corrao, G., Bagnardi, V., Zambon, A. & La Vecchia, C. (2004) Other Yes Yes Yes Yes Yes 
22.  Corrao, G., Bagnardi, V., Zambon, A. & Torchio, P. (1998) Diseases of the digestive system Yes Yes No Yes Yes 
23.  Corrao, G., Rubbiati, L., Bagnardi, V., Zambon, A., et al. (2000) Diseases of the circulatory system Yes Yes Yes Yes Yes 
24.  Costanzo, S., Di Castelnuovo, A., Donati, M. B., Iacoviello, L., et al. (2011) Diseases of the circulatory system Yes Yes Yes Yes Yes 
25.  Dennis, L. K. (2000) Neoplasms Yes Yes Yes No Yes 
26.  Di Castelnuovo, A., Costanzo, S., Bagnardi, V., Donati, M. B., et al. (2006) All-cause mortality Yes Yes No No Yes 
27.  Di Castelnuovo, A., Rotondo, S., Iacoviello, L., Donati, M. B., et al. (2002) Diseases of the circulatory system Yes Yes No No Yes 
28.  Ellison, R., Zhang, Y., Mclennan, C. & Rothman, K. (2001) Neoplasms Yes Yes No No Yes 
29.  Fedirko, V., Tramacere, I., Bagnardi, V., Rota, M., et al. (2011) Neoplasms Yes Yes No Yes Yes 
30.  Feigin, V. L., Rinkel, G. J. E., Lawes, C. M. M., Algra, A., et al. (2005) Diseases of the circulatory system Yes Yes No No Yes 
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# Reference details Disease/health problem area Q1 Q2 Q3 Q4 Q5 
31.  Foran, H. M. & O'Leary, K. D. (2008) External causes of morbidity and mortality Yes No Yes No Yes 
32.  Friberg, E., Orsini, N., Mantzoros, C. S. & Wolk, A. (2010) Neoplasms No Yes Yes No Yes 
33.  Henderson, J., Gray, R. & Brocklehurst, P. (2007a) Pregnancy and conditions originating in the perinatal period  Yes Yes Yes Yes Yes 
34.  Henderson, J., Kesmodel, U. & Gray, R. (2007) Pregnancy and conditions originating in the perinatal period  Yes Yes Yes No* Yes 
35.  Holman, C. D., English, D. R., Milne, E. & Winter, M. G. (1996) All-cause mortality Yes Yes No Yes No 
36.  Howard, A. A., Arnsten, J. H. & Gourevitch, M. N. (2004) Endocrine, nutritional and metabolic diseases  Yes Yes No Yes Yes 
37.  Irving, H. M., Samokhvalov, A. V. & Rehm, J. (2012) Diseases of the digestive system Yes Yes Yes No Yes 
38.  Islami, F., Fedirko, V., Tramacere, I., Bagnardi, V., et al. (2011) Neoplasms Yes Yes No No Yes 
39.  Islami, F., Tramacere, I., Rota, M., Bagnardi, V., et al. (2010) Neoplasms Yes Yes No No Yes 
40.  Kan, H. P., Huang, Y. Q., Tan, Y. F. & Zhou, J. (2011) Neoplasms Yes Yes Yes No Yes 
41.  Key, J., Hodgson, S., Omar, R. Z., Jensen, T. K., et al. (2006) Neoplasms Yes Yes Yes Yes Yes 
42.  Kim, H. S., Kim, J. W., Shouten, L. J., Larsson, S. C., et al. (2010) Neoplasms Yes Yes Yes No Yes 
43.  Kodama, S., Saito, K., Tanaka, S., Horikawa, C., et al. (2011) Diseases of the circulatory system Yes Yes Yes No Yes 
44.  Kool, B., Ameratunga, S. & Jackson, R. (2009) External causes of morbidity and mortality Yes Yes Yes Yes No 
45.  Koppes, L. L. J., Bouter, L. M., Dekker, J. M., Heine, R. J., et al. (2005) Endocrine, nutritional and metabolic diseases  Yes Yes No No Yes 
46.  Koppes, L. L. J., Dekker, J. M., Hendricks, H. F. J., Bouter, L. M., et al. (2006) Diseases of the circulatory system Yes Yes No No No 
47.  Korte, J. E., Brennan, P., Henley, S. J. & Boffetta, P. (2002) Neoplasms Yes Yes No No Yes 
48.  Latino-Martel, P., Chan, D. S., Druesne-Pecollo, N., Barrandon, E., et al. (2010) Pregnancy and conditions originating in the perinatal period  Yes Yes No No Yes 
49.  Lönnroth, K., Williams, B., Stadlin, S., Jaramillo, E., et al. (2008) Infectious and parasitic diseases Yes Yes No No Yes 
50.  Mao, Q., Lin, Y., Zheng, X., Qin, J., et al. (2010) Neoplasms Yes Yes Yes No Yes 
51.  Mazzaglia, G., Britton, R., Altmann, D. R. & Chenet, L. (2001) Diseases of the circulatory system Yes Yes Yes No Yes 
52.  McCambridge, J., McAlaney, J. & Rowe, R. (2011) Other Yes Yes Yes Yes Yes 
53.  McFadden, C. B., Brensinger, C. M., Berlin, J. A. & Townsend, R. R. (2005) Diseases of the circulatory system Yes Yes No No Yes 
54.  Middleton Fillmore, K., Chikritzhs, T., Stockwell, T., Bostrom, A., et al. (2009) Neoplasms Yes Yes No No Yes 
55.  Moskal, A., Norat, T., Ferrari, P. & Riboli, E. (2007) Neoplasms Yes Yes No No Yes 
56.  Neafsey, E. J. & Collins, M. A. (2011) Mental and behavioural disorders Yes Yes No No Yes 
57.  Odendaal, H. J., Steyn, D. W., Elliott, A. & Burd, L. (2009) Pregnancy and conditions originating in the perinatal period  No Yes No No No 
58.  Padilla, H., Michael, J. & Djousse, L. (2010) Diseases of the circulatory system Yes Yes No No No 
59.  Parsons, J. K. & Im, R. (2009) Diseases of the genitourinary system  Yes Yes Yes No Yes 
60.  Patra, J., Bakker, R., Irving, H., Jaddoe, V. W. V., et al. (2011) Pregnancy and conditions originating in the perinatal period  Yes Yes Yes Yes Yes 
61.  Patra, J., Taylor, B., Irving, H., Roerecke, M., et al. (2010) Diseases of the circulatory system Yes Yes Yes No Yes 
62.  Pelucchi, C., Galeone, C., Tramacere, I., Bagnardi, V., et al. (2012) Neoplasms Yes Yes No No Yes 
63.  Peters, R., Peters, J., Warner, J., Beckett, N., et al. (2008) Mental and behavioural disorders Yes Yes Yes Yes No 
64.  Polygenis, D., Wharton, S., Malmberg, C., Sherman, N., et al. (1998) Pregnancy and conditions originating in the perinatal period  Yes Yes Yes Yes Yes 
65.  Rehm, J., Samokhvalov, A. V., Neuman, M. G., Room, R., et al. (2009) Infectious and parasitic diseases Yes Yes Yes No* Yes 
66.  Rehm, J., Taylor, B., Mohapatra, S., Irving, H., et al. (2010b) Diseases of the digestive system Yes Yes Yes No Yes 
67.  Reid, M. C., Boutros, N. N., O'Connor, P. G., Cadariu, A., et al. (2002) Other Yes Yes No Yes No 
68.  Reynolds, K., Lewis, B., Nolen, J., Kinney, G., et al. (2003). Diseases of the circulatory system Yes Yes Yes No Yes 
69.  Rimm, E. B., Klatsky, A., Grobbee, D. & Stampfer, M. J. (1996) Diseases of the circulatory system No Yes No No No 
70.  Roerecke, M. & Rehm, J. (2010) Diseases of the circulatory system Yes Yes Yes No Yes 
71.  Roerecke, M. & Rehm, J. (2011) Diseases of the circulatory system Yes Yes Yes Yes Yes 
72.  Roerecke, M. & Rehm, J. (2012) Diseases of the circulatory system Yes Yes Yes No Yes 
73.  Ronksley, P. E., Brien, S. E., Turner, B. J., Mukamal, K. J., et al. (2011) Diseases of the circulatory system Yes Yes Yes Yes Yes 
 Mapping systematic review level evidence          54 
 
# Reference details Disease/health problem area Q1 Q2 Q3 Q4 Q5 
74.  Rota, M., Bellocco, R., Scotti, L., Tramacere, I., et al. (2010) Neoplasms No Yes No No Yes 
75.  Rota, M., Pasquali, E., Scotti, L., Pelucchi, C., et al. (2012a) Neoplasms Yes Yes No No Yes 
76.  Rota, M., Scotti, L., Turati, F., Tramacere, I., et al. (2012b) Neoplasms Yes Yes No No Yes 
77.  Samokhvalov, A. V., Irving, H. M. & Rehm, J. (2010b) Diseases of the circulatory system Yes Yes Yes No Yes 
78.  Samokhvalov, A. V., Irving, H. M. & Rehm, J. (2010c) Diseases of the respiratory system Yes Yes Yes No Yes 
79.  Samokhvalov, A. V., Irving, H., Mohapatra, S. & Rehm, J. (2010a) Diseases of the nervous system Yes Yes Yes No Yes 
80.  Shuper P. A., Neuman M., Kanteres F., Baliunas D., Joharchi N., Rehm J. (2010) Infectious and parasitic diseases No No No No No 
81.  Smith, G. S., Branas, C. C. & Miller, T. R. (1999) External causes of morbidity and mortality Yes Yes Yes No No 
82.  Song, D. Y., Song, S., Song, Y. & Lee, J. E. (2012) Neoplasms Yes Yes Yes Yes Yes 
83.  Sun, Q., Xu, L., Zhou, B., Wang, Y., et al. (2011) Neoplasms Yes Yes Yes No Yes 
84.  Suzuki, R., Orsini, N., MigNone, L., Saji, S., et al. (2008) Neoplasms Yes Yes No No Yes 
85.  Taylor, B. & Rehm, J. (2012) External causes of morbidity and mortality Yes Yes Yes No Yes 
86.  Taylor, B., Irving, H. M., Baliunas, D., Roerecke, M., et al. (2009) Diseases of the circulatory system Yes Yes Yes No Yes 
87.  Taylor, B., Irving, H. M., Kanteres, F., Room, R., et al. (2010) External causes of morbidity and mortality Yes Yes Yes No Yes 
88.  Testa, M., Quigley, B. M. & Eiden, R. D. (2003) Pregnancy and conditions originating in the perinatal period  Yes Yes Yes No Yes 
89.  Teunissen, L. L., Rinkel, G. J. E., Algra, A. & Van Gijn, J. (1996) Diseases of the circulatory system Yes Yes No No No 
90.  Tramacere, I., Negri, E., Bagnardi, V., Garavello, W., et al. (2010a) Neoplasms Yes Yes No No Yes 
91.  Tramacere, I., Negri, E., Pelucchi, C., Bagnardi, V., et al. (2012a) Neoplasms Yes Yes No No Yes 
92.  Tramacere, I., Pelucchi, C., Bagnardi, V., Rota, M., et al. (2012) Neoplasms Yes Yes No No Yes 
93.  Tramacere, I., Pelucchi, C., Bonifazi, M., Bagnardi, V., et al. (2012b) Neoplasms Yes Yes No No Yes 
94.  Tramacere, I., Scotti, L., Jenab, M., Bagnardi, V., et al. (2010b) Neoplasms Yes Yes No Yes Yes 
95.  Turati, F., Gallus, S., Tavani, A., Tramacere, I., et al. (2010) Neoplasms Yes Yes No No Yes 
96.  Turati, F., Garavello, W., Tramacere, I., Bagnardi, V., et al. (2010) Neoplasms Yes Yes No No Yes 
97.  Turati, F., Garavello, W., Tramacere, I., Pelucchi, C., et al. (2013) Neoplasms Yes Yes No No Yes 
98.  Wang, J., Pan, H. F., Ye, D. Q., Su, H., et al. (2008) Diseases of the musculoskeletal system Yes Yes Yes Yes No 
99.  Zeegers, M. P., Tan, F. E., Verhagen, A. P., Weijenberg, M. P., et al. (1999) Neoplasms Yes Yes Yes No Yes 
100. Zeisser, C., Stockwell, T. R., Chikritzhs, T., Cherpitel, C., et al. (2013) External causes of morbidity and mortality Yes Yes Yes No Yes 
101. Zeka, A., Gore, R. & Kriebel, D. (2003) Neoplasms Yes No No No Yes 
102. Zhang, X., Zhang, Y. & Hu, Q. (2010) Pregnancy and conditions originating in the perinatal period  Yes Yes Yes No No 
103. Zhu, K. J., Zhu, C. Y. & Fan, Y. M. (2012) Diseases of the skin and subcutaneous tissue  Yes Yes No No Yes 
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Appendix 5. Data extraction tables and AMSTAR assessment 
Table 12. Summary of methods: Systematic reviews and meta-analyses 
Reference Search strategy Inclusion criteria Data extraction and QA Methods of analysis AMSTAR 
rating 
Anstey et al., 
2009 
 
Databases searched: PubMed, 
PsycINFO, Cochrane Library,  
Years searched: Inception to June 
2007 
Keywords/MESH terms: e.g. 
alcohol*, drink*, drunk*, cognit*, intell*, 
IQ, memory 
Other strategies: Reference lists of 
retrieved articles were screened 
Limits: English language 
Population(s): NR
Exposure: NR 
Outcome(s): Minimum 1-year follow-
up, had to include dementia or 
cognitive decline. Studies needed to 
have (i) screened for dementia at 
baseline or adjusted for cognitive 
function; or (ii) measured cognition at 
baseline and follow-up and either  
dementia assessment at baseline 
(excluding participants with cognitive 
impairment 
or dementia) or adjusted for incident 
dementia and/or baseline cognition 
performance 
Study design(s): NR. Experimental 
and clinical studies were excluded 
Process for selection: Retrieved 
articles examined by at least two 
authors 
Data extraction variables: Study 
design 
(sample source, number of 
participants, observation period), 
sample characteristics (percentage 
female, average age, years of 
education), measurement of alcohol 
(amount and type of alcohol 
consumed, history of past 
consumption, frequency of 
consumption), measurement of 
dementia or cognition, unadjusted and 
adjusted estimates of association with 
95% confidence intervals and 
covariates. 
Process for data extraction: Double 
checked by a second reviewer who 
was blinded to the title, authors, 
publication date, and journal name of 
the article 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; fixed effects unless 
heterogeneity detected 
Measure of effect: Relative risk  
Assessment of heterogeneity: Chi-
squared tests 
Assessment of publication bias: NR 
Sensitivity analyses: NR 
Dose-response analyses: NR 
5 
Bagnardi et 
al., 2001 
 
Databases searched: Medline, 
Current Contents, EMBASE, CAB 
Abstracts, Core Biomedical Collection 
Years searched: 1996–2000 
Keywords/MESH terms: NR 
Other strategies: Screened 
references of retrieved studies, hand 
search of relevant journals, compared 
search results with other general 
reviews and meta-analyses. 
Limits: NR 
Population(s): NR
Exposure: NR 
Outcome(s): Expressed as relative 
risk or odds ratio 
Study design(s): Case-control or 
cohort study 
Process for selection: Two reviewers 
independently reviewed each article 
Data extraction variables: NR 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: NR 
Assessment of publication bias: NR 
Sensitivity analyses: NR 
Dose-response analyses: Based on 
methods proposed by Greenland and 
Longnecker. 
2 
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Bagnardi et 
al., 2011 
 
Databases searched: Medline 
Years searched: 1960 to Jan 2010 
Keywords/MESH terms: Ethanol, 
alcohol drinking, alcohol, alcoholic 
beverages, lung cancer, lung 
neoplasm 
Other strategies: Reference lists of 
retrieved articles and of reviews and 
meta-analyses published on the issue 
were screened 
Limits: English language 
Population(s): Never smokers
Exposure: Alcohol consumption 
Outcome(s): Lung cancer; risk 
estimates and CIs or calculable 
Study design(s): Case–control or 
cohort 
Process for selection: Three 
investigators independently 
determined the eligibility of each article 
for inclusion 
Data extraction variables: Study 
design, country, gender, categories of 
alcohol intake considered, RR 
estimates and 95% CIs, adjustment 
variables and the number of cases and 
controls or the number of events and 
subjects at risk for the reported 
exposure levels 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: Q and 
I2 statistics 
Assessment of publication bias: 
Egger’s test 
Sensitivity analyses: Influence 
analysis used (i.e. one study omitted 
at a time from the pooled analysis); 
compared the summary effect 
estimates for subgroups stratified on 
study or quality characteristics e.g. 
study design (cohort or case–control), 
geographic area, definition of ‘never 
smokers’, gender and adjustment for 
potential confounders. 
Dose-response analyses: Based on 
methods proposed by Greenland and 
Longnecker. 
4 
Baliunas et 
al., 2009 
Databases searched: Medline, 
CINAHL, EMBASE, CAB Abstracts, 
WHOLIS, SIGLE, ETOH, Web of 
Science, AIM database. 
Years searched: Jan 1980 to Jan 
2008 
Keywords/MESH terms: Alcohol or 
ethanol, diabetes, case-control or 
cohort or prospective, and risk 
Other strategies: References of 
reviewed articles and relevant reviews 
screened. 
Limits: None 
Population(s): NR
Exposure: Alcohol consumption 
Outcome(s): Morbidity or 
mortality due to diabetes 
Study design(s): Cohort and case-
control 
Process for selection: One 
researcher; limited duplication by a 
second researcher 
Data extraction variables: 
Descriptors of study design, measure 
of association (hazard ratios, odds 
ratios, relative risks) 
Process for data extraction: One 
researcher; limited duplication by a 
second researcher  
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: Q 
test, I2 statistic 
Assessment of publication bias: 
Funnel plots; Egger and Begg tests 
Sensitivity analyses: Model variation 
by self-reported outcome for diabetes; 
analysis repeated using most adjusted 
estimates available. 
Dose-response analyses: Meta-
regression using linear, first-order, and 
second order fractional polynomial 
regression of inverse variance–
weighted data; Chi-squared 
distribution to determine best fit. 
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Baliunas et 
al., 2010 
Databases searched: Medline, 
PubMed, CINAHL, EMBASE 
Years searched: Inception to May 
2008 
Keywords/MESH terms: alcohol, 
ethanol, incidence, incident, risk, 
seroincidence, seroconvert*, HIV*, 
human immunodeficiency virus, STI, 
STIs, sexually 
transmitted infection*, STD, STD, 
sexually transmitted disease* 
Other strategies: None 
Limits: No language restrictions 
Population(s): NR
Exposure: Average consumption, 
binge consumption, and consumption 
prior to, or at the time of, sex 
Outcome(s): NR 
Study design(s): NR 
Process for selection: NR 
Data extraction variables: Study 
design, measures of association,  
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects 
Measure of effect: Relative risk  
Assessment of heterogeneity: Q-
statistic and I2 statistic 
Assessment of publication bias: 
Egger and Begg tests 
Sensitivity analyses: Stratified by 
sex, compared developed and 
developing countries, MSM vs. 
samples of other men. 
Dose-response analyses: NA 
2.5 
Bay & 
Kesmodel,  
2011 
Databases searched: Medline, 
Embase, Web of Science, Scopus and 
The Cochrane Library 
Years searched: NR; undertaken Feb 
2010 
Keywords/MESH terms: alcohol, 
alcohol drinking, alcohol-related 
disorders, pregnancy, motor skills, 
motor skills disorders, and child 
development 
Other strategies: Review of the 
reference lists of included papers 
Limits: English language 
Population(s): NR
Exposure: Categorized levels or 
continuous measures of average 
alcohol consumption 
or binge drinking and/or children with a 
diagnosis of FAS, children with 
reported maternal alcohol 
consumption in pregnancy and 
specialist-confirmed alcohol traits, 
and/or children of mothers with 
diagnosed alcoholism 
Outcome(s): Evaluation and scoring 
of children’s motor function using 
standardised or validated test 
Study design(s): Cohort and case-
control 
studies 
Process for selection: Reviewed 
independently by two authors 
Data extraction variables: NR 
Process for data extraction: NR 
Details of QA tool/checklist: 
Newcastle–Ottawa Scale 
Process for quality assessment: NR 
How were studies combined: 
Narrative synthesis 
Measure of effect: NA 
Assessment of heterogeneity: NA 
Assessment of publication bias: NA  
Sensitivity analyses: NA 
Dose-response analyses: NA 
3 
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Bellocco et 
al., 2012 
Databases searched: Medline, 
EMBASE 
Years searched: 1966 to Nov 2010 
Keywords/MESH terms: Alcohol 
drinking, kidney, renal cell carcinoma, 
cancer, neoplasm 
Other strategies: NR 
Limits: English language 
Population(s): NR
Exposure: At least three levels of 
alcohol consumption 
Outcome(s): Renal cell carcinoma; 
risk estimates and SE/CIs or 
calculable 
Study design(s): Cohort and case-
control 
Process for selection: Three authors 
independently selected articles. 
 
Data extraction variables: Study 
design, country, gender, categories of 
alcohol consumption, RR estimates 
and CIs, adjustment variables, and the 
number of cases and controls or 
number of events and cohort size. 
Process for data extraction: NR 
Details of QA tool/checklist: Quality 
score assigned based on the 
Newcastle and Ottawa scale 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk  
Assessment of heterogeneity: Chi- 
squared and I2 statistic 
Assessment of publication bias: NR 
Sensitivity analyses: NR 
Dose-response analyses: Used a 
random effects meta-regression model 
in a nonlinear dose–response 
relationship framework to provide the 
best-fitting two-term fractional-
polynomial model 
6 
Berg et al., 
2008 
Databases searched: MEDLINE, 
Cochrane Central Register of 
Controlled Trials, Current Contents, 
PsycINFO 
Years searched: NR; undertaken May 
2007 
Keywords/MESH terms: Alcohol, 
alcoholic, alcoholism, beer, wine, 
liquor, osteoporosis, osteopenia, bone 
mineral density, BMD, bone resorption 
(full details in article) 
Other strategies: Searched 
references of included studies and 
pertinent reviews 
Limits: English language 
Population(s): Adults both exposed 
and not exposed to alcohol 
Exposure:  
Outcome(s): Osteoporotic fracture 
rate, bone density, bone response to 
oestrogen 
Study design(s): Experimental, 
cohort and case-control studies 
Process for selection: Two reviewers 
independently assessed each 
reference 
 
Data extraction variables: 
Association between alcohol 
consumption and the outcome, 
adjustment for potential confounders. 
Process for data extraction: Two 
authors extracted data 
Details of QA tool/checklist: Based 
on internal validity criteria of the US 
Preventive Services Task Force 
Process for quality assessment: 
Number of reviewers NR; reports that 
differences were discussed until 
agreement reached. 
How were studies combined: Meta-
analysis (hip fracture); random effects 
Measure of effect: Relative risk 
Assessment of heterogeneity: Q and 
I2 statistics 
Assessment of publication bias: NR 
Sensitivity analyses: NR 
Dose-response analyses: NA 
5 
Chen et al., 
2008a 
 
Databases searched: PubMed, 
EMBASE, Cochrane Library, Chinese 
Biomedical Literature Database 
System 
Years searched: Inception to Apr 
2006 
Keywords/MESH terms:  
Other strategies: Screened 
references in 1997 World Cancer 
Research Fund report, articles 
selected for extraction, and relevant 
review articles or meta-analyses 
Limits: None 
Population(s): NR
Exposure: Total alcohol, beer, wine, 
spirits, or any alcoholic beverages 
Outcome(s): Nasopharyngeal 
carcinoma 
Study design(s): NR; case reports 
and case series excluded 
Process for selection: Evaluated 
independently by two reviewers 
Data extraction variables: Not fully 
described 
Process for data extraction: 
Extracted from the eligible articles by 
two reviewers 
using an electronic abstraction 
database 
Details of QA tool/checklist: 
Evaluated using a modification of the 
criteria used by Longnecker et al. 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk  
Assessment of heterogeneity: Q and 
I2 statistic 
Assessment of publication bias: 
Funnel plots 
Sensitivity analyses: Each study was 
excluded from the meta-analysis in 
turn 
Dose-response analyses: Conducted 
with models that tested for both linear 
and quadratic trends. 
6.5 
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Chong et al., 
2008 
Databases searched: PubMed, Web 
of Science, EMBASE, Medline, 
Cochrane Library, abstracts from the 
Association for Research in Vision and 
Ophthalmology, and National Institutes 
Of Health Clinical Trial Databases 
Years searched: Inception to Jun 
2007 
Keywords/MESH terms: alcohol, 
wine, beer, liquor, age-related macular 
degeneration,  age-related 
maculopathy, macular degeneration, 
retinal degeneration, drusen, choroidal 
neovascularization, geographic 
atrophy 
Other strategies: References 
screened in pertinent articles and 
books 
Limits: No limits placed on the year or 
language of publication. 
Population(s): NR
Exposure: Alcohol consumption 
Outcome(s): Clear definition of age-
related macular degeneration; 
estimates of odds ratios (ORs), 
relative risks, or the primary data to 
calculate. 
Study design(s): Prospective cohort 
studies; follow-up of at least one year; 
appropriate statistical techniques to 
adjust for key potential confounders 
(particularly age and smoking) 
Process for selection: Undertaken 
independently by two reviewers 
Data extraction variables: NR 
Process for data extraction: 
Undertaken independently by two 
reviewers 
Details of QA tool/checklist: Downs 
& Black instrument; three ratings: A = 
high quality; B = moderate quality; C = 
low quality. 
Process for quality assessment: 
Undertaken independently by two 
reviewers 
How were studies combined: Meta-
analysis 
Measure of effect: Odds ratio 
Assessment of heterogeneity: I2 
statistic 
Assessment of publication bias: 
Visual inspection of funnel plot 
Sensitivity analyses: Exclude 
volunteer-based studies and studies 
with the highest alcohol consumption 
category including consumption < 30 
g/day 
Dose-response analyses: Unable to 
determine 
7.5 
Corrao et al., 
2004 
Databases searched: MEDLINE, 
Current Contents, EMBASE, CAB 
Abstracts, and Core Biomedical 
Collection 
Years searched: 1966-1998 
Keywords/MESH terms: Alcohol 
consumption, relative risk, malignant 
neoplasms (oral cavity and pharynx, 
oesophagus, colon, rectum, liver, 
larynx, and breast), essential 
hypertension, coronary heart disease, 
haemorrhagic stroke, ischemic stroke, 
gastroduodenal ulcer, liver cirrhosis, 
chronic pancreatitis, injuries and 
violence. 
Other strategies: Screened reference 
lists of retrieved articles, hand search 
of relevant epidemiology and medicine 
journals, compared search with that of 
general reviews and meta-analyses 
published on this issue. 
Limits: NR 
Population(s): NR
Exposure: At least three levels of 
alcohol consumption 
Outcome(s): Odds ratio or relative 
risk 
Study design(s): Cohort and 
case-control 
Process for selection: Two 
researchers independently determined 
the eligibility of each paper. 
 
NB: Criteria for selection in the final 
analysis were: high quality score; 
reporting estimates adjusted for the 
main risk; or performed with a 
prospective cohort design. 
Data extraction variables: NR 
Process for data extraction: NR 
Details of QA tool/checklist: 
Questions related to the study design 
(9 items), data collection methods for 
alcohol consumption (4 questions), 
and data analysis (2 items). 
Process for quality assessment: 
Two researchers independently scored 
the quality of the studies. 
Discrepancies resolved by discussion. 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: Q-
statistic. 
Assessment of publication bias: NR 
Sensitivity analyses: NR 
Dose-response analyses: Four step 
procedure: (i) weighed least squares 
regression models fitted by prepooling 
the results of all included studies; (ii) 
meta-regression models fitted; (iii) 
pooled RR and corresponding 95% 
CIs were derived from the parameters 
of the meta-regression models; (iv) the 
consistency of the model based RR 
was evaluated with reference studies 
reporting relative risks for light 
consumption (≤25 g/day). 
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Costanzo et 
al., 2011 
Databases searched: PubMed, 
EMBASE Years searched: NR; 
undertaken Mar 2011 
Keywords/MESH terms: alcohol, 
wine, beer, liquor, spirits, 
cardiovascular disease 
mortality, morbidity, survival, and 
death 
Other strategies: Screened 
references of retrieved articles and 
reviews 
Limits: English language 
Population(s): NR
Exposure: Different categories of 
alcohol exposure 
Outcome(s): Vascular mortality 
(cardiovascular disease, coronary 
heart disease and ischemic heart 
disease), non-fatal vascular events 
(acute myocardial infarction, stroke 
and coronary heart disease) 
Study design(s): NR 
Process for selection: Two authors 
independently reviewed articles 
Data extraction variables: Alcohol 
intake (g/day) assigned as the 
midpoint of the reported ranges; 
frequency counts, adjusted 
RR, and 95% CI; covariates describing 
the characteristics of the study. 
Process for data extraction: NR 
Details of QA tool/checklist: 
Newcastle-Ottawa Scale; a second 
quality scale considered the 
assessment of alcohol drinking 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: NR 
Assessment of publication bias: 
Inspection of funnel plots; Egger test 
Sensitivity analyses: Tested the 
inclusion of interaction terms between 
the covariates (design of study, 
country setting, duration of follow-up) 
and alcohol intake (amount) 
Dose-response analyses: Models to 
be fitted were selected from among 
fractional polynomial curves of the 
second order. The best fit was defined 
as that with the highest likelihood. 
7 
Di 
Castelnuovo 
et al., 2006 
Databases searched: PubMed 
Years searched: Inception to Dec 
2005 
Keywords/MESH terms: Alcohol, 
beer, wine, spirits, mortality, death 
Other strategies: Screened reference 
lists of retrieved studies. 
Limits: None 
Population(s): NR
Exposure: NR 
Outcome(s): All-cause mortality 
Study design(s): NR 
Process for selection: NR 
Data extraction variables: NR 
Process for data extraction: NR  
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: 
Assessment of publication bias: 
Sensitivity analyses: 
Dose-response analyses: Models to 
be fitted were selected from among 
fractional polynomial curves of the 
second order. Best fitting curve 
defined as that with the highest 
likelihood; based on random effects 
model. 
3 
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Fedirko et al., 
2011 
 
Databases searched: PubMed 
Years searched: Inception to May 
2010 
Keywords/MESH terms: Alcohol, 
ethanol, alcoholic beverages, 
colorectal neoplasms 
Other strategies: Reference lists of 
the identified articles and previous 
literature reviews and meta-analyses 
were screened. 
Limits: English language 
Population(s): NA
Exposure: Total alcohol intake; at 
least three categories of consumption 
Outcome(s): Colorectal cancer 
incidence or mortality; risk reported as 
OR/RR 
Study design(s): Case-control or 
cohort 
Process for selection: NR 
Data extraction variables: Study 
design, country, number of patients, 
duration of follow-up, type of controls, 
sex, variables adjusted for in the 
analysis, risk estimates for categories 
of alcohol consumption (and 95% CIs), 
the number of cases and non-cases or 
(person-years) for each level of 
alcohol consumption 
Process for data extraction: NR  
Details of QA tool/checklist: 
Predefined criteria (scoring 0-10) that 
addressed study design, assessment 
of alcohol drinking, and data analysis. 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: 
Assessment of heterogeneity: Chi-
squared and I2 statistic; subgroup 
analyses and meta-regression models 
conducted to investigate heterogeneity 
(further details not provided in 
methods) 
Assessment of publication bias: 
Egger and Begg-Mazumdar tests, trim 
and fill method, and contour enhanced 
funnel plots 
Sensitivity analyses: Assessed 
whether estimates were robust to the 
inclusion of studies (i) with a reference 
category for alcohol exposure different 
from non-drinkers, (ii) reporting 
estimates not adjusted for the main 
risk factors (age, sex, body fatness, 
smoking, and physical activity), and 
(iii) not reporting 95% CI for adjusted 
risk estimates. 
Dose-response analyses: Based on 
both linear and non-linear random 
effects models. Methods were adapted 
to account for correlation between 
reported risk estimates within the 
same study, heterogeneity between 
the studies, and a nonlinear dose–risk 
relation. The final dose–risk relation 
model was selected from tests of 
fractional polynomial random effects 
models and linear random effect 
models (defined as the one with the 
lowest Akaike’s information criterion). 
6 
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Henderson et 
al., 2007a; 
2007b 
Databases searched: Medline, 
EMBASE, CINAHL, PsycINFO 
Years searched: Inception to 2005 
Keywords/MESH terms: Full strategy 
reported 
Other strategies: NR 
Limits: Published between Jan 1970 
and Jul 2005; English language; peer-
reviewed articles 
Population(s): 
Exposure: Average weekly 
alcohol consumption grouped into two 
or more categories; or measure of 
binge drinking reported separately 
from heavy drinking 
Outcome(s): Miscarriage, stillbirth, 
intrauterine growth restriction, preterm 
birth, low birth weight, small for 
gestational age at birth or birth defects 
including fetal alcohol syndrome or 
neurodevelopmental outcomes 
Study design(s): Case–control, 
cohort or 
cross-sectional studies 
Process for selection: Reviewed 
independently by two members of the 
research team 
Data extraction variables: NR 
Process for data extraction: Each 
article was data extracted by a single 
reviewer and checked for accuracy by 
a second 
Details of QA tool/checklist: 
Newcastle–Ottawa Scale 
Process for quality assessment: NR 
How were studies combined: 
Narrative synthesis 
Measure of effect: NA  
Assessment of heterogeneity: NA 
Assessment of publication bias: NA 
Sensitivity analyses: NA 
Dose-response analyses: NA  
4 
Irving et al., 
2012 
Databases searched: Medline, 
EMBASE, CINAHL, Web of Science, 
ETOH and AIM 
Years searched: Jan 1980 – Jan 
2008 
Keywords/MESH terms: Alcohol, 
alcohol consumption, alcohol intake, 
ethanol, heavy drinking, and 
pancreatitis 
Other strategies: Hand searched 
content pages of major 
epidemiological journals; screened 
reference lists of relevant and review 
articles 
Limits: Human studies, no language 
restrictions applied 
Population(s): NR
Exposure: Three or more 
quantitatively measured exposure 
categories of alcohol consumption 
Outcome(s): Pancreatitis morbidity 
and/or mortality; report hazard ratios, 
relative risks or odds ratios and their 
95% confidence intervals (or 
information to compute them) 
Study design(s): Case-control or 
cohort study 
Process for selection: NR 
Data extraction variables: Study 
details, year of publication, sample 
size, country, age, sex, endpoints, 
adjustments, study design, exposure 
and outcome measures, RRs of 
pancreatitis and corresponding 95% 
CIs for each category of alcohol 
consumption 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: Q and 
I2 statistics 
Assessment of publication bias: 
Visual inspection of Begg's funnel plot; 
Begg-Mazumdar and Egger tests 
Sensitivity analyses:  
Dose-response analyses: Methods 
proposed by Greenland and 
Longnecker; fitted first and second 
degree fractional polynomial models 
using a random effects model; best 
fitting model selected based on a 
closed-test comparison between 
fractional polynomial models 
5 
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Islami et al., 
2010 
 
 
Databases searched: PubMed 
Years searched: Inception to May 
2010 
Keywords/MESH terms: Alcohol, 
alcoholic beverage, ethanol, wine, 
beer, spirit, drinking, intake, 
consumption, drinking pattern, larynx, 
neoplasm, cancer, tumor, Laryngeal 
neoplasm 
Other strategies: Searched the 
bibliographies of relevant original and 
review articles, a recent systematic 
report, and IARC monograph reports 
Limits: NR 
Population(s): NR
Exposure: Alcohol consumption 
Outcome(s): Laryngeal cancer;  ratio 
measure of effect and CIs 
Study design(s): Case-control or 
cohort 
Process for selection: NR 
Data extraction variables: Design 
and country of studies, number and 
sex of participants, source of controls 
and duration of follow-up, variables for 
which study results were controlled, 
number of cases and non-cases for 
each alcohol consumption level, and 
RRs and corresponding 95% CIs for 
each category. 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk  
Assessment of heterogeneity: I2 
statistic 
Assessment of publication bias: 
Begg and Mazumdar’s test, Egger’s 
test, funnel plots 
Sensitivity analyses: Selected only 
studies: (1) with population-based 
controls; (2) using exclusively non-
drinkers as reference category; and (3) 
presenting RRs adjusted for main 
potential confounding factors (age, 
sex, and tobacco use). 
Dose-response analyses: Used a 
random-effects meta-regression model 
in a non-linear dose–risk relationship 
framework to provide the best-fitting 
two-term fractional–polynomial model. 
4 
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Islami et al., 
2011 
 
Databases searched: PubMed 
Years searched: Jan 1999 to Jun 
2010 
Keywords/MESH terms: Esophageal 
neoplasms, cohort, prospective,  case-
control, case control 
Other strategies: Reviewed 
bibliographies of relevant original and 
review articles and systematic reports; 
used a list of publications prepared for 
an earlier meta-analysis (articles 
published up to 2000) 
Limits: English language 
Population(s): NR
Exposure: Total alcohol intake 
Outcome(s): Oesophageal squamous 
cell carcinoma or all oesophageal 
cancer combined; risk estimates and 
CIs or calculable 
Study design(s): Case-control or 
cohort 
Process for selection: NR 
Data extraction variables: Study 
design, study area and period, number 
of participants, sex, source of controls, 
variables controlled for, number of 
cases and non-cases, RR and CIs for 
each alcohol consumption level 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk  
Assessment of heterogeneity: I2 
statistic 
Assessment of publication bias: 
Begg’s and Egger’s tests 
Sensitivity analyses: Subgroup 
analyses including: (i) only prospective 
studies; (ii) studies with more precise 
estimates (i.e. those with SE <0.5 
[light/moderate or <0.3 [heavy]); (iii) 
only population–based controls; (iv) 
oesophageal squamous cell 
carcinoma only; (v) geographic area; 
(vi) estimates adjusted for main 
potential confounding factors (age, sex 
and smoking); (vii) sex; (viii) excluding 
two studies that reported adjusted RRs 
without 95% CIs; (ix) excluding two 
studies with potential overlap with 
other studies; (x) studies with 
exclusively non-drinkers as the 
reference category; and (xi) mortality 
vs. incidence. 
Dose-response analyses:  
3 
Kan et al., 
2011 
 
 
Databases searched: Medline, 
EMBASE, the Cochrane Library 
Years searched: 1966-2010 
Keywords/MESH terms: Alcohol, 
extrahepatic bile duct, cancer, biliary 
tract cancers, cholangiocarcinoma, 
gallbladder cancer, Vater’s ampulla 
cancer 
Other strategies: References in 
abstracted articles and previous 
relevant reviews screened 
Limits: English language 
Population(s): NR 
Exposure: NR 
Outcome(s): RR or equivalent 
Study design(s): Case–control or 
cohort 
Process for selection: NR 
Data extraction variables: Authors, 
published year, country, age range, 
study design, participant number and 
adjusting 
variables 
Process for data extraction: Data 
abstracted independently by two 
reviewers 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Odds ratio 
Assessment of heterogeneity: I2 
statistic 
Assessment of publication bias: 
Begg’s and Egger’s tests 
Sensitivity analyses: Excluded 
studies which potentially biased the 
results 
Dose-response analyses: NA 
4 
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Key et al., 
2006 
Databases searched: Medline, 
EMBASE, Pascal, Science Citation 
Index, Social Sciences Citation Index, 
Index to Scientific and Technical 
Proceedings, Biological Abstracts 
(BIOSIS), Biological Sciences, AIDS 
and Cancer Research Abstracts, 
Biology Digest, Conference Papers 
Index, Cochrane Library, NHS 
National Research Register (NRR), 
SIGLE, NTIS, TOXLINE 
Years searched: Jan 1966 to Dec 
2003 
Keywords/MESH terms: Breast, 
neoplasm, ethanol  
Other strategies: Screened reference 
lists of identified articles, citation 
searching, identification of grey 
literature, and searches of conference 
proceedings. 
Limits: None 
Population(s): NR
Exposure: NR 
Outcome(s): incident first primary 
breast cancer 
Study design(s): Case-control and 
cohort 
Process for selection: NR 
Data extraction variables: NR 
Process for data extraction: Data 
abstracted independently by two 
reviewers 
Details of QA tool/checklist: Simple 
three-point scoring system used; 1 = 
studies with inadequate design; 2 = 
studies with acceptable design but 
insufficient control for confounding; 3 = 
studies with acceptable design and 
adequate control for confounding. 
Process for quality assessment: 
Studies scored independently by two 
reviewers 
How were studies combined: Meta-
analysis 
Measure of effect: Odds ratio 
Assessment of heterogeneity: Q 
statistic, meta-regression (data 
collected before or after disease onset, 
whether the controls were hospital or 
community based [case-control 
studies]; pre or postmenopausal; and 
nationality of the study population 
[USA or Can/Europe/other]) 
Assessment of publication bias: 
Funnel plots 
Sensitivity analyses: Assessed how 
differing quality criteria and control for 
confounding affected d the size of the 
risk estimate. 
Dose-response analyses: Used 
“pool-first” method then calculated 
dose-response slopes (among 
drinkers) for each study by use of log 
linear regression and a variable 
intercept; dose-response slopes were 
pooled using a random effects model. 
6.5 
Kodama et 
al., 2011 
Databases searched: Medline, 
EMBASE 
Years searched: Inception to Dec 
2009 
Keywords/MESH terms: Alcohol 
drinking, alcohol related, disorders, 
alcoholism, alcoholic beverage, 
ethanol, arrhythmias, atrial fibrillation 
Other strategies: Screened reference 
lists from identified articles 
Limits: No language restrictions 
Population(s): NR
Exposure: Daily alcohol consumption 
Outcome(s): Identify atrial fibrillation 
separate from other arrhythmias; 
report (or allow calculation of) effect 
measures and corresponding 95% CIs 
Study design(s): Cohort or case-
control study 
Process for selection: Independently 
reviewed by two authors  
Data extraction variables: Study 
details, year of publication, geographic 
region, study design, selection of study 
population, participants’ 
characteristics, characteristics of 
outcome, methods of assessment of 
alcohol consumption, methods for 
ascertainment of atrial fibrillation, 
category of alcohol intake, number of 
participants and cases, and study-
specific controlled variables. 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: Q and 
I2 statistics 
Assessment of publication bias: 
Visual inspection of a funnel plot; Begg 
and Egger tests; “trim and fill” 
procedure 
Sensitivity analyses: Meta-
regression analyses used to assess 
the influence of study characteristics 
on study results. 
Dose-response analyses: Weighted, 
least-squared regression models used; 
also restricted cubic splines with knots 
at the 25th, 50th, and 75th centiles of 
the distribution of alcohol 
consumption. 
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Kool et al., 
2009 
Databases searched: Medline, 
EMBASE, CINAHL, PsycINFO, and 
Scopus 
Years searched: 1983 to 2007 
Keywords/MESH terms: Accidental 
falls, accidents, home, alcohol, ethyl, 
BAC, alcohol drinking. 
Other strategies: Reference lists of 
retrieved articles, proceedings of 
conferences, hand-searching journals, 
internet searches (policy and research 
websites) and contact with key 
researchers in the field.  
Limits: English language papers. 
Population(s): Young and middle 
aged adults aged 25-60 years. Studies 
including subjects in residential care, 
work-related falls, or studies of injuries 
limited to a specific body region (e.g., 
hip fracture, traumatic brain injury, 
maxillofacial injuries) were excluded. 
Exposure: Acute or usual alcohol 
consumption (a defined period 
immediately prior to the event) 
Outcome(s): Magnitude of fall risk, 
self-reported falls (injurious and non 
injurious),ED visit or admission to 
hospital for a fall related injury, death 
as a result of a fall-related injury and 
fractures as a result of falls. 
Study design(s): Case control, 
cohort , case-crossover studies 
Process for selection: NR 
 
Data extraction variables: 
Participants, comparison group, 
exposure, confounders 
considered, outcomes, results and 
study quality  
Process for data extraction: NR 
Details of QA tool/checklist: GATE 
LITE (a visual framework used to 
appraise epidemiological studies). 
Process for quality assessment: NR 
How were studies combined: 
Narrative synthesis; meta-analysis 
was not attempted because of the 
heterogeneity of the eligible studies 
Measure of effect: NA  
Assessment of heterogeneity: 
Identified studies were heterogeneous 
in many respects and were not 
considered sufficiently robust to 
combine quantitatively. 
Assessment of publication bias: NA 
Sensitivity analyses: NA 
Dose-response analyses: NA 
4.5 
Latino-Martel 
et al., 2010 
Databases searched: Pubmed  
Years searched: up to May 7 2009 
Keywords/MESH terms: Leukaemia, 
alcohol drinking, alcoholic beverages, 
ethanol, acetaldehyde, risk, risk factor, 
risk assessment, food, pregnancy, 
maternal exposure, prenatal exposure 
delayed effects, maternal-fetal 
exchange, prenatal nutrition 
physiology, parents, fetal alcohol 
syndrome 
Other strategies: In-process 
publications were searched and the 
reference list of relevant articles and 
reviews. 
Limits: No language restrictions.  
 
 
Population(s): Children aged 0-18 
years 
Exposure: Maternal alcohol intake 
during pregnancy (compared with no 
alcohol intake) 
Outcome(s): Risk of childhood 
leukaemia 
Study design(s): Case control studies 
Process for selection: NR 
Data extraction variables: Study 
design, first author, publication year, 
country, case recruitment period, 
number and characteristics of cases 
and controls, alcohol consumption 
assessment, participation rate of 
cases and controls, age of children, 
leukaemia type, control for 
confounding, and additional 
information  
Process for data extraction: Data 
extracted independently by two 
investigators using a standardised 
data collection form, and then 
compared 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Odds ratio  
Assessment of heterogeneity: 
Cochrane Q test and I2 statistic.   
Assessment of publication bias: 
Funnel plots, Egger's test. 
Sensitivity analyses: Analyses 
conducted by type of leukaemia, age 
at diagnosis, alcoholic beverage, and 
pregnancy trimester if at least three 
studies available. 
Dose-response analyses: Dose-
response meta-analyses used method 
proposed by Greenland and 
Longnecker. Dose-response slopes for 
an increment of one drink per week 
were estimated using the midpoint of 
each category of alcohol intake. 
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Lönnroth et 
al., 2008 
Databases searched: PubMed 
Years searched: NR 
Keywords/MESH terms: Alcohol, 
alcoholism, tuberculosis 
Other strategies: Private collection of 
scientific tuberculosis publications; 
screened a report of a systematic 
review of the association between 
smoking and tuberculosis; reference 
lists of all reviewed articles screened. 
Limits: NR 
Population(s): NR 
Exposure: Amount of alcohol intake or 
a clinical diagnosis of an alcohol use 
disorder 
Outcome(s): Active tuberculosis 
Study design(s): Case-control and 
cohort studies 
Process for selection: NR 
Data extraction variables: Setting, 
inclusion criteria of study subjects, 
definition of exposure and outcome, 
mechanisms for ascertainment of 
exposure and outcome, and 
confounders were controlled for. 
Process for data extraction: NR  
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Adjusted odds 
ratio 
Assessment of heterogeneity: Q 
test, I2 statistic  
Assessment of publication bias: 
Funnel plots 
Sensitivity analyses: Excluded three 
studies with highest standard errors. 
Dose-response analyses: NA 
3.5 
Mao et al., 
2010 
Databases searched: Medline, 
PubMed, Web of Science, and the 
Cochrane Library. 
Years searched: 1980-2009 
Keywords/MESH terms: Alcohol, 
bladder cancer 
Other strategies: References of 
reviewed articles and previous reviews 
screened. 
Limits: English language 
Population(s): NR
Exposure: NR 
Outcome(s): Bladder cancer 
Study design(s): Case-control and 
cohort 
Process for selection: NR 
Data extraction variables: Reference 
details, study design, sample size, 
anatomical size of the neoplasm, 
adjusted effect estimates, exposure 
assessment, adjusted covariates. 
Process for data extraction: NR  
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Odds ratio 
(relative risks were assumed to 
approximate to an odds ratio) 
Assessment of heterogeneity: 
Random effect model; Q test, I2 
statistic. Meta-regression used to 
explore influence of study design, 
geographical region, alcohol 
assessment, and publication year. 
Assessment of publication bias: 
Egger and Begg tests. 
Sensitivity analyses: Sex, study 
design, study location, smoking status 
and type of alcohol (beer, wine or 
spirits). 
Dose-response analyses: NR 
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McCambridge 
et al., 2011 
 
 
Databases searched: Medline, Web 
of Knowledge, Global Health Archive, 
CINAHL, PsycInfo, EMBASE and 
Health Management Information 
Consortium 
Years searched: 1964 to 2008 
Keywords/MESH terms: Adolescent, 
teen, young person, young people, 
young adult, alcohol, binge drinking, 
drinking culture, problem drinking, 
drinking problem, hazardous drinking, 
substance, adult, cohort, longitudinal, 
prospective, lifetime  
Other strategies: Citation searching; 
bibliographies of relevant studies 
checked and Science Citation Index 
used for citation searches. Three 
journals were hand searched: 
Addiction Abstracts; Addiction; and 
Journal of Studies on Alcohol and 
Drugs. Experts were contacted for 
further information. 
Limits: Only peer-reviewed published 
data were used 
Population(s): Cohorts formed from 
general population sources. Specific 
populations including children of 
alcoholic parents, mental health 
patients and offenders were excluded 
Exposure: Alcohol consumption 
between ages 15 to 19 years. 
Outcome(s): Behavioural effects (and 
associated harm) at age 20 or greater. 
Study design(s): Cohort studies 
Process for selection: Undertaken 
independently by two reviewers; 
second reviewer was blinded to the 
outcome of the first. 
Data extraction variables: Cohort 
type, age, sample size, follow up rate, 
adolescent behavioural variables, 
adult outcomes 
Process for data extraction: 
Duplicated by a second reviewer.  
Details of QA tool/checklist: Authors 
assessed likelihood of residual 
confounding and whether each study 
had at least one of the following 
characteristics: (1) follow-up rates of 
80% or greater; or (2) sample sizes of 
1,000 participants or more.  
Process for quality assessment: 
Two reviewers undertook assessment, 
disagreements were resolved by 
discussion. 
 
How were studies combined: 
Narrative synthesis; meta-analysis 
was deemed inappropriate  
Measure of effect: NA  
Assessment of heterogeneity: NA 
Assessment of publication bias: NA 
Sensitivity analyses: NA 
Dose-response analyses: NA 
3 
Parsons et 
al., 2009 
Databases searched: Medline, the 
Cochrane Library, Web of Science and 
abstracts from AUA annual meetings 
(2002-2008).  
Years searched: Up to Mar 2008  
Keywords/MESH terms: Prostatic 
hyperplasia, lower urinary tract 
symptoms and alcohol 
Other strategies: Reviewed the 
references of retrieved articles. 
Limits: English language publications 
 
 
Population(s): NR
Exposure: Alcohol intake 
Outcome(s): Benign prostatic 
hyperplasia or lower urinary tract 
symptoms 
Study design(s): Case control or 
cohort study. 
Process for selection: If eligibility 
disagreement occurred, the senior 
investigator made final decision. 
Data extraction variables: Study 
design, outcomes, adjusted effect 
estimates, categories/quantities of 
alcohol intake, and covariates in final 
adjusted models. Pooled analysis – 
total alcohol consumption, exposure 
levels. 
Process for data extraction: NR 
Details of QA tool/checklist: Did not 
use a formal score for quality 
assessment.  
Process for quality assessment: NA 
How were studies combined: Meta-
analysis  
Measure of effect: Relative risk   
Assessment of heterogeneity: Chi-
squared test  
Assessment of publication bias: 
Egger’s test, Begg-Mazumdar test.  
Sensitivity analyses: Repeated 
analyses after substituting different 
measures of intake and excluding 
studies that measured incident benign 
prostatic hyperplasia.  
Dose-response analyses: Not 
applicable 
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Patra et al., 
2010 
Databases searched: Medline, 
EMBASE, CINAHL, CABS, WHOlist, 
SIGLE, ETOH, and Web of Science 
Years searched: Jan 1980 to Jun 
2009 
Keywords/MESH terms: Alcohol, 
ethanol, stroke, cerebrovascular, 
intracranial embolism, thrombosis, 
case, cohort, ratio, risk, prospective, 
follow 
Other strategies: Bibliographies of 
key retrieved articles, relevant reviews 
and meta-analyses were hand 
searched. 
Limits: None 
Population(s): NR
Exposure: Three or more alcohol 
exposure groups 
Outcome(s):Medically confirmed 
ischemic or haemorrhagic stroke 
Study design(s): Cohort or case-
control study 
Process for selection: NR 
Data extraction variables: Study 
details, source of publication, country 
of origin, study design, characteristics 
of the study population, measures of 
outcome and exposure, duration of 
follow-up, confounding factors 
controlled for by matching or 
adjustment, and RR and 
corresponding 95% confidence 
intervals of stroke types, assessment 
of current or life time abstention, and 
level of alcohol consumption. RRs 
were abstracted by sex, subtype of 
stroke (ischemic or haemorrhagic), 
end point incidence (mortality, 
morbidity), and level of alcohol 
consumption. 
Process for data extraction: Five 
included and five excluded studies 
randomly chosen to be abstracted 
independently by a second reviewer. 
Where disagreements existed, both 
authors discussed until a consensus 
was reached. 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk  
Assessment of heterogeneity: 
Cochrane Q test, I2 statistic. 
Assessment of publication bias: 
Visual inspection of Begg's funnel plot; 
Begg–Mazumdar test and the Egger’s 
test 
Sensitivity analyses: Examined 
impact of each stroke type.  
Dose-response analyses: Conducted 
using linear and first- and second-
order fractional polynomials to 
estimate a best fitting curve to the 
data. Best-fit curves or lines were 
assessed using standard goodness-of-
fit statistics with an emphasis on 
reduced deviance (gain) compared 
with the quadratic model. 
5 
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Patra et al., 
2011 
Databases searched: Medline, 
EMBASE, CINAHL, CABS, WHOlist, 
SIGLE, ETOH and Web of Science 
Years searched: Jan 1980  to Jun 
2009 
Keywords/MESH terms: Alcohol, 
ethanol, light drinking, moderate 
drinking, birth weight, low birth weight, 
gestational age, small for gestational 
age, preterm, pregnancy outcome, 
pregnancy complication, prenatal, 
case, cohort, ratio, risk, prospective, 
follow 
Other strategies: Reference lists 
hand searched 
Limits: No language restrictions were 
applied.  
 
 
Population(s): NR
Exposure: Alcohol consumption 
before and during pregnancy 
Outcome(s): Medically confirmed low 
birth weight (<2500 g), preterm birth 
(<37 weeks) and small for gestational 
age (<10th percentile of gestational 
age-adjusted birth weights)  
Study design(s): Case control and 
cohort studies reporting incidence, 
hazard ratios, relative risks or odds 
ratios. 
Process for selection: Reviewed 
independently by two reviewers. 
Discrepancies were resolved in 
consultation with a third reviewer 
 
 
 
 
Data extraction variables: Author 
details, publication year, source of 
publication, country of origin, study 
design, characteristics of the study 
population, measures of outcome and 
exposure, duration of follow-up , 
confounding factors controlled for by 
matching or adjustment, and the risk 
estimates (relative risk or odds ratios 
or hazard ratios) of birth outcomes 
studied, compared with abstainers, 
associated with alcohol consumption 
and the corresponding confidence 
intervals 
Process for data extraction: All data 
were independently extracted by 
means of a standardised protocol. Five 
included and five excluded studies 
randomly chosen to be abstracted 
independently by a second reviewer. 
Where disagreements existed, both 
authors discussed until a consensus 
was reached. 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk  
Assessment of heterogeneity: 
Cochrane Q test, I2 statistic. 
Assessment of publication bias: 
Visual inspection of Begg’s funnel plot; 
Begg–Mazumdar test and the Egger’s 
test  
Sensitivity analyses: Examined type 
of study and compared risks of both 
pregnancy outcomes on pre-
pregnancy (i.e. until pregnancy is 
known) and during pregnancy. 
Dose-response analyses: Conducted 
meta-regression using linear as well 
as first- and second-order fractional 
polynomial regression to estimate a 
best fitting curve to the data (assessed 
using decreased deviance compared 
with the reference model). 
 
 
 
 
5 
Pelucchi et 
al., 2012 
Databases searched: PubMed 
Years searched: Inception to Oct 
2010 
Keywords/MESH terms: alcohol, 
ethanol, bladder, urinary tract, cancer, 
neoplasm, carcinoma, case-control, 
case-control studies, cohort, cohort 
studies, epidemiology 
Other strategies: Reference list of all 
papers of interest screened. 
Limits: NR 
Population(s): NR
Exposure: Considered at least three 
levels of alcohol consumption. 
Outcome(s): OR/RR estimates and 
corresponding CI (or information 
sufficient to calculate them) 
Study design(s): Case-control and 
cohort studies. 
Process for selection: Two authors 
assessed potentially relevant articles. 
Data extraction variables: Study 
design, country, period of enrolment 
and/or follow-up, number of subjects 
(cases, controls or non-cases or 
cohort size), gender, covariates 
adjusted for in the analysis, risk 
estimates for categories of alcohol 
consumption, the number of cases and 
non-cases for each level of alcohol 
consumption considered. 
Process for data extraction: NR  
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk  
Assessment of heterogeneity: Chi-
squared test. 
Assessment of publication bias: 
Sensitivity analyses: Excluded each 
study at a time from the meta-analysis 
Dose-response analyses: NA 
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Peters et al., 
2008 
Databases searched: Medline, 
EMBASE, and PsycInfo 
Years searched: 1995 to Mar 2006. 
Keywords/MESH terms: Alcohol, 
wine, beer, dementia, vascular 
dementia, multi-infarct dementia, 
Alzheimer’s 
disease, cognitive Impairment, 
cognitive decline 
Other strategies: None 
Limits: English language publications 
relating to humans. Authors report that 
all searches were limited to people 
aged 65 years and above. 
 
 
Population(s): People aged 65 years 
and above 
Exposure: Alcohol consumption 
Outcome(s): Incident cognitive 
decline/dementia 
Study design(s): Case control studies 
Process for selection: Two reviewers 
appraised all studies independently; 
discrepancies in decisions were 
discussed. 
Data extraction variables: NR 
Process for data extraction: Content 
was summarised in extraction tables 
independently by two reviewers. 
Details of QA tool/checklist: 
Assessed using ‘standard’ criteria 
assessing key factors (e.g. appropriate 
design, recruitment, analysis, and 
provision of suitable information 
relating to key aspects of the study). 
(Authors refer to Alberta Heritage 
Foundation for Medical Research 
2004) 
Process for quality assessment: NR 
 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk   
Assessment of heterogeneity: NR  
Assessment of publication bias: NR 
Sensitivity analyses: NR 
Dose-response analyses: Not 
applicable 
4.5 
Rehm et al., 
2010 
Databases searched: Medline, 
EMBASE, Web of Science, CINAHL, 
PsycInfo, ETOH and Google Scholar 
Years searched: Jan 1980 to Jan 
2008 
Keywords/MESH terms: Alcohol, 
alcohol consumption, alcohol intake, 
heavy drinking, liver diseases and liver 
cirrhosis 
Other strategies Reviewed content 
pages of major epidemiological 
journals and the searched reference 
lists  
Limits: None 
 
 
Population(s): NR
Exposure: Three or more categories 
of alcohol consumption 
Outcome(s): Clinically defined liver 
cirrhosis morbidity and/or mortality 
(defined as ICD codes: 581 in ICD7 
and 571 in ICD8 and ICD9, and K70, 
K74 in ICD10). 
Study design(s): Case control or 
cohort study 
Process for selection: NR 
Data extraction variables: Study 
details, sample size, country, region, 
ethnicity, age, sex, end-points, 
adjustments, design of the study 
baseline, methods of interview, time 
period of alcohol consumption, number 
of beverages, patterns of drinking, and 
RR with corresponding 95% CIs for 
each category of alcohol consumption. 
Process for data extraction: 
Independently extracted by two 
reviewers. Third reviewer extracted 
data from a random sample of 15 
articles to assess inter-rater reliability. 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk   
Assessment of heterogeneity:  
Cochrane Q-test, I2 statistic  
Assessment of publication bias 
Egger’s test, Begg-Mazumdar test 
Sensitivity analyses: Sensitivity 
analyses were conducted to check if 
this procedure resulted in biased 
results compared with restricting the 
analyses to ‘pure’ categories, and 
excluding studies with ‘mixed’ 
categories.  
Dose-response analyses: Used the 
method proposed by Greenland et al. 
to back calculate and pool study-
specific trend estimates. 
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Roerecke & 
Rehm, 2010 
Databases searched: Medline, 
EMBASE, Web of Science, ETOH, 
National Institute on Alcohol Abuse 
and Alcoholism and AIM. 
Years searched: Jan 1980  to Jul 
2008 (updated to Dec 2008) 
Keywords/MESH terms: Alcohol, 
ethanol, heavy drinking occasion,  
heavy episodic drinking, binge 
drinking, alcoholic intoxication, 
problem drinking, hangover, irregular, 
pattern, inebriation, coronary heart 
disease, coronary artery disease, 
ischemic 
heart disease, ischaemic heart 
disease, myocardial infarction, sudden 
cardiac death, angina pectoris, 
coronary death, case cohort, ratio, 
risk, prospective, follow 
Other strategies: Screened 
references of retrieved articles  
Limits: No language restrictions were 
applied. Peer reviewed publications. 
Population(s): NR
Exposure: Heavy drinking episodes 
(≥60 g or ≥5 standard drinks per 
occasion) or intoxication 
Outcome(s): Ischaemic heart disease 
(defined according to standard WHO 
criteria)  
Study design(s): Cohort or case 
control studies reporting incidence, 
hazard ratios, relative risks, or odds 
ratios 
Process for selection: One reviewer 
assessed inclusion based on titles and 
abstracts; potentially eligible studies 
were screened jointly by two 
reviewers. 
Data extraction variables: Study 
design, endpoint, exposure 
assessment, and adjustment for 
confounders. 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk   
Assessment of heterogeneity: 
Cochrane’s Q-test, I2 statistic 
Assessment of publication bias: 
Examined small study effects. 
Sensitivity analyses: Omitted each 
study separately from the meta-
analyses 
Dose-response analyses: Potential 
dose-response relationship examined 
by including a dummy variable 
representing 9 or more drinks per 
irregular heavy drinking occasion on 
the within-study level. 
 
4.5 
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Roerecke & 
Rehm, 2012 
Databases searched: Medline, 
EMBASE and Web of Science. 
Years searched: Jan 1980 to Apr 
2010 
Keywords/MESH terms: Alcohol 
drinking, alcoholic beverages, 
beverages, alcohol, drinking, intake, 
consumption, ethanol, drinking, intake, 
consumption, myocardial ischemia, 
myocardial infarct, coronary disease, 
heart diseases, coronary artery 
disease, coronary heart disease, 
angina, cardiac death, ischaemic heart 
disease, ischaemic heart disease, 
cardiac event, coronary event, cohort 
studies, epidemiologic studies, follow 
up studies, longitudinal studies, 
prospective studies, case control 
studies, retrospective studies, ratio, 
risk 
Other strategies: Reference lists 
screened for relevant studies. 
Limits: None 
Population(s): NR
Exposure: At least three categories of 
alcohol consumption among current 
drinkers; cover a reference period >2 
weeks for average alcohol 
consumption at baseline; determined 
by at least a combination of usual 
frequency and usual volume or the 
number of drinks in the specified 
reference period. 
Outcome(s): Clinically defined 
ischaemic heart disease morbidity or 
mortality (defined as ICD codes: ICD-
9: 410–414, ICD-10: I20–25) 
Study design(s): Cohort or case 
control  studies 
Process for selection: One reviewer 
assessed inclusion based on titles and 
abstracts; potentially eligible studies 
were screened jointly by two 
reviewers. 
Data extraction variables: Relative 
risk estimates and corresponding 
variances, number of cases and 
controls or people at risk for each 
reported category of average alcohol 
intake (if not directly reported, we 
estimated these based on standard 
formulas)  study design, end-point, 
sex, country, age at baseline, length of 
follow-up, first year of baseline 
assessment and specific adjustment 
for covariates. We converted alcohol 
intake into g/day using the mid-points 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk   
Assessment of heterogeneity:  
Cochrane’s Q test, I2 statistic 
Assessment of publication bias: 
‘Peter’s regression-based test’ 
Sensitivity analyses: Influence of 
single studies was examined by 
omitting studies one by one and re-
estimating the pooled RR.  
Dose-response analyses: Used 
fractional polynomials to derive the 
best-fitting function using the ‘pool first’ 
approach. Goodness-of-fit statistics 
were used to choose the best-fitting 
model. 
 
4.5 
Rota et al., 
2012a 
 
 
Databases searched: Medline 
Years searched: Inception to Sep 
2011 
Keywords/MESH terms: Alcohol 
drinking, 
alcoholic beverages, ethanol, epithelial 
ovarian cancer, epithelial ovarian 
neoplasms 
Other strategies: Reference lists from 
relevant studies, reviews and meta-
analysis screened. 
Limits: NR 
Population(s): NR
Exposure: Alcohol consumption 
Outcome(s): Epithelial ovarian 
cancer; risk estimates and CIs or 
calculable 
Study design(s): Case-control and 
cohort 
Process for selection: NR 
Data extraction variables: Study 
design, country, cancer grading 
(invasive or borderline) and cancer 
histotype, number of subjects, type of 
controls and period of enrolment, 
duration of follow-up, RR estimates 
and CIs, and variables adjusted for in 
the analysis. 
Process for data extraction: NR 
Details of QA tool/checklist: NR  
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risks  
Assessment of heterogeneity: Chi-
squared and I2 statistic 
Assessment of publication bias: 
Contour-enhanced funnel plot and 
Egger's test 
Sensitivity analyses: Conducted 
stratified analyses for study design, 
type of controls, study geographic 
area, cancer grading, cancer 
histotype, reference category and 
studies adjusting for the main potential 
confounding factors (age, parity and 
oral contraceptive use). 
Dose-response analyses: Used 
linear and non-linear meta regression 
models. 
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Rota et al., 
2012b 
 
 
Databases searched: PubMed 
Years searched: Inception to Dec 
2010 
Keywords/MESH terms: Alcohol 
drinking, 
alcoholic beverages, prostate 
neoplasms 
Other strategies: Reference lists of 
potentially relevant articles screened 
Limits: English language 
Population(s): NR
Exposure: Alcohol consumption 
Outcome(s): Prostate cancer; risk 
estimates and CIs or calculable 
Study design(s): NR 
Process for selection: Three authors 
assessed potentially relevant articles 
Data extraction variables: Study 
design, country, period of enrolment, 
number of participants, RR estimates 
and CIs for each level of alcohol 
consumption, and variables adjusted 
for in the analysis 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: Chi- 
squared and I2 statistic 
Assessment of publication bias: 
Contour-enhanced funnel plot and 
Egger's test 
Sensitivity analyses: Excluded one 
study at a time from the analysis. 
Conducted subgroup analyses by 
study design, type of controls, study 
geographic area, reference category, 
and of studies adjusting for main 
potential confounding factors (age, 
race, and smoking). 
Dose-response analyses: Used a 
random effects meta-regression model 
in a nonlinear dose–response 
relationship framework to provide the 
best-fitting two-term fractional-
polynomial model 
3.5 
Samokhvalov 
et al., 2010a 
Databases searched: Medline, 
EMBASE, Web of Science, CINAHL, 
PsycInfo, ETOH, and Google Scholar 
Years searched: Jan 1960 to Sep 
2008 
Keywords/MESH terms: Alcohol,  
alcohol, alcohol consumption, alcohol 
intake, drinking, alcoholism, alcohol 
abuse, alcohol misuse, epilepsy, 
epileptic, seizures 
Other strategies: Major 
epidemiological journals and reference 
lists were reviewed manually. 
Limits: None 
 
Population(s): NR
Exposure: Three or more categories 
of alcohol consumption 
Outcome(s): Epilepsy morbidity or 
unprovoked seizures. Studies on 
primarily alcohol-induced seizures or 
seizures provoked by other factors 
were excluded. 
Study design(s): Case control or 
cohort study reporting hazard ratios, 
relative risks, or odds ratios 
Process for selection: NR 
Data extraction variables: NR 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk   
Assessment of heterogeneity: 
Cochrane Q test, I2 statistic 
Assessment of publication bias: 
Egger’s test, Begg & Mazumdar test 
Sensitivity analyses: NR  
Dose-response analyses: Used 
methods proposed by Greenland and 
Longnecker to back calculate and pool 
risk estimates. First and second 
degree fractional polynomial models 
were fitted to derive the dose-
response curve. The best fitting model 
was selected based on a closed test 
comparison and overall model fit 
assessed using the Q statistic. 
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Reference Search strategy Inclusion criteria Data extraction and QA Methods of analysis AMSTAR 
rating 
Samokhvalov 
et al., 2010b 
Databases searched: Medline, 
EMBASE, Web of Science, CINAHL, 
PsycINFO, ETOH and Google Scholar 
Years searched: Jan 1960 to Apr 
2009 
Keywords/MESH terms: Alcohol, 
alcohol consumption, alcohol intake, 
drinking, alcoholism, alcohol abuse 
alcohol misuse, rhythm, arrhythmia, 
dysrhythmia, tachyarrhythmia, 
bradyarrhythmia, tachycardia, 
bradycardia, conduction, fibrillation, 
flutter, atrial, ventricular, paroxysmal, 
exstrasystol. Performed additional 
broad search using keywords atrial 
fibrillation, rhythm and ‘risk factor’.   
Other strategies: Major 
epidemiological journals and reference 
lists were reviewed manually.  
Limits: None  
Population(s): NR
Exposure: Three or more categories 
of alcohol consumption 
Outcome(s): Medically diagnosed 
onset of atrial fibrillation verified by 
ECG data (according to the diagnostic 
criteria of the International Statistical 
Classification of Diseases) 
Study design(s): Case control or 
cohort studies 
Process for selection: One reviewer 
assessed inclusion based on titles and 
abstracts; potentially eligible studies 
were screened jointly by two 
reviewers. 
Data extraction variables: NR 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk   
Assessment of heterogeneity: 
Cochrane Q-statistic, I2 statistic 
Assessment of publication bias: 
Visual inspection of Begg’s funnel plot, 
Begg–Mazumdar test and Egger test  
Sensitivity analyses: NR 
Dose-response analyses: Used 
methods proposed by Greenland and 
Longnecker to back calculate and pool 
risk estimates. First and second 
degree fractional polynomial models 
were fitted to derive the dose-
response curve. The best fitting model 
was selected based on a closed test 
comparison and overall model fit 
assessed using the Q statistic. 
6 
Samokhvalov 
et al., 2010c 
Databases searched: Medline, 
EMBASE, Web of Science, ETOH and 
AIM 
Years searched: Jan 1980  to Aug 
2009 
Keywords/MESH terms: Alcohol, 
alcohol consumption, alcohol intake, 
ethanol, alcoholism, heavy drinking, 
pneumonia. 
Other strategies: Reviewed reference 
lists of identified studies and review 
articles. 
Limits: None 
 
 
Population(s): NR
Exposure: alcohol consumption  
Outcome(s): Morbidity and/or 
mortality related to community-
acquired pneumonia. (Diagnoses had 
to meet ICD criteria: 480–486 in ICD-
8, 481–486 in ICD-9 and J10–J18 in 
ICD-10). 
Study design(s): Case control or 
cohort study 
Process for selection: NR 
Data extraction variables: Study 
details, sample size, country, region, 
ethnicity, age, sex, endpoints, 
adjustments, study design, methods of 
interview, time-period of alcohol 
consumption, response rates, and 
RRs and corresponding 95% CIs for 
each category of alcohol consumption. 
Process for data extraction: 
Independently undertaken by two 
reviewers, differences were resolved 
with help of a third reviewer. 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk   
Assessment of heterogeneity: 
Cochrane Q statistic, I2 statistic 
Assessment of publication bias:  
Egger’s test  and Begg-Mazumdar test 
Sensitivity analyses: Excluded a 
dataset that contributed 60% of the 
total number of participants. 
Dose-response analyses: Used 
methods proposed by Greenland and 
Longnecker to back calculate and pool 
risk estimates. First and second 
degree fractional polynomial models 
were fitted to derive the dose-
response curve. The best fitting model 
was selected based on a closed test 
comparison and overall model fit 
assessed using the Q statistic. 
5.5 
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Reference Search strategy Inclusion criteria Data extraction and QA Methods of analysis AMSTAR 
rating 
Song et al., 
2012 
Databases searched: PubMed, 
EMBASE, Medline 
Years searched: Inception to Aug 
2011 
Keywords/MESH terms: Alcohol, 
wine, beer, liquor, ethanol, spirit, renal 
cell carcinoma, kidney cancer, renal 
cell cancer, renal adenocarcinoma, 
kidney adenocarcinoma 
Other strategies: Screened 
references from retrieved articles 
Limits: English language 
Population(s): NR
Exposure: Total alcoholic beverage or 
specific alcoholic beverage intake 
Outcome(s): Incident renal cell, 
kidney cancer, renal, or kidney 
adenocarcinoma; risk estimates and 
CIs 
Study design(s): Cohort and case-
control 
Process for selection: Two authors 
independently assessed eligibility 
 
Data extraction variables: Reference 
details, publication year, country, study 
design, study period, participants’ age 
and 
sex, endpoint, exposure assessment, 
and the number of cases and controls 
or person–years for each category of 
alcoholic beverage intake and 
covariates for  adjustment in the 
analysis 
Process for data extraction: NR 
Details of QA tool/checklist: 
Newcastle-Ottawa scale 
Process for quality assessment: 
Each study was assessed 
independently by two authors and 
scores averaged. Discrepancies in >1 
score between two authors were 
resolved by consensus 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk  
Assessment of heterogeneity: Q and 
I2 statistic. A meta-regression analysis 
investigated the association by study 
design, sex, smoking adjustment or 
hypertension adjustment. 
Assessment of publication bias: 
Egger’s test 
Sensitivity analyses: NR 
Dose-response analyses: Examined 
the non-linearity of the relationship 
using restricted cubic splines. 
5 
Sun et al., 
2011 
 
 
Databases searched: Medline, 
EMBASE 
Years searched: Inception to Apr 
2010 
Keywords/MESH terms: Alcohol, 
beer, wine, liquor, lifestyle, 
endometrial cancer, uterine corpus 
cancer, endometrial carcinoma 
Other strategies: References of 
retrieved articles screened 
Limits: English language 
Population(s): NR
Exposure: Alcohol consumption 
Outcome(s): Endometrial cancer 
incidence or mortality, and RR/OR 
estimates 
Study design(s): Prospective or case-
control; adjusted for potential 
endometrial cancer risk factors e.g. 
age, BMI, or parity 
Process for selection: Conducted 
independently by two authors 
Data extraction variables: Reference 
details, year of publication, country, 
years of follow-up or study period, 
study design, type of controls, age 
range of participants,  sample size, 
exposure of alcohol consumption, type 
of alcoholic beverage, covariates, risk 
estimates and 95% CI;  most 
completely adjusted estimate was 
extracted. 
Process for data extraction: Data 
extracted independently by two 
researchers 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random-effects model 
Measure of effect: Relative risk 
Assessment of heterogeneity: Q and 
I2 statistic 
Assessment of publication bias: 
Egger’s test 
Sensitivity analyses: Assessed 
location of the study (US vs. other 
countries), and adjustment for 
hormone replacement 
therapy (HRT) use 
Dose-response analyses: NA 
5.5 
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Reference Search strategy Inclusion criteria Data extraction and QA Methods of analysis AMSTAR 
rating 
Taylor et al., 
2009 
Databases searched: Medline, 
EMBASE, CINAHL, PubMED, CABS 
(BIDS), WHOLIST, SIGLE, ETOH, 
Alcohol In Moderation and Web of 
Science 
Years searched: 1980 to Jan 2008 
Keywords/MESH terms: Alcohol, 
ethanol, hypertension, hypertensive, 
case control, cohort, prospective), 
risks. 
Other strategies: Reference lists of 
retrieved studies were reviewed. 
Limits: None 
 
 
Population(s): NR
Exposure: At least three levels of 
alcohol consumption 
Outcome(s): Hypertension 
(physiological measures, self-report of 
doctor-diagnosed hypertension or 
reported use of hypertensive 
medication were accepted for outcome 
ascertainment) 
Study design(s): Case control or 
cohort study 
Process for selection: NR  
 
Data extraction variables: Levels of 
alcohol exposure, number of cases 
within each exposure level, total 
population at risk at each exposure 
level, adjusted estimates of RR and 
corresponding 95% confidence 
intervals 
Process for data extraction: 
Duplicate extraction undertaken on 
random sample of 15 studies. 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk   
Assessment of heterogeneity: Q and 
I2 statistic 
Assessment of publication bias: 
Begg-Mazumdar test, Egger’s test and 
‘trim and fill’ method.  
Sensitivity analyses: NR 
Dose-response analyses: Best-fitting 
curves were estimated using linear, 
first-order and second-order fractional 
polynomial regression; assessed using 
standard goodness of fit statistics. 
Comparison of curves was made using 
a chi-squared distribution. 
5.5 
Taylor et al., 
2010 
Databases searched: Medline, 
EMBASE, CINAHL, PubMed, CABS 
(BIDS), WHOKIST, SIGLE, ETOH, 
Alcohol in Moderation, Web of 
Science.  
Years searched: Jan 1980 to Nov 
2008 
Keywords/MESH terms: Alcohol, 
case control, case crossover, risk, 
injury, motor vehicle accidents, 
poisonings, falls, suicide, homicide, 
drowning 
Other strategies: Reference lists of 
retrieved studies were reviewed 
Limits: None. 
 
 
 
Population(s): NR
Exposure: Acute alcohol consumption 
Outcome(s): Injury (adopted a broad 
definition with no strict adherence to 
ICD codes or other diagnostic criteria 
required) 
Study design(s): Case control or 
case crossover study 
Process for selection: NR 
 
Data extraction variables: Level of 
alcohol exposures in each study, 
number of cases at each exposure 
level, total population at risk at each 
exposure level, adjusted estimates of 
relative risk and corresponding 95% 
confidence intervals. 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk   
Assessment of heterogeneity: Q-
statistic, I2 statistic  
Assessment of publication bias:  
Begg-Mazumdar test, Egger’s test 
Sensitivity analyses: NR 
Dose-response analyses: Best-fitting 
curves were estimated using linear, 
first-order and second-order fractional 
polynomial regression; assessed using 
standard goodness of fit statistics. 
Comparison of curves was made using 
a chi-squared distribution. 
5.5 
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Reference Search strategy Inclusion criteria Data extraction and QA Methods of analysis AMSTAR 
rating 
Taylor & 
Rehm, 2012 
Databases searched: Medline, 
EMBASE, CINAHL, PubMED, Google 
Scholar, CABS,WHOLIST, SIGLE, 
ETOH, Alcohol in Moderation, and 
Web of Science 
Years searched: Jan 1980 to Dec 
2010 
Keywords/MESH terms: Alcohol, 
case control, case crossover, risk, 
injury, motor vehicle accidents 
Other strategies: Reference lists of 
retrieved studies were reviewed 
Limits: None 
 
Population(s): NR
Exposure: Alcohol consumption  
Outcome(s): Fatal motor vehicle 
injury (adopted a broad definition with 
no strict adherence to ICD codes or 
other diagnostic criteria required) 
Study design(s): Case control and 
cohort study 
Process for selection: NR 
 
Data extraction variables: Level of 
alcohol exposures in each study, 
number of cases at each exposure 
level, total population at risk at each 
exposure level, adjusted estimates of 
relative risk or odds ratios and 
corresponding 95% confidence 
intervals. 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk   
Assessment of heterogeneity: Q-
statistic, I2 statistic 
Assessment of publication bias: 
Begg-Mazumdar test, Egger’s test 
Sensitivity analyses: Post hoc 
sensitivity analysis performed to test 
whether the inclusion of six separate 
data sets had any more influence over 
the pooled estimate than one 
aggregated data set  
Dose-response analyses: Used 
linear and first-order fractional 
polynomial regression of the inverse-
variance weighted data to estimate a 
best fitting curve; assessed using 
standard goodness of fit statistics. 
Comparisons of curves were made 
using a chi-square distribution.  
 
4 
Tramacere et 
al., 2010a 
 
Databases searched: PubMed 
Years searched: Inception to Sep 
2009 
Keywords/MESH terms: Alcohol, 
mouth, oral, pharynx, pharyngeal, 
cancer, carcinoma, neoplasm 
Other strategies: Reference lists of 
potentially relevant articles screened 
Limits: NR 
Population(s): NR
Exposure: At least three levels 
of alcohol consumption 
Outcome(s): Oral and pharyngeal 
cancers; risk estimate and CIs or 
calculable 
Study design(s): Case-control and 
cohort 
Process for selection: Three authors 
assessed potentially relevant papers 
Data extraction variables: Study 
design, country, number of subjects, 
duration of follow-up and type of 
controls, sex, variables adjusted for in 
the analysis, RR estimates for 
categories of alcohol drinking and the 
corresponding 95% CIs and the 
number of cases and non-cases or 
person-years for each level of alcohol 
consumption. 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk 
Assessment of heterogeneity: Chi-
squared 
Assessment of publication bias: NR 
Sensitivity analyses: Examined 
influence of studies using: (i) a 
reference category different from non- 
or occasional drinkers; (ii) reporting 
estimates not adjusted for the main 
risk factors (i.e. sex, age and 
smoking); and (iii) studies in which the 
SE was computed by multiplying the 
crude SE by 1.5. 
Dose-response analyses: Used a 
random-effects meta-regression model 
in a non-linear dose–response 
relationship framework to provide the 
best fitting two-term fractional–
polynomial model 
3 
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Reference Search strategy Inclusion criteria Data extraction and QA Methods of analysis AMSTAR 
rating 
Tramacere et 
al., 2012a 
 
 
Databases searched: PubMed 
Years searched: Inception to June 
2010 
Keywords/MESH terms: Alcohol 
drinking, alcoholic beverages, stomach 
neoplasms 
Other strategies: Reference lists of 
potentially relevant articles screened 
Limits: English language 
Population(s): NR
Exposure: NR 
Outcome(s): OR/RR and 95% CI 
Study design(s): Case-control and 
cohort 
Process for selection: Three authors 
assessed potentially relevant papers 
Data extraction variables: Study 
design, country, number of subjects 
(cases, controls or cohort size), type of 
controls and period of enrolment, 
duration of follow-up, cancer site, sex 
distribution of the study population, 
variables adjusted for in the analysis, 
RR estimates and CIs, number of 
cases and non-cases or person-years 
for each category of alcohol 
consumption 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk 
Assessment of heterogeneity: Chi-
squared test; I2 statistic 
Assessment of publication bias: 
Contour enhanced funnel plot, Egger’s 
test 
Sensitivity analyses: NR 
Dose-response analyses: Used a 
random-effects meta-regression model 
in a nonlinear dose–response 
relationship framework to provide the 
best-fitting two-term fractional-
polynomial model 
4 
Tramacere et 
al., 2010b 
 
 
Databases searched: PubMed 
Years searched: Inception to Mar 
2009 
Keywords/MESH terms: Alcohol, 
pancreas, pancreatic, cancer, 
carcinoma, neoplasm 
Other strategies: Checked reference 
list of all papers of interest 
Limits: English language 
Population(s): NR
Exposure: At three levels of alcohol 
consumption 
Outcome(s): Pancreatic cancer; risk 
estimates and CIs or calculable 
Study design(s): Case-control and 
cohort 
Process for selection: Two authors 
assessed potentially relevant articles 
Data extraction variables: Study 
design, 
country, number of subjects, period of 
enrolment or follow-up, sex, 
confounders controlled for in the 
analysis, risk estimates and CIs, and 
the number of cases and non-cases 
for each level of alcohol consumption. 
Process for data extraction: NR 
Details of QA tool/checklist: Quality 
of each study assessed using 
following criteria: study design (3 
questions), assessment of alcohol 
drinking (4 questions) and analysis (3 
questions). An overall quality score 
was obtained for each study (range 0 
to 10). 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: Chi-
squared; used random effects model 
when significant heterogeneity was 
found. 
Assessment of publication bias: NR 
Sensitivity analyses: Calculated 
summary estimates in strata of sex, 
study design, geographic area, quality 
score, and allowance for tobacco 
smoking. 
Dose-response analyses: Used a 
random-effect meta-regression model 
in a non-linear dose-response 
relationship framework, which 
provided the best fitting two-term 
fractional-polynomial model. 
4 
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Reference Search strategy Inclusion criteria Data extraction and QA Methods of analysis AMSTAR 
rating 
Tramacere et 
al., 2012b 
 
Databases searched: PubMed 
Years searched: Inception to Oct 
2010 
Keywords/MESH terms: Alcohol 
drinking, alcoholic beverages, stomach 
neoplasms, esophageal neoplasms 
Other strategies: Reference lists of 
potentially relevant articles screened 
Limits: English language 
Population(s): NR
Exposure: Alcohol consumption 
Outcome(s): Oesophageal and/or 
gastric cardia adenocarcinoma; risk 
estimate and CIs or calculable 
Study design(s): Case-control and 
cohort 
Process for selection: Three authors 
assessed potentially relevant papers 
Data extraction variables: Study 
design, country, gender, categories of 
alcohol intake considered, RR 
estimates and 95% CIs, adjustment 
variables and the number of cases and 
non-cases or person-years for each 
category of alcohol consumption 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis 
Measure of effect: Relative risk 
Assessment of heterogeneity: Chi-
squared and I2 statistic 
Assessment of publication bias: 
Contour-enhanced funnel plot, Egger’s 
test 
Sensitivity analyses: NR 
Dose-response analyses: Used a 
random effects meta-regression model 
in a nonlinear dose–response 
relationship framework, to choose the 
best-fitting two-term fractional-
polynomial model 
4 
Tramacere et 
al., 2012c 
Databases searched: PubMed 
Years searched: up to January 2011 
Keywords/MESH terms: ‘Alcohol 
drinking’ or ‘alcohol beverages’ and 
‘lymphoma’. 
Other strategies: None  
Limits: English language only. 
Population(s): NR
Exposure: Alcohol consumption  
Outcome(s): Hodgkin lymphoma 
Study design(s): Case control and 
cohort study reporting relative risk or 
odds ratio 
Process for selection: NR 
Data extraction variables: Study 
design, country, sex, cancer type, 
number of participants, types of 
controls, period of enrolment, duration 
of follow up, RR estimates and 95% 
CIs, adjustment variables.   
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Relative risk 
Assessment of heterogeneity: Chi-
squared test and I2 statistic  
Assessment of publication bias: 
Begg-Mazumdar test, Egger’s test 
Sensitivity analyses: NR 
Dose-response analyses: Used a 
random effects meta-regression model 
in a nonlinear dose–response 
relationship framework, to choose the 
best-fitting two-term fractional-
polynomial model 
4.5 
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Reference Search strategy Inclusion criteria Data extraction and QA Methods of analysis AMSTAR 
rating 
Zeisser et al., 
2013 
Databases searched: Medline, 
PsycINFO 
Years searched: 1970 to 2009 
Keywords/MESH terms: Emergency 
room, emergency department, 
accident and emergency and alcohol, 
drinking, alcohol drinking. Broad 
results so refined search to focus on 
injury 
Other strategies: Searches of online 
journals, reference lists and internet 
search (Google, Google Scholar and 
the National Drug Research Institute). 
Key national and international 
researchers were contacted. 
Limits: Peer-reviewed studies 
published in English.  
 
Population(s): Samples drawn 
specifically from Emergency 
Department populations  
Exposure: Self-reported alcohol use 
within 6 hours of injury 
Outcome(s): Injury (applied a broad, 
general definition without strict 
adherence to ICD codes or diagnostic 
criteria). 
Study design(s): Case control or 
case crossover study 
Process for selection: NR 
Data extraction variables: Sample, 
study characteristics, demographics, 
nature of injury(s), alcohol 
consumption  
Process for data extraction: Two 
reviewers independently coded the 
studies and matching and control 
variables. All coding discrepancies 
were discussed in detail. A third 
reviewer checked the coding sheet for 
accuracy, completeness, and 
consistency; any discrepancies were 
discussed until resolved.  
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Odds ratio 
Assessment of heterogeneity: Q-
statistic 
Assessment of publication bias: 
Funnel and precision plots and 
regression analysis (Egger’s test). 
Sensitivity analyses: Meta-
regression examined impact of study 
design and alcohol consumption recall 
period, and gender. 
Dose-response analyses: NA 
5 
Zhu et al., 
2012 
Databases searched: Medline 
Years searched: NR 
Keywords/MESH terms: NR 
Other strategies: NR 
Limits: Full published English-
language papers. 
 
Population(s): NR
Exposure: Alcohol consumption 
Outcome(s): Psoriasis 
Study design(s): Case control studies 
reporting odds ratios 
Process for selection: NR 
Data extraction variables: NR 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Odds ratio 
Assessment of heterogeneity: Chi-
squared  
Assessment of publication bias:  
Egger’s test, visual inspection of 
funnel plots 
Sensitivity analyses: One-way 
sensitivity analyses 
Dose-response analyses: NA 
 
3 
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Table 13. Summary of methods: Mendelian randomisation approach 
Reference Search strategy Inclusion criteria Data extraction and QA Methods of analysis
Chen et al., 
2008b 
Databases searched: Medline, Web of 
Knowledge 
Years searched: Up to Oct 2006 
Keywords/MESH terms: Aldehyde 
dehydrogenase 2, ALDH2, hypertension, 
blood pressure, cardiovascular diseases, 
coronary disease, heart disease, 
coronary artery disease 
Other strategies: Reviewed 
bibliographies of retrieved articles. 
Limits: None 
Population(s): Individuals with ALDH2 
genotype 
Exposure: Alcohol consumption 
Outcome(s): Systolic or diastolic blood 
pressure, hypertension 
Study design(s): NR 
Process for selection: Undertaken 
independently by two reviewers. 
Data extraction variables: First author’s 
name, year of publication, country and 
city in which the study was performed, 
name of the study, study design, number 
and source of participants, sex, method 
of assessment of drinking status, 
categories of alcohol drinking, mean 
alcohol drinking and standard deviation 
by ALDH2 genotype, distribution of 
potential confounding factors by 
genotype with p-values, distribution of 
genotypes among hypertensive and non-
hypertensive participants, mean blood 
pressure and standard deviation by 
ALDH2 genotype, and reported effect 
estimates and 95% confidence intervals 
for ALDH2 genotype and hypertension 
risk. 
Process for data extraction: Used a 
standard protocol for data extraction. 
Carried out independently by two 
reviewers. 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; fixed effects model. Estimates 
of the causal effect of alcohol on blood 
pressure were calculated using standard 
instrumental variable estimation methods. 
Instrument strength was assessed using 
the first-stage F-statistic. 
Measure of effect: Odds ratio 
(hypertension); mean difference (blood 
pressure) 
Assessment of heterogeneity: I2 
statistic 
Assessment of publication bias: 
Egger’s test, Begg-Mazumdar test 
Sensitivity analyses: Repeated 
instrumental variable estimation analysis 
assuming a correlation of 0.2 in all 
genotypes and all studies.  
Dose-response analyses: NA 
Lewis & Davey 
Smith, 2005 
Databases searched: Medline, Web of 
Knowledge 
Years searched: Up to Mar 2004 
Keywords/MESH terms: oesophageal, 
esophageal, ALDH2, aldehyde 
dehydrogenase 
Other strategies: Cited reference search 
of retrieved articles and reviewed 
bibliographies of retrieved articles 
Limits: NR 
Population(s): Individuals with ALDH2 
genotype 
Exposure: Alcohol consumption 
Outcome(s): Oesophageal cancer 
Study design(s): NR 
Process for selection: NR 
Data extraction variables: NR 
Process for data extraction: NR 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: Meta-
analysis; random effects model 
Measure of effect: Odds ratio 
Assessment of heterogeneity: I2 
statistic 
Assessment of publication bias: 
Egger’s test 
Sensitivity analyses: NR 
Dose-response analyses: NA 
 Mapping systematic review level evidence          83 
 
Reference Search strategy Inclusion criteria Data extraction and QA Methods of analysis
Wang et al., 
2011 
Databases searched: Medline, 
EMBASE 
Years searched: Up to May 2010 
Keywords/MESH terms: Colorectal 
neoplasia, colon neoplasia, rectal 
neoplasia; ALDH2 or aldehyde 
dehydrogenase 2; gene or polymorphism. 
Other strategies: Reviewed 
bibliographies of retrieved articles. 
Limits: NR 
Population(s): Individuals with ALDH2 
genotype 
Exposure: Alcohol intake 
Outcome(s): Colorectal neoplasia 
Study design(s): NR 
Process for selection: NR 
Data extraction variables: First author’s 
name, year of publication, country and 
city in which the study was performed, 
age, gender, number and source of 
participants, 487Lys allele frequency in 
controls and drinking status by ALDH2 
genotype. 
Process for data extraction: Two 
reviewers independently extracted data 
from each article. Discrepancies were 
resolved by discussion until consensus 
was achieved. 
Details of QA tool/checklist: NR 
Process for quality assessment: NR 
How were studies combined: 
Cumulative and recursive cumulative 
meta-analyses; fixed effects models 
unless evidence of heterogeneity 
Measure of effect: Odds ratio 
Assessment of heterogeneity: Q 
statistic. I2 statistic 
Assessment of publication bias: 
Egger’s test, Begg–Mazumdar test 
Sensitivity analyses: Limited to studies 
including >500 individuals. 
Dose-response analyses: Not 
applicable 
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Table 14. Summary of methods: Pooled data analyses 
Reference Source of study data Inclusion criteria for sites Data collection Methods of analysis
Borges et al., 
2006 
Project title: Emergency Room 
Collaborative Alcohol Analysis Project 
(ERCAAP); WHO Collaborative Study on 
Alcohol and Injuries (WHO-ER) 
Years of data collection: 1994-2002 
(ERCAAP); 2001-2002 (WHO-ER) 
Number of data sites: 16 (ERCAAP); 12 
(WHO-ER) 
Countries: Argentina, Australia, Canada, 
Mexico, Poland, Spain, USA (ERCAAP); 
Argentina, Belarus, Brazil, Canada, 
China, Czech Republic, India, Mexico, 
Mozambique, South Africa, Sweden, New 
Zealand (WHO-ER). 
 
Population(s): All patients aged 18 and 
older admitted to the emergency room. 
Exposure: Self-reported alcohol 
consumption in the 6 hours prior to the 
injury or illness event; blood alcohol 
concentration (BAC) estimate. Injured 
patients who reported drinking after the 
event and had a positive BAC were 
excluded. 
Outcome(s): Injury 
Process for selection of sites: NR 
Data collected: Reason for ER visit, self-
reported alcohol consumption in the 6 
hours prior to the injury or illness event, 
quantity and frequency of usual drinking 
during the last year, demographic 
characteristics, BAC, per capita 
consumption of ethanol, legal drinking 
age, legal level of intoxication while 
driving, ER type and level of trauma care. 
Process for data collection: NR 
Measure of effect: Relative risk (RR) 
Calculation of effect size: Case-
crossover method was used taking into 
account the amount of expected person-
time exposure to alcohol. The numerator 
of the RR was the summation of 
unexposed hours in the control period 
(last 12 months) among the injury cases 
who reported exposure during the hazard 
period (6-hour prior). The denominator of 
the RR was the summation of exposed 
hours in the control period (last 12 
months) among the injury cases that 
reported no exposure during the hazard 
period (6-hour prior). 
How were studies combined: Meta-
analysis; fixed and random effects model 
Assessment of heterogeneity: Chi-
squared 
Sensitivity analyses: Meta-regression 
examined the influence of site-level 
contextual variables. 
 
Cherpitel et 
al., 2003b 
2003c 
Project title: Emergency Room 
Collaborative Alcohol Analysis Project 
Years of data collection: 1984-1997 
Number of data sites: 30 emergency 
rooms 
Countries: USA, Mexico, Canada, 
Australia, Spain, Italy 
 
Population(s): All patients aged 18 and 
older admitted to the emergency room. 
Exposure: Self-reported alcohol 
consumption in the 6 hours prior to the 
injury or illness event; blood alcohol 
concentration (BAC) estimate. Injured 
patients who reported drinking after the 
event and had a positive BAC were 
excluded. 
Outcome(s): Injury 
Process for selection of sites: Selected 
by the country investigator on the basis of 
the size of geographic area and 
population density covered by the 
emergency room. 
Data collected: Reason for ER visit, self-
reported alcohol consumption in the 6 
hours prior to the injury or illness event, 
quantity and frequency of usual drinking 
during the last year, demographic 
characteristics, BAC, per capita 
consumption of ethanol, legal drinking 
age, legal level of intoxication while 
driving, ER type and level of trauma care. 
Process for data collection: Standard 
25-minute questionnaire 
Measure of effect: Odds ratio 
Calculation of effect size: Linear logistic 
regression controlling for gender and age 
and for gender, age and consuming five 
or more drinks on an occasion at least 
monthly (5+ monthly). 
How were studies combined: Meta-
analysis; fixed and random effects model 
Assessment of heterogeneity: Q-
statistic 
Sensitivity analyses: Analyses were 
repeated with highly influential ERs 
removed. Meta-regression examined the 
influence of site-level contextual 
(organizational and socio-cultural) 
variables. 
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Reference Source of study data Inclusion criteria for sites Data collection Methods of analysis
Collaborative 
Group on 
Hormonal 
Factors in 
Breast Cancer, 
2002 
Project title: Collaborative Group on 
Hormonal Factors in Breast Cancer 
Years of data collection: 1984-2001 
Number of data sites/studies: 65 
Countries: USA, Canada, The 
Netherlands, UK, Australia, Denmark, 
New Zealand, Slovenia, Germany, Italy, 
France, Greece, and other countries not 
specified 
 
Population(s): NR
Exposure: Alcohol intake 
Outcome(s): Incident invasive breast 
cancer 
Study design: Case control and cohort 
studies including at least 100 women 
Process for selection of sites/studies: 
NA 
Data collected: NR 
Process for data collection: NR 
Measure of effect: Relative risk 
Calculation of effect size: Obtained 
from ‘observed minus expected’ values 
by the one-step method. All analyses 
were routinely stratified by study, and 
centre within study; by age; by parity and, 
where appropriate, age when the first 
child was born and age at first birth; and 
by smoking history. 
How were studies combined: Mantel- 
Haenszel stratification technique 
Assessment of heterogeneity: NR 
Sensitivity analyses: Dose-response 
relationship explored by fitting a linear 
trend in the log relative risk of breast 
cancer across increasing categories of 
consumption. In estimating such trends, 
the median consumption within a given 
category was taken to be the level of 
alcohol consumption for that category. 
 
Freudenheim 
et al., 2005 
 
Genkinger et 
al., 2006 
 
Cho et al., 
2004 
Project title: Pooling Project of 
Prospective Studies of Diet and Cancer 
Years of data collection: 1980-1996 
Number of data sites/studies: 7 
Countries: NR 
Population(s): NR. Participants excluded 
if they reported a history of cancer (other 
than non-melanoma skin cancer) at 
baseline. 
Exposure: Alcohol consumption 
Outcome(s): ≥50 incident cases of lung 
cancer 
Study design: Cohort studies 
Process for selection of sites/studies: 
NA 
Data collected: NR 
Process for data collection: Follow-up 
questionnaires and review of medical 
records and linkages with cancer 
registries.  
 
Measure of effect: Relative risk 
Calculation of effect size: Cox 
proportional hazards model; age at 
baseline and the year that the baseline 
questionnaire was returned were 
included as stratification variables. 
Adjusted for smoking status, smoking 
duration, amount smoked, education, 
body mass index, and energy intake. 
How were studies combined: Meta-
analysis; random effects model. 
Assessment of heterogeneity: Q-
statistic 
Sensitivity analyses: Tested whether 
there were differences in the RRs 
between the strata by using meta-
regression. Reclassified never smokers 
in the highest drinking category as former 
smokers. 
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Reference Source of study data Inclusion criteria for sites Data collection Methods of analysis
Morton et al., 
2005 
Project title: International Lymphoma 
Epidemiology Consortium (InterLymph) 
Years of data collection: 1990-2004 
Number of data sites/studies: 9  
Countries: USA, Sweden, UK, Italy 
 
Population(s): NR. Participants known to 
be HIV positive were excluded from 
analyses. 
Exposure: Alcohol consumption 
Outcome(s): Non-Hodgkin’s lymphoma 
(NHL) 
Study design: Case control studies 
Process for selection of sites/studies: 
Voluntary case-control consortium 
established in 2000 to facilitate 
collaboration among major 
epidemiological studies of lymphoma 
worldwide. 
Data collected: NR 
Process for data collection: NR 
 
Measure of effect: Odds ratio 
Calculation of effect size: Unconditional 
logistic regression; controlled for age, 
sex, ethnic origin and socioeconomic 
status. 
How were studies combined: Meta-
analysis; random effects model (inverse 
variance method) 
Assessment of heterogeneity: Chi-
squared test 
Sensitivity analyses: NR  
Purdue et al., 
2009 
Project title: International Head and 
Neck Cancer Epidemiology (INHANCE) 
Consortium 
Years of data collection: 1984-2006 
Number of data sites/studies: 15 
Countries: Italy, France, Switzerland, 
Central Europe, USA, Puerto Rico, Latin 
America, Spain, Ireland, Poland, Canada, 
Australia, Cuba, India, Sudan 
 
Population(s): NR. Individuals with 
missing data on age, sex, or 
race/ethnicity, and participants from the 
India and Sudan centres were excluded.  
Exposure: Alcohol consumption 
(frequency of drinking, duration of 
drinking, and different types of alcoholic 
beverages consumed). 
Outcome(s): Oral cavity, oropharynx, 
hypopharynx, oral cavity or pharynx not 
otherwise specified, larynx, and head and 
neck cancer unspecified. Cancers of the 
salivary gland were excluded. 
Process for selection of sites: NR 
Data collected: NR 
Process for data collection: Study 
interviews conducted face-to-face. 
Measure of effect: Odds ratio 
Calculation of effect size: Unconditional 
logistic regression; controlled for age, 
gender, education, race/ethnicity, study 
centre, pack-years of cigarette smoking, 
years of cigar smoking, years of pipe 
smoking, and consumption frequency of 
other beverages.. 
How were studies combined: Two-
stage random effects modelling approach 
Assessment of heterogeneity: 
Likelihood ratio tests 
Sensitivity analyses: Stratified by 
geographic region. 
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Table 15. Summary of AMSTAR measurement tool assessment 
Author (Year) 
AMSTAR measurement tool criteria
1 2 3 4 5 6 7 8 9 10 11 Score 
Anstey et al., 2009 Can’t 
answer 
Yes Yes No No Yes No NA Yes No Yes 5 
Bagnardi et al., 2001 Can’t 
answer 
Can't 
answer 
Yes No No No No NA Yes No No 2 
Bagnardi et al., 2011 Can’t 
answer 
Can’t 
answer 
No No No Yes No NA Yes Yes Yes 4 
Baliunas et al., 2009 Can’t 
answer 
No Yes No No Yes No NA Yes Yes Yes 5 
Balinuas et al., 2010 Can’t 
answer 
Can’t 
answer 
No No No Yes No NA Yes Partial No 2.5 
Bay & Kesmodel, 2011 Can’t 
answer 
Can’t 
answer 
Yes No No Yes Yes No Can’t 
answer 
NA No 3 
Bellocco et al., 2012 Can’t 
answer 
Can’t 
answer 
No No Yes Yes Yes Yes Yes No Yes 6 
Berg et al., 2008 Can’t 
answer 
Yes Yes No No Yes Yes Can’t 
answer 
Yes No No 5 
Chen et al., 2008a Can’t 
answer 
Yes Yes No Yes Yes Yes Yes Yes Partial No 6.5 
Chong et al., 2008 Can’t 
answer 
Yes Yes Yes No Yes Yes No Yes Partial Yes 7.5 
Corrao et al., 2004 Can’t 
answer 
Yes Yes No No No Yes Yes Yes No Yes 6 
Costanzo et al., 2011 Can’t 
answer 
Can’t 
answer 
Yes No No Yes Yes Yes Yes Yes Yes 7 
Di Castelnuovo et al., 2006 Can’t 
answer 
Can’t 
answer 
No No No Yes No NA Yes No Yes 3 
Fedirko et al., 2011 Can’t 
answer 
Can’t 
answer 
No No No Yes Yes Yes Yes Yes Yes 6 
Henderson et al., 2007a; 2007b Can’t 
answer 
Partial Partial No No Yes Yes Yes Yes NA No 4 
Irving et al., 2012 Can’t 
answer 
Can’t 
answer 
Yes No No Yes No NA Yes Yes Yes 5 
Islami et al., 2010 Can’t 
answer 
Can’t 
answer 
No No No Yes No NA Yes Yes Yes 4 
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Author (Year) 
AMSTAR measurement tool criteria
1 2 3 4 5 6 7 8 9 10 11 Score 
Islami et al., 2011 Can’t 
answer 
Can’t 
answer 
No No No No No NA Yes Yes Yes 3 
Kan et al., 2011 Can’t 
answer 
Partial Yes No No Yes No NA Yes Partial No 4 
Key et al., 2006 Can’t 
answer 
Can’t 
answer 
Yes Yes No Yes Yes Yes Yes Partial No 6.5 
Kodama et al., 2011 Can’t 
answer 
Partial Yes No No Yes No NA Yes Yes Yes 5 
Kool et al., 2009* Can’t 
answer 
Can’t 
answer 
Yes Can’t 
answer 
Partial Yes Yes Yes Yes Na Yes 4.5 
Latino-Martel et al., 2010 Can’t 
answer 
Can’t 
answer 
No Can’t 
answer 
Yes Yes No Na Yes Yes Yes 5 
Lönnroth et al., 2008 Can’t 
answer 
Can’t 
answer 
No No No Yes No NA Yes Partial Yes 3.5 
Mao et al., 2010 Can’t 
answer 
Can’t 
answer 
Yes No Yes Yes No NA Yes Yes No 5 
McCambridge et al., 2011 Can’t 
answer 
Yes Yes No No Yes No NA Yes NA No 3 
Parsons & Im, 2009 Can’t 
answer 
Partial Partial Can’t 
answer 
Can’t 
Answer 
Yes No NA Yes Partial No 3.5 
Patra et al.,  2010 Can’t 
answer 
No Yes No No Yes No NA Yes Yes Yes 5 
Patra et al., 2011 Can’t 
answer 
Yes Yes Can’t 
answer 
No No No Na Yes Yes Yes 5 
Pelucchi et al., 2012 Can’t 
answer 
Yes No No No Yes No NA Yes No Yes 4 
Peters et al., 2008 Can’t 
answer 
Yes Yes Can’t 
answer 
Partial No Partial No Yes Partial No 4.5 
Rehm et al., 2010 Can’t 
answer 
Partial Yes Can’t 
answer 
Partial Yes No NA Yes Yes Yes 6 
Roerecke & Rehm, 2010 Can’t 
answer 
No Yes No No Yes No Na Yes Partial Yes 4.5 
Roerecke & Rehm, 2011 Can’t 
answer 
No Yes Can’t 
answer 
No Yes No Na Yes Partial Yes 4.5 
Rota et al., 2012a Can’t 
answer 
Can’t 
answer 
No No No Yes No NA Yes Partial Yes 3.5 
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Author (Year) 
AMSTAR measurement tool criteria
1 2 3 4 5 6 7 8 9 10 11 Score 
Rota et al., 2012b Can’t 
answer 
Partial No No No No No NA Yes Yes Yes 3.5 
Samokhvalov et al., 2010a Can’t 
answer 
Can’t 
answer 
Yes Can’t 
answer 
No Yes No Na Yes Yes Yes 5 
Samokhvalov et al., 2010b Can’t 
answer 
Partial Yes Can’t 
answer 
Partial Yes No NA Yes Yes Yes 6 
Samokhvalov et al., 2010c Can’t 
answer 
Partial Yes Can’t 
answer 
No Yes No Na Yes Yes Yes 5.5 
Song et al., 2012 Can’t 
answer 
Partial Yes No No Yes Yes No Yes Partial No 5 
Sun et al., 2011 Can’t 
answer 
Yes Yes No No Yes No NA Yes Partial Yes 5.5 
Taylor et al., 2009 Can’t 
answer 
Partial Yes Can’t 
answer 
No Yes No Na Yes Yes Yes 5.5 
Taylor et al., 2010 Can’t 
answer 
Can’t 
answer 
Yes Can’t 
answer 
Partial Yes No NA Yes Yes Yes 5.5 
Taylor & Rehm, 2012 Can’t 
answer 
No Yes Can’t 
answer 
No Yes No Na Yes Yes No 4 
Tramacere et al., 2010a Can’t 
answer 
Can’t 
answer 
No No No Yes No NA Yes No Yes 3 
Tramacere et al., 2010b Can’t 
answer 
Can’t 
answer 
No No No Yes Yes Yes Yes No No 4 
Tramacere et al., 2012a Can’t 
answer 
Can’t 
answer 
No No No Yes No NA Yes Yes Yes 4 
Tramacere et al., 2012b Can’t 
answer 
Can’t 
answer 
No No No Yes No NA Yes Yes Yes 4 
Tramacere et al., 2012c Can’t 
answer 
Can’t 
answer 
No Can’t 
answer 
Partial Yes No NA Yes Yes Yes 4.5 
Zeisser et al., 2013 Can’t 
answer 
Yes Yes Yes No No No Na Yes Yes No 5 
Zhu et al., 2012 Can’t 
answer 
Can’t 
answer 
No Can’t 
answer 
No Yes No No Yes Yes No 3 
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Table 16. Assessment of publication bias 
Study Disease/health 
problem area 
Methods used to assess publication bias Findings from publication bias assessment
Bagnardi et al., 2011 Lung cancer Egger’s test The asymmetry test for publication bias was not statistically significant. 
Baliunas et al., 2009 Type II diabetes Funnel plots; Egger and Begg tests No significant publication bias was detected. 
Balinuas et al., 2010 HIV infection Egger and Begg tests Both the Egger’s and Begg’s tests showed no publication bias (P = 0.526 and P = 
0.067, respectively). 
Chen et al., 2008a Nasopharyngeal 
narcinoma 
Funnel plots Publication bias was not evident in the funnel plots. The authors note that publication 
bias may still be of concern because four studies were excluded that reported an 
association with alcohol drinking but did not present numeric data. 
Chong et al., 2008 Age-related macular 
degeneration 
Visual inspection of funnel plot The funnel plot revealed asymmetry, suggesting that publication bias may be present. 
The authors suggested the presence of publication bias reflected an absence of 
studies with small sample sizes and small or null effects. 
Costanzo et al., 2011 Fatal & non-fatal 
cardiovascular 
events 
Inspection of funnel plots; Egger test The funnel plot analysis was symmetrical for all categories of beer, spirit and wine 
intake, except for the lowest category of wine intake. Three studies which determined 
the asymmetry were excluded in subgroup analyses. 
Fedirko et al., 2011 Colorectal cancer Egger and Begg-Mazumdar tests, trim and fill 
method, and contour enhanced funnel plots 
Authors note that the presence of publication bias was unlikely. 
Irving et al., 2012 Pancreatitis Visual inspection of Begg's funnel plot; Begg-
Mazumdar and Egger tests 
Both tests suggested no significant asymmetry of the funnel plot, indicating no 
evidence of substantial publication bias. 
Islami et al., 2010 Laryngeal cancer Begg and Mazumdar’s test, Egger’s test, funnel 
plots 
No evidence of publication bias. The funnel plot and tests did not suggest significant 
publication bias. 
Islami et al., 2011 Oesophageal 
squamous cell 
carcinoma 
Begg’s and Egger’s tests Egger’s test was marginally significant for light alcohol drinking (p<0.03), however, the 
authors noted that the funnel plot was fairly symmetrical and did not suggest major 
publication bias. The funnel plot and Egger’s weighted regression method did not 
suggest publication bias for moderate alcohol drinking. However, for heavy alcohol 
drinking, both the funnel plot and Egger’s method (p<0.004) suggested significant 
publication bias. The authors report that the elimination of studies contributing to 
publication bias produced results that were qualitatively similar to those of prospective 
studies. 
Kan et al., 2011 Extrahepatic bile 
system cancer 
Begg’s and Egger’s tests There was no evidence of publication bias. 
Key et al., 2006 Breast cancer Funnel plots No evidence of publication bias. 
Kodama et al., 2011 Atrial fibrillation Visual inspection of a funnel plot; Begg and Egger 
tests; “trim and fill” procedure 
Publication bias suggested for heavy alcohol consumption on visual inspection of the 
funnel plot, supported by Egger’s test (p>0.03) but not Begg’s test. Adjusted using the 
trim and fill method; inclusion of four negative unpublished results to produce a 
hypothetically symmetrical funnel plot modestly attenuated the pooled estimate for 
heavy alcohol consumption but it remained statistically significant (p<0.001). 
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Study Disease/health 
problem area 
Methods used to assess publication bias Findings from publication bias assessment
Latino-Martel et al., 2010 Childhood leukemia Funnel plots, Egger's test. No evidence of publication bias. However, the authors note that 12 studies on risk 
factors of childhood leukemia, other than alcohol intake during pregnancy, in which 
maternal alcohol consumption was considered a potential confounder were excluded 
from the review. 
Lönnroth et al., 2008 Tuberculosis Funnel plots Publication bias was suspected for high exposure studies, and three studies with the 
highest standard error excluded. Exclusion modestly attenuated the pooled relative risk 
but it remained statistically significant. 
Mao et al., 2010 Bladder cancer Egger and Begg tests. No evidence of publication bias in any subgroup. 
Parsons & Im, 2009 Benign prostatic 
hyperplasia 
Egger’s test, Begg-Mazumdar test. No evidence of publication bias. 
Patra et al.,  2010 Stroke Visual inspection of Begg's funnel plot; Begg–
Mazumdar test and the Egger’s test 
Publication bias was not detected by either test. 
Patra et al., 2011 Low birthweight, 
preterm birth and 
SGA 
Visual inspection of Begg’s funnel plot; Begg–
Mazumdar test and the Egger’s test 
No evidence of publication bias. 
Peters et al., 2008 Dementia and 
cognitive decline 
Methods not reported. Authors note that publication bias was not indicated by funnel plots and bias indicators 
were non-significant. 
Rehm et al., 2010 Liver cirrhosis Egger’s test, Begg-Mazumdar test Publication bias was not detected by either test. 
Roerecke & Rehm, 2010 Ischaemic heart 
disease 
Examined small study effects. Peters et al.’s test did not indicate presence of publication bias or small-study effects. 
An adjusted effect that assumed the presence of publication bias corresponded to a 
pooled relative risk that was slightly lower than the effects found in the main meta-
analyses. 
Roerecke & Rehm, 2012 Ischaemic heart 
disease 
‘Peter’s regression-based test’ Only one of the models showed evidence of publication bias (women, mortality at 12-
24g/day). Sensitivity analyses omitting studies one by one and re-estimating the 
pooled RR did not reveal any substantial influence of a particular study on the pooled 
effect estimates. 
Rota et al., 2012a Ovarian cancer Contour-enhanced funnel plot and Egger's test No evidence of publication bias, no asymmetry according to the Egger's test. 
Rota et al., 2012b Prostate cancer Contour-enhanced funnel plot and Egger's test No evidence of publication bias, no asymmetry according to the Egger's test 
Samokhvalov et al., 
2010a 
Unprovoked 
seizures and 
epilepsy 
Egger’s test, Begg & Mazumdar test Visual inspections of the funnel plot and both tests revealed no significant asymmetry. 
Samokhvalov et al., 
2010b 
Atrial fibrillation Visual inspection of Begg’s funnel plot, Begg–
Mazumdar test and Egger test 
The funnel plot and both tests showed no evidence of asymmetry. 
 
Samokhvalov et al., 
2010c 
Pneumonia Egger’s test  and Begg-Mazumdar test No evidence of publication bias. 
Song et al., 2012 Renal cell cancer Egger’s test No evidence of publication bias. 
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Study Disease/health 
problem area 
Methods used to assess publication bias Findings from publication bias assessment
Sun et al., 2011 Endometrial cancer Egger’s test No evidence of publication bias.  
Taylor et al., 2009 Hypertension Begg-Mazumdar test, Egger’s test and ‘trim and fill’ 
method. 
Publication bias was not detected by either test. 
Taylor et al., 2010 Injury Begg-Mazumdar test, Egger’s test Publication bias was not detected by either test. 
Taylor & Rehm, 2012 Fatal motor vehicle 
injury 
Begg-Mazumdar test, Egger’s test Publication bias was detected by the Begg’s (p = 0.421) and Egger’s (p = 0.032) tests; 
visual inspection of the funnel plot showed scarcity of studies reporting lower or null 
effects. 
Tramacere et al., 2012a Gastric cancer Contour enhanced funnel plot, Egger’s test No evidence of publication bias. 
Tramacere et al., 2012b Oesophageal and 
gastric cardia 
adenocarcinoma 
Contour-enhanced funnel plot, Egger’s test No evidence of publication bias. 
Tramacere et al., 2012c  Hodgkin lymphoma Begg-Mazumdar test, Egger’s test No evidence of publication bias. 
Zeisser et al., 2013 Injury Funnel and precision plots and regression analysis 
(Egger’s test). 
The funnel plot indicated substantial asymmetry and therefore publication bias. The 
authors note that this asymmetry was largely attributable to one study with a large 
effect size and standard error (0.902). After exclusions of this study the funnel plot no 
longer showed evidence of significant publication bias. 
Zhu et al., 2012 Psoriasis Egger’s test, visual inspection of funnel plots No evidence of publication bias. 
 
 
 Mapping systematic review level evidence   
   
   
 93 
 
 Mapping systematic review level evidence   
   
   
 94 
 
  
 
 
